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 Mycobacterium tuberculosis, the causative agent of the infectious disease 
Tuberculosis, is one of the most successful human pathogen. The disease remains a global 
health priority due to the spread of HIV and multidrug resistant strains. Therefore, there is 
a need to extend the understanding of the physiology and pathogenicity of M. tuberculosis 
in order to develop new therapies, antimicrobial drugs and vaccines. 
 Mycobacterium possesses a unique cell envelope responsible for the reduced 
susceptibility to antibiotics and pathogenicity due to the high lipid content. It is composed 
by the plasma membrane, an unusual lipid-rich cell wa and an outermost layer known as 
the capsule. Moreover, other complex metabolites play a role in M. tuberculosis virulence 
such as inorganic polyphosphate, a polymer involved in stringent response and long term 
survival. In this study, a transposon mutant library was generated in order to identify new 
genetic determinants related to cell envelope; furthermore, specific mutants strains were 
generated to investigate the role of MmpL factors in mycolic acids transport, to test the 
role of a group of ABC-transporters in capsule biosynthesis and also to assess the function 
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1.1 OVERVIEW  
 
 Tuberculosis (TB) is an infectious disease that afflicts human and is caused by the 
bacterium Mycobacterium tuberculosis. It can develop as a pulmonary and extrapulmonary 
disease; the first one corresponds to the most common type which affects the lungs, whilst 
the second one can target several other organs and tissues. The transmission of the disease 
occurs by direct contact from person to person, via bacilli expelled through the air.  
 The problem of TB as global health crisis was highlighted in 2011 by the World 
Health Organisation (WHO), who placed it as the second causal agent of death by 
infection, only surpassed by the human immunodeficien y virus (HIV), with 1.4 million 
TB deaths reported (430,000 HIV-associated TB deaths). The statistics also showed 9 
million new cases (Fig. 1.1) and an estimated prevalence of 12 million cases. 
Geographically, the estimated number of cases occurred mainly in Asia (59%) and Africa 
(26%), with some cases in the Eastern Mediterranean r gion (7.7%) and a few in Europe 
(4.3%) and the Americas (3%). While 3.7% of new TB patients in the world have been 
diagnosed with multidrug-resistant strains (MDR-TB), the levels are much higher in 
individuals previously treated (20%). Moreover, extensively drug-resistant TB (XDR-TB) 
represents 9% of MDR-TB cases and it has been identified in 84 countries (WHO, 2012). 
 





Figure 1.1: Estimated number of new TB cases in the year 2011 (used with permission from WHO, 2012). 
 
 
1.2 HISTORY OF TB 
 
 The genus Mycobacterium is estimated to have appeared more than 150 million 
years ago. An ancestral strain of M. tuberculosis was proposed to have been present in East 
Africa 3 million years ago suggesting that early hominids may have been a host. Written 
texts have been found describing TB in India as early s 3,300 years ago and in China 
2,300 years ago (Gutiérrez et al., 2005; Daniel, 2006); moreover, typical skeletal 
abnormalities of TB in ancient Egyptian mummies together with molecular evidence 
indicate the disease has been a burden throughout te whole human era as well (Nerlich et 
al., 1997; Crubézy et al., 1998). The first documented account of TB emerged around 460 
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BC, it was called “phthisis” by ancient Greeks and considered the most widespread disease 
of the times by Hippocrates who described tuberculosis and understood its clinical features 
(Coar, 1982). Between the 17th and 19th centuries became the principal cause of death in 
Europe reaching the highest mortality rates and even though pulmonary form of the TB 
was established as pathology with several symptoms by R. Morton in 1689, although it was 
not clasiffied and described as a disease until 1810 by G.L. Bayle. The disease was not 
named tuberculosis until 1839 by J.L. Schönlein (Bayle, 1810; Schönlein, 1839; Daniel, 
2006). Finally, in 1882, Hermann Heinrich Robert Koch identified the tubercle bacillus 
demonstrating it was the causative factor of the dis ase. For this work, he was awarded the 
Nobel Prize in Medicine or Physiology in 1905 (Koch, 1882; Daniel, 2005). 
 Although several therapies and techniques were attempted to prevent TB over the 
years, it was not until 1921 when Albert Calmette and Camille Guerin accomplished a 
successful attenuation of the aetiological agent of bovine form of TB, Mycobacterium 
bovis. They developed a vaccine called Bacille Calmette-Gu rin (BCG) that was used in 
humans (Calmette, 1928) and remains the only vaccine in use today regardless its partial 
efficacy. This changed drastically with the introduction of chemotherapy, the discovery of 
paraaminosalicylic acid and thiosemicarbazone during the Second World War resulted the 
first agents with bacteriostatic effects for treating TB patients. After its isolation in 1944, 
streptomycin was used as the first bactericidal drug against the bacteria (Schatz et al., 
1944; Hinshaw and Feldman, 1945) followed by the first oral drugs, isoniazid and 
rifamycins in 1952 and 1957, respectively. Together, these drugs accomplished effective 
public health measures against the disease and includ g curing latent tuberculosis infected 
patients (Daniel, 2006). Nowadays, access to TB care h s expanded substantially since the 
mid-1990s, when the World Health Organisation launched a new global strategy and began 
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systematically monitoring the progress of the disease together with the development of 
new drugs and new vaccines. However, the global burden of TB remains enormous and the 
response to MDR-TB and XDR-TB is still slow (WHO, 2012). 
 
 
1.3 ORIGINS AND EVOLUTION OF Mycobacterium tuberculosis  
 
 Mycobacterium is a genus of the Actinobacteria phylum, which contains around 
120 described species, the majority of which are saprophytic soil species. Within the genus 
Mycobacterium, there is a small and closely related group known as the Mycobacterium 
tuberculosis complex (MTBC), which includes seven species and subspecies of both 
human and veterinary significance because they cause similar pathologies in various 
mammalian hosts, i.e., Mycobacterium canettii, Mycobacterium africanum, 
Mycobacterium pinnipedii, Mycobacterium microti, M. bovis (Brosch et al., 2002; Smith et 
al., 2006a; Ventura et al., 2007). Typical MTBC members, show more than 99.9% 
sequence similitude at nucleotide level, virtually identical 16S rRNA sequences and a strict 
clonal population structure, with little or no evidence suggesting exchange of chromosomal 
DNA (Smith et al., 2006b). 
 M. tuberculosis is a Gram-positive bacterium which possesses a cell wall with high 
amount of lipids which is distinctive of some members of the order Actinomycetes such as 
Corynebacterium, Mycobacterium, Nocardia and Rhodococcus, all of which containing 
characteristically high proportions of guanine and cytosine in their genomes (Woese, 1987; 
Brennan and Nikaido, 1995). Despite its classification as a Gram-positive, the cell wall of 
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M. tuberculosis is impervious to Gram-staining reagents. Instead, more abrasive “acid-
fast” detection techniques are used to stain mycobacteri  (Minnikin, 1982).   
 As mentioned before, members of MTBC show poor genetic and allelic variation, 
therefore the general consensus indicates that the modern members of the complex would 
have a single African ancestor that resulted from a so-called “evolutionary bottleneck” that 
evolved in a clonal fashion around 35,000 years ago (Sreevatsan et al., 1997; Brosch et al 
2002; Gutiérrez et al., 2005). Nevertheless, genomic analysis of the group reveals that 
previous horizontal gene transfer events originated the arrangement of M. tuberculosis 
genome and also the existence, approximately 3 million years ago, of an ancient wider 
group of species from where MTBC evolved (Gutiérrez et al., 2005; Smith et al., 2009).  
 Existing strains of M. tuberculosis can be clustered in six major lineages 
geographically distributed and whose diversity, calculated using the mutation rate, should 
have been developed 250 to 1000 years before (Hirsh et al., 2004; Gagneux et al., 2006). 
Despite the similarities, it is yet possible to differentiate amongst members of the MTBC, 
discriminating by deletions, single nucleotide polymorphisms (SNPs), the distribution of 
variable regions or mutations (Mostowy et al., 2002; Tsolaki et al., 2004). Moreover, these 
molecular peculiarities can be used to elucidate the evolutionary scenario faced by the 
members of the genus, for instance, while the deletion of chromosomal region of 
difference 9 (RD9) allows to classify strains as animal-adapted, the M. tuberculosis 
deletion TbD1 defines the modern strains and both support the idea that M. tuberculosis 
likely evolved to M. bovis (Brosch et al., 2002). The idea that TB evolved as a zoonosis 
comes from work done on now extinct animals: mycobaterial lipid biomarkers have been 
detected in 17,000 years old bone samples from an exti ct  bison, which is much older than 
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the oldest human remains (9,000 years old) shown to contain traces of the TB bacillus (Lee 
et al., 2012). 
 
 
1.4 BIOLOGY AND PATHOGENESIS OF Mycobacterium tuberculosis  
 
 As an airborne disease, the bacterium is transmitted through aerosols, by which M. 
tuberculosis bacilli are inhaled and penetrate the lungs. Even though TB targets any tissue 
or organ, the respiratory tract corresponds to the main site of entry and, therefore, the most 
important place of disease appearance, since extra pulmonary TB accounts for not more 
than 10% of all cases (Kaufmann, 2001; Smith et al., 2009).  
 Inhaled M. tuberculosis faces a very special immunological unit formed by both the 
respiratory tract and the bronchoalveolar spaces. In this compartment, tissue-specific cells 
and interactions form the first-line defence, where humoral factors (surfactant proteins A–
D) and other effectors activate alveolar macrophages. Moreover, a local immune response 
takes place under the control of dendritic cells (DC) and macrophages (Kaufmann, 2001; 
Holt et al., 2008; Schwander and Dheda, 2011). Normally, most of people succeed 
controlling the primary infection via a cell-mediated immune response; although 5-10% of 
the cases develop the disease (Stewart et al., 2003).  
 
1.4.1 Binding of M. tuberculosis to alveolar macrophages 
 Intimate pathogen–macrophage contacts occur inside the alveoli by specific 
receptor-ligand interactions as part of the innate immunity, where M. tuberculosis 
components, such as polysaccharides and glycolipids, are recognised by the receptor of the 
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host. On the other hand, in vitro analysis have demonstrated that M. tuberculosis binds to 
mononuclear phagocytes opsonically via the receptors, CR1, CR3, CR4 and the surfactant 
protein A receptor (SpA-R), and also non-opsonically to the miceoglial mannose receptor 
(MR) and CD14, and possibly to macrophage scavenger receptors. The list of diverse 
ligands that the pathogen displays on its surface, including β-glucans, mannose, fucose, 
mannan, lipoarabinomannan (LAM) or Man-LAM, engage multiple receptors on the host 
simultaneously (Ehlers and Daffé, 1998; Ernst, 1998), such as Toll-like receptors, group 
that sense a wide diversity of molecule like lipoprotein, phosphatidylinositol mannans 
(PIMs) and lipomannan (LM) in the case of TLR2, or f reign DNA in the case of TLR9 
(Bafica et al., 2005), the receptor repertoire also includes C-type lectin receptors (CLR) 
(Tanne et al., 2009), dectin 1 (Rothfuchs et al., 2007), the mannose receptor (Court et al., 
2010) and mincle (Schoenen et al., 2010), playing an major role in the production of 
cytokines and in the inflammatory response (Dorhoi et al., 2010; Ernst, 2012) (Fig. 1.2).   
 
1.4.2 Innate immune response following infection of macrophages 
 Once infected, alveolar macrophages release a set of antimicrobial molecules such 
as pro-inflammatory cytokines, which activate both local and systemic responses in 
different ways; for instance, while the production f tumour necrosis factor (TNF), 
lymphotoxin (LT) promotes the expression of chemokines recruiting inflammatory cells to 
the lung (Fig. 1.2) (Cooper et al., 2011), the production of vimentin mediates lysis of 
infected cells by NK cells (Garg et al., 2006). These factors govern innate immune 
responses and provide the basis for the specific immunity by inducing activation of 
antimicrobial activity in macrophages, the migration f activated phagocytes to the lymph 
nodes, the recruitment and maturation of DCs and fially the arrival of antigen-specific T 
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lymphocytes to the site of infection (Stenger, 2005; Cooper, 2009). In the case of infection 
involving M. tuberculosis the adaptive immune response is crucial due to the delayed 





Figure 1.2: Molecular and cellular bases of immune response against M. tuberculosis. The diagram shows 
innate cytokines production by infected cells and immune system cells acting during initiation, expansio  and 
chronic stages of TB. At the infection site the antimicrobial activity is carried out by the phagocytes producing 
IFN-γ, TNF, LT and IL-1R1, while IL-12p80 promotes migration of activated DCs to the lymph node, to start the 
adaptive immune response. In the lymph node, the typ of cytokine determine the function of the T cell. IL 
regulate protective and inflammatory responses at different stages. IFN- γ, interferon-γ; IL, interleukin; LT, 
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 In mice infected with M. tuberculosis, antigen-specific T cell response can be 
observed 11–14 days post-infection. Initially, the activated DCs migrate from the infection 
place to the lymph node to start the acquired immune process by presenting the antigen to 
the naive T cells (Tailleux et al., 2003). The activation of T cells and the initiation of the 
acquired immune response to M. tuberculosis is delayed, likely due to the impaired 
migration of infected DCs (Wolf et al., 2008; Blomgran and Ernst, 2011). 
 Contradictorily, the first steps of the general response against mycobacteria 
infection seem to provide favourable cellular conditions to the bacillus, as once engulfed, 
the pathogen can regulate both trafficking and maturation of phagosomes, evading the 
lysosomally mediated antimicrobial mechanisms. Furthermore, no anti-mycobacterial 
activity has been detected in CD4+ T cells on the first 7 days of infection. In this scenario, 
the role of the innate immune response to the M. tuberculosis infection seems more to set 
up favourable conditions to the adaptive T cell response rather than a prompt antimicrobial 
reaction (Gallegos et al., 2008; Ernst, 2012).      
 
1.4.3 Adaptive immune response to M. tuberculosis 
 The survival to mycobacterial infection strictly depends on the development of an 
efficient adaptive immune response. Regardless the correct activation of the immune 
system, M. tuberculosis is still able to overcome the defensive mechanisms, since the 
bacillus limits both phagocytes and macrophage action (Cooper, 2009).        
 The role of CD4 and CD8 T lymphocytes in the control of M. tuberculosis 
dissemination in the lung has been demonstrated; th bacterium induces a broad immune 
response that requires the participation of unconventional T cells as well as conventional T 
cells (Kaufmann, 2001). Both CD4+ and CD8+ T cells have shown a role in fighting M. 
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tuberculosis infection due to their cytotoxic ability (Tan et al., 1997). Mycobacteria-
specific CD4+ T cells are typically of the Th1 type, which is a potent producer of IL-12 
and IFN-γ, both of which are critical in actimicrobial-mycobacterial activities of 
macrophages (Cooper t al., 1997a; Cooper et al., 2011), while Th2 cytokines, such as 
interleukin IL-4 and IL-10 are scarce, though not fully absent (Lin et al., 1996). On the 
other hand, CD8+ T cells, which can also produce IFN-γ, play an essential role killing M. 
tuberculosis-infected cells (Serbina and Flynn, 2001). The lymphocyte-mediated 
cytotocixity has been described to occur via two mechanisms. First, by exocytosis of 
cytotoxic granules such as perforin or granzyme, and secondly,and second by the CD95 
(Fas) apoptotic pathway (Nagata, 1999; Cooper et al., 1997b). During M. tuberculosis 
infection, the lysis of infected macrophages by CD8+ T cells takes place using both 
mechanisms (Canaday et al., 2001; Lazarevic and Flynn, 2002; Carranza et al., 2006; 
Woodworth et al., 2008).    
 The desire effects of developing an adaptive immune response during the M. 
tuberculosis infection are the control of the bacterial growth and the eradication of the 
pathogen. Although, after an infectious episode, comm nly the humans become 
asymptomatic but develop a latent infection (Ernst, 2012). 
 
1.4.4  Granuloma and persistent bacteria 
 As the bacterial load increases, T cells first migrate to the site of infection where 
they attract and activate more macrophages in an attemp  to eradicate the pathogen and 
leading to the formation of a granulomatous lesion. A chronic inflammatory tissue 
response is causative of the granuloma and is initiated by either an infectious agent or a 
non-infectious factor. Aggregates of host cells such as macrophages, DCs as well as 
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lymphocytes B and T (at later stages of formation) all contribute to the granuloma structure 
(Kaufmann, 2001; Ernst, 2012).   
 The chronic M. tuberculosis infection implies that the bacterium overcomes the 
immune response. M. tuberculosis has developed several systems to avoid the antibacteri l 
features of the macrophages, allowing it to live and replicate in a protected intracellular 
environment where controlling the macrophage death pathway constitutes one of the 
pathogen survival mechanisms (Behar et al., 2010). An interesting strategy shown by 
virulent M. tuberculosis strains is the prevention of apoptosis while inducing the necrotic 
death of infected cells. Several studies has partially described how the pathogen 
accomplishes that task, but the mechanisms are still no  totally clear; for instance, the 
bacteria suppresses TNF and induces the production of both lipoxin A4 (LXA 4) (Chen et 
al., 2008) and leukotriene B4 (LTB4) (Fig. 1.2) modulating the response of phagocytes and 
eliminating their protective action (Wada et al., 2006; Cooper et al., 2011). Additionally, 
ESX1 also recruits new macrophages and contributes to the development of the 
granulomas   (Davis and Ramakrishnan, 2009) unlike it happens during a normal infection, 
where the macrophages undergo apoptosis mediated by TNF in vitro (Keane et al., 1997). 
In terms of the structure, M. tuberculosis is shielded by a singular lipid-rich cell wall tha is 
composed of long chain fatty acids and glycolipids which contribute to its capacity to 
survive in host phagocytes, and that also provide the source of glycolipid antigens for a 
specialized population of T-cells (Daffé and Draper, 1998).  
 An effective control of the M. tuberculosis infection requires a continuous supply 
of immune effectors to granulomas, it has been demonstrated that defective trafficking of 
monocytes and DCs cells is related to a poor control of the infection, allowing granuloma 
formation and TB reactivation (Scott and Flynn, 200). Therefore, an enhancement in the 
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cell migration confers more resistance to the infection and also control of the chronic 
disease, as it occurs in CXC-chemokine receptor 3 (CXCR3)-deficient mice (Chakravarty 
et al., 2007). In the case of humans, both active infection and the reactivation of the disease 
have been associated to polymorphisms in genes encoding chemokines and their receptors, 
indicating that the proper traffic of effectors is crucial for the control of the disease (Flores-
Villanueva et al., 2002; Ernst, 2012). 
 The immune response against different mycobacterial species infection shows 
different features compared to M. tuberculosis, this fact also occurs between different 
strains. The genetic variability of the pathogen allows the strains to show several 
mechanisms of action in order to control immunity differentially, including the 
dissemination by using the inflammatory response (Cooper, 2009). Following 
phagocytosis, the environment and immune state of the host determine how the infection 
progresses under mechanisms yet to be determined. The granuloma consists in an 
important structural unit since it is there where th ransition, from a disease with latent 
and subclinical characteristics into an active infection, occurs; at this stage sequestration 
takes place, the bacterium induces an alteration of host lipids biosynthesis, and the 
elimination of the non-replicating bacilli does not take place. Moreover, the pro-
inflammatory response induces a macrophages and mononuclear cells recruitment into the 
infected tissue, that later will form a stratified structure composed by foamy macrophages 
and phagocytes inside a fibrous cuff surrounded by lymphocytes (Russell, 2007; Russell et 
al., 2009). The features presented by granuloma during latency are different depending on 
the phase of the infection, and three major types can be described: solid granuloma 
containing bacilli and necrotic granuloma observed on early phases of active disease and 
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caseous granuloma observed at later phases or during severe infection (Fig. 1.3) (Reece 
and Kaufmann, 2011; Gengenbacher and Kaufmann, 2012). 
 
 
Figure 1.3: Progression of the human tuberculosis granuloma. Diagram showing the stages of 
formation of granuloma in the lung.  Phagocystosis f bacilli in the alveoli induces a pro-inflammatory 
response which triggers the recruitment of macrophages and mononuclear cells to the site of infection 
which form the early phase of granuloma together with foamy macrophages that will finally end up 
covered by a fibrous capsule surrounded by lymphocytes. Latter stages of granuloma upon an active 
infection will exhibit caseous and necrotic tissue (Adapted with permission from Russell t al., 2009. 
Confirmation Nº 11128999). 
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 Upon an active infection, latter stages of granuloma exhibit accumulation of 
caseous tissue that develops to necrosis and finally ends up in the collapse and rupture of 
the granuloma, releasing virulent bacteria and disseminating the disease (Fig. 1.4) (Kaplan 





Figure 1.4: Phases of M. tuberculosis infection. Diagram showing the cycle of TB infection in humans and 
indicating immunological, clinical and epidemiological distinctive features of each stage of the disease.  
PAMP: pathogen associated molecular pattern; TNF: tumor necrosis factor. (Adapted with permission from 
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1.4.5 Adaptation of M. tuberculosis to the intracellular environment 
 In addition to the mechanisms previously stated, the success as a pathogen 
exhibited by M. tuberculosis lies in the ability to shut down its metabolism and vital 
functions during the intracellular life, where host-pathogen interactions are still not well 
understood. The dormancy state developed confers an extremely high capacity to resist the 
defensive mechanisms of the host and also drug treatments, key factors in the survival and 
persistence shown by M. tuberculosis (Gengenbacher and Kaufmann, 2012).  
 The progression of a primary infection can lead to three different pathways: active 
disease, latent infection or eradication. The resultant situation depends on the response of 
the host at cellular level, where the pathogen faces a variety of drastic conditions that are 
usually impaired in immunocompromised individuals, in whom the risk of active disease is 
highly increased (Barry et al., 2009).  
 The phagosomal conditions faced by M. tuberculosis after phagocytosis 
corresponds to a nitrosative, oxidative, hypoxic and poor in nutrients environment, where 
bacteria modifies its metabolism in order to survive (Schnappinger et al., 2003). The 
adaptive repertoire includes the modification of pathways and also the utilisation of host-
derived molecules, with crucial roles in virulence. In the first case, for instance, there have 
been reported the upregulation of lipid metabolism genes (Brzostek et al., 2007), the 
utilisation of lipids via glyoxylate cycle (McKinney et al., 2000), carbon dioxide fixation 
via anaplerotic reactions (Beste et al., 2011) and the critical role of gluconeogenesis in 
dormancy (Marrero et al., 2010); on the other hand, M. tuberculosis has been shown to 
utilise host molecules as nutrients, such as  cholesterol that is crucial in the maintenance of 
chronic infection (Pandey and Sassetti, 2008) and also triacylglycerol (Daniel et al., 2011). 
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 To tolerate the acidic environment within the phagolysosome, M. tuberculosis has 
has developed several mechanisms, such as excluding the host proton ATPase or by 
secreting urease (Reyrat et al., 1995; Sturgill-Koszycki et al., 1994). Moreover, the cell 
wall integrity is crucial in the survival under this harsh condition, since it has been 
demonstrated that resistance to elevated acidic stress is a desirable feature in order to 
succeed as a pathogen inside the late phagolysosome (Vandal et al., 2008; 2009). 
 The defensive mechanisms against M. tuberculosis displayed inside the phagosome 
also includes the production of both oxygen and nitrogen reactive species (ROS and RNS, 
respectively). Two crucial enzymes have been described related to these functions, namely 
phagocyte oxidase (NOX2) which produces hydroxyl radic ls (Bedard and Krause, 2007) 
and the inducible nitric oxide synthase (iNOS), which produces nitrate and nitrite (Nathan 
and Shiloh, 2000). In order to avoid the toxic effect caused by ROS and NOS, two 
mechanisms have been described, namely detoxification and damage repair. In the first 
case, involving enzymes such as catalase peroxidase, sup roxide dismutases, NADPH-
dependent peroxidases or peroxynitrite reductase; while in the second mechanism the 
strategy consists in the substitution of molecules by ynthesis de novo and the degradation 
via proteosome (Gengenbacher and Kaufmann, 2012). 
 During the last few years, a new adaptive mechanism to intracellular life has been 
described in M. tuberculosis consisting in a metal detoxification system used by the bacilli 
to counteract the zinc poisoning response developed by macrophages. The gene ctpC 
encodes for a putative zinc efflux pump and it has been characterized as crucial microbial 
virulence determinant, since its absence produces hypersensitivity to zinc poisoning 
(Botella et al., 2011; 2012). 
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 It is likely that unfavourable conditions inside the granuloma induce the metabolic 
downshift that leads M. tuberculosis into the dormancy state, nutrient starvation models 
have shown an arrested growing-machinery along withdecreased respiration rates, low 
intracellular ATP levels and increased resistance to isoniazid, metronidazole and 
rifampicin (Betts et al., 2002), moreover, as it occurs with LuxR family transcription factor 
gene, a deletion reported to be involved in recovery from dormancy state during 
anaerobiosis have shown not to be related to bacteri l growth and long term survival under 
aerobiosis (Fang et al., 2013), During oxygen starvation, the upregulation f lipid 
metabolism genes occurs as well, hypoxic non-replicating BCG cells have shown to 
accumulate triacylglycerol forming intracellular droplets that are required for reactivation 
(Low et al., 2009). The adaption during the hypoxic state is carried out by the DosS/DosT-
DosR regulation complex, shifting the bacteria metabolically from the aerobic to the 
anaerobic status, controlling the reverse process and responding to NO and CO as well 
(Kumar et al., 2007). Therefore, active growth and persistent state  are seemingly 
disengaged processes, supporting the fact that TB drugs targeting active growth normally 
fail to eradicate non-growing M. tuberculosis (Gengenbacher and Kaufmann, 2012).  
 Studies have shown that the growth of M. tuberculosis is also restricted under 
phosphate limitation but, interestingly, the genes encoding for polyphosphate kinase and 
ppGpp synthetase, ppk1 and relA respectively, have been found to be upregulated during 
phosphate starvation, along with inorganic polyphosate accumulation and triggering the 
stringent response (Rifat e al., 2009). Due to the phosphate-limited environment inside the 
macrophage phagosomes, it can envisage that polyphosphate plays an important role in 
persistence by acting as a phosphate store and source of phosphate molecule when 
studying M. tuberculosis persistence. 
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 The infection with M. tuberculosis in dormant stage produces a disease without 
clinical manifestation, the reactivation occurs by the re-establishing of both metabolic and 
replicative machinery. A few factors regarding regrowth have been described, such as 
resuscitation-promoting factor (Rpf) which has shown to have lysozyme activity in 
Micrococcus luteus (Cohen-Gonsaud et al., 2005) and implicated in resuscitation from 
dormancy in M. tuberculosis (Kana et al., 2008), as well as factors related to degradation 
of the cell wall and peptidoglycan in Bacillus species (Shah et al., 2008; Giebel et al., 
2009). A model has been hypothesised where an equilibri m between dormant and 
replicating populations of bacteria exists during the progression from latent to active 
infection, and the resuscitation would occur by eith r stochastic events or mediated by 
signals; nevertheless, the mechanisms at molecular level remain far unknown 
(Gengenbacher and Kaufmann, 2012).  
 
1.4.6 Vaccines, drugs and treatment  
 In spite of numerous researches and the use of chemot rapy, current rates of TB 
prevalence are higher than in the past, claiming a life every ten seconds with increasing 
global mortality rates. As described above, M. tuberculosis utilises different ways to 
survive and evade the immune system. Persistence along with the emergence of MDR and 
XDR strains makes the development and synthesis of novel drugs and therapies a priority 
in order to achieve effective control.  
 Due to little concrete information on the cellular or metabolic status of persistent 
mycobacteria, drug treatments available are extended and current antibiotics require long 
periods of time to cure patients and preventing relapse. Moreover, drug resistance due to 
genetic mutations has resulted into loss of susceptibility to antibiotics, therefore, during the 
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past decade, the efforts in order to develop new diagnostics, drugs and vaccines against TB 
have been intensified. The most effective regimen requires a combination of at least three 
drugs and lasts for six months, with an initial phase of two months where isoniazid, a 
rifamycin, pyrazinamide and ethambutol are administrated, and later, a phase of four 
months using isoniazid and rifampycin. The long therapy generates natural resistance in 
the pathogen and lack of motivation on patients (Sacchettini et al., 2008; Koul et al., 2011; 
WHO, 2012). Table 1.1 shows the current first and second-line drugs, their most common 
mutations and also their respective mechanisms of action.  
 According to the resistance pattern, the WHO classifie  the strains as follows: 
- MDR-TB: strain who display resistance to the first-line drugs isoniazid and rifampicin. 
Individuals are either infected primarily with drug-resistant bacteria, or drug resistance can 
appear during the treatment under non-optimal conditions. The success of the treatment 
against infection by MDR-TB is achieved only in 50% to 70% of the cases. 
- XDR-TB: a highly lethal strain who shows resistance to isoniazid, rifampicin and 
fluoroquinolones. Additionally, the strain presents resistance to any of the second-line 
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Table 1.1: Commonly used TB drugs  
(Adapted with permission from Sacchettini et al., 2008. Confirmation Nº 11129031) 
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 Therefore, in order to succeed in the global control of TB, exists an urgent need for 
new TB drugs that could shorten treatments duration, target MDR or XDR strains and 
simplify the treatments (Koul et al., 2011). New TB drugs have been discovered and can 
be found in different clinical trials phase already. i.e., Fluoroquinolones, Rifampicin 
analogues, Rifalazil, SQ109, TMC207, Sudoterb, Nitroimidazoles, OPC‑67683 
(Sacchettini et al., 2008).  
 In the case of the vaccines, the BCG vaccine for the prevention of TB is almost 100 
years old, protecting with an effectiveness of approximately 75% against the severe forms 
of TB such as tuberculous meningitis or miliary tuberculosis (Trunz et al., 2006), 
unfortunately, its efficacy in preventing pulmonary TB in adults is highly variable since the 
range of protection showed is between 0 to 80% withan average of 50% (Brewer, 2000). 
The use of BCG is not recommended in children infected with HIV, due to the risk of 
dissemination of BCG disease (WHO, 2009).  
 Currently, the clinical trials for new vaccines include eleven candidates for 
prevention of TB and one immunotherapeutic vaccine. Some of them are AERAS-
402/Crucell Ad35 (adeno-vectored vaccine), M72 and Hybrid-1 (protein subunit vaccines), 
VPM 1002 (live recombinant vaccine), RUTI (non-live accine, based on fragmented 
bacteria). The expectations indicate that one or tw vaccines in Phase II should enter to 
Phase III within the next 2–3 years, perhaps licensing one new vaccine in 7 years time 
(Brennan et al., 2012; WHO, 2012). Unfortunately, in the case of f rmer promising 
MVA85A (attenuated vaccinia-vectored vaccine), the last phase IIb trials have revealed 
that it did not induce a good cell-mediated immune response, either showed the desired 
effects against the infection in children (Pathan et al., 2012; Tameris et al., 2013). 
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1.5 MYCOBACTERIAL CELL WALL 
 
 Mycobacteria have a distinct lipid-rich cell wall which is associated with 
pathogenicity (Takayama et al., 2005; Kaur et al., 2009). The structure possesses an 
unusual low permeability that contributes to the resistance of mycobacteria to therapeutic 
agents, provides a physical protection against hostile environmental conditions such as 
inside macrophages (Brennan and Nikaido, 1995; Wang et al., 2000), it is involved in the 
interaction with the host cell, the immunomodulation and virulence as well (Cox et al., 
1999; Kan-Sutton et al., 2009). The mycobacterial cell wall is formed of mycolyl-
arabinogalactan-peptidoglycan (mAGP) complex found on the inner side of the outer 
membrane (Azuma and Yamamoto. 1963; Lederer t al., 1975; Daffé et al., 1990; Besra et 
al., 1995; Brennan, 2003; Takayama et al., 2005) and additional lipids such as phthiocerol 
dimycocerosates, phenolic glycolipids, glycopeptidolipids, menaquinones and trehalose-
based lipooligosaccharides forming the outer region of the cell wall (Fig. 1.5) (Yassin et 
al., 1988; Brennan and Nikaido, 1995; Brennan and Crick, 2007). The arrangement of the 
hydrocarbon chains of the lipids forms a thick asymmetric bilayer, the structure and the 
composition suggest that the fluidity gradually increases from the innermost part toward 
the outer surface, may affect permeability of the bilayer and also explain the different 












Figure 1.5: Arrangement of structural components in the mycobacterial cell wall. Mycolyl arabinogalactan 
(mAG) is linked to peptidoglycan (PG) by a phosphoryl part. The diagram shows the interactions between th  
methyl-branched long-chain components and the mycolic acid matrix. Arabinogalactan (AG), diacyl trehalose 
(DAT), lipoarabinomannan (LAM), mycolyl-arabinogalact n-peptidoglycan (mAGP), Nacetylglucosamine (NAG), 
N-acetylmuramic acid (NAM), penta-acyl trehalose (PAT), phthiocerol dimycocerosates (PDIM), peptidoglycan 
(PG), plasma membrane (PM), sulfated tetra-acyl trehalose (SL), trehalose monomycolate (TMM), trehalose 




1.5.1 Structure of mAGP 
 The insoluble cell wall matrix is located beyond the membrane and it is composed 
by a cross-linked peptidoglycan (PG) bound to arabinogalactan (AG), which is esterified 








 Peptidoglycan is a macromolecular structure localised on the external side of the 
bacterial cell membrane of the majority of eubacteria (Schleifer and Kandler, 1972). It 
preserves cell structure by maintaining the osmotic pressure, the cell form and it plays a 
crucial role in cell division as well (Nanninga, 1998). 
 The structure of bacterial peptidoglycan is composed by linear glycan chains linked 
by a peptide linkage which binds peptide subunits of tw  chains or a bridge formed by two 
peptide subunits. The glycan chains are formed by units of N-acetylglucosamine (GlcNAc) 
and N-acetylmuramic acid (MurNAc) linked by β1→4 bonds. The carboxyl group of 
the N-acetylmuramic acid residue is replaced by a peptid subunit, normally is L-alanyl-γ
D-glutamyl-diaminopimelyl (or L-lysyl)-D-alanyl-D-al nine in the growing peptidoglycan, 
without one or both of the D-alanine residues in the mature version of peptidoglycan 
(Adam et al., 1969; Petit et al., 1969). The biosynthesis of PG involves 
glycosyltransferases for the linear glycan chains ad transpeptidases for peptide cross-
bridges, including two mechanisms: septation and elongation (van Heijenoort, 2001). The 
PG structure of Mycobacterium contains unusual features: it is N-glycolylated, in addition 
to N-acetylated, muramic acid units; it exhibits direct cross-linkage between meso-
diaminopimelic acid components and also the replacement of L-alanine by glycine in the 
peptide chains of M. tuberculosis and M. smegmatis. However, in M. leprae the muramic 
acid units are exclusively N-acetylated (due to the non-functional namH gene) and the 
uncross-linked peptide side chains consist of tri- and tetrapeptides, containing additional 








 AG, a branched polymer of galactose and arabinose, is the most important cell wall 
polysaccharide of mycobacteria located immediately outside the PG. The function has been 
proposed to produce a viscous hydrophilic region betwe n the PG and MA layers. A 
structural model indicates that AG contains 125 glycosyl units, composed by: a galactan 
domain of 30 Galf residues, three arabinan domains of 31 Araf units each and a specific 
linker unit that binds it covalently to PG composed by a rhamnosyl residue attached to a N-
acetylglucosaminosyl-1-phosphate unit (Bhamidi et al., 2008). The galactan unit is made 
of a disaccharide repeating unit: [→6-D-Galfβ1→5-D-Galfβ]15 while arabinan chains are 
attached to O-5 of Galf residues 8, 10 and 12 of galactan. The arabin domain contains a 
non-reducing extreme of an Ara6 motif, Arafβ1 → 2Arafα1 → 5(Arafβ1 → 2Arafα1 → 3)-
Arafα1 → 5Arafα1 →, whose position 5 of both the terminal β-Araf and the penultimate 2-
α-Araf are the attachment sites for the mycolic acids. Under physiological conditions, 
approximately two-thirds of the Ara6 motifs are mycolylated (McNeil et al., 1990; 1991).  
 The arabinan domain is formed by a central structue made up of linear α–1,5-
linked Araf units and branches to form a α–3,5-branch site (Lee t al., 2006; Alderwick et 
al., 2007; Bhamidi et al., 2008, Kaur et al., 2009).  
 
1.5.1.3 Mycolic Acids 
 Mycolic acids (MA) are β-hydroxy fatty acids with a long α-alkyl side chain, they 
can be represented by the formula shown in Fig. 1.6 (Asselineau and Lederer, 1950). The 
mycolic unit is formed by the long alkyl chain along with the meromycolate chain which 
normally incorporates up to two functional groups. The merochain exhibits different 
modifications, including double bonds, keto or methoxy functional groups, cis- or trans- 
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cyclopropanations and epoxidations as well, which vary depending on the species (Barry et 
al., 1998).  
 MA are usually bound to the cell wall by esters formed between the acid and an 
alcohol of a sugar, often as pentaarabinose tetramycolates. They can also be found as non-
bound esters, such as glucose monomycolate (GMM), glycerol monomycolate (MMG), 
trehalose mono- and dimycolates (TMM and TDM), and s free MA (Takayama et al., 
2005; Andersen et al., 2009; Verschoor et al., 2012). MA ccur in a specific group of Gram-
positive bacteria such as Corynebacterineae, including the genera Mycobacterium, 
Nocardia, Rhodococcus and Corynebacterium. In Corynebacterium the MA are smallest 
(C28–C40) and not essential (Gebhardt et al., 2007), unlike in Mycobacterium species 
where they have been found to be essential for growth and survival in vitro and in vivo, 
with length between C60–C90 (Vilchèze et al., 2000; Portevin et al., 2004). Rhodococcus 
has MA in the range of C30–C54 and Nocardia in the range of C42–C66, in both cases the 
mero-chain does not exhibit functional groups other than one or more double bonds 
(Sutcliffe, 1998; Nishiuchi et al., 1999; Verschoor et al., 2012). 
 In M. tuberculosis, MA are composed by highly hydrophobic fatty acids with α-
side chains of three different types found, namely α- (the most abundant form, accounting 
for >70%), methoxy- and keto-mycolic acids (Fig. 1.6) (Qureshi et al., 1978; Takayama et 
al., 2005).  
 
 




Figure 1.6: Mycolic acid structure. 1: general formula, a–d: varying lengths of methylene chains. 2-5: major 
types of mycolic acid from MTBC according to the functional groups; 6: a related wax ester from M. 
paratuberculosis. (Adapted with permission from Verschoor et al., 2012. License Nº 3244830256376). 
 
 
1.5.2 Noncovalently bound glycoconjugates: free lipids of M. tuberculosis 
 The glycoconjugates of the outer membrane correspond t  a group of lipids 
noncovalently bound to the cell wall, they are intercalated within the lipids region formed 
by the MA of the mAGP complex, this group includes: Phthiocerol dimycocerosate 
(DIM/PDIMs), phenolic glycolipids (PGLs), acyltrehaloses (TMM, TDM and GMM), 
sulfolipids (SLs), phosphatidyl-myoinositolmannosides (PIMs), lipomannan (LM) and 








 These are an important group of virulence factors in the envelope of mycobacteria, 
formed by trehalose-containing glycolipids (Fig. 1.7). Trehalose is a non-reducing 
disaccharide of glucose (α-D-Glcp-(1<->1)-α-D-Glcp) and it is found in organisms such as 
bacteria, yeast, fungi, plants and invertebrates, but it is absent in mammals. In 
mycobacteria, it can be found free in the cytoplasm or esterified to a different fatty acyl 
groups in the cell envelope. The free version of trehalose could be a storage carbohydrate 
as well as a stress protectant, while the acyltrehaloses found in the cell envelope of M. 
tuberculosis include diacyltrehaloses (DAT), polyacyltrehaloses (PAT), sulfatides (SL), 
triacyltrehaloses (TAT), trehalose dimycolates (TDM), trehalose monomycolate (TMM) 
and polar species-specific lipooligosaccharides (LOS) (Kaur et al., 2009). Trehalose 
dimycolate (TDM), known as cord factor, accumulates in a cord-like fashion outside the 




Figure 1.7: Acyltrehaloses. Structures of trehalose dimycolate (TDM) and monomycolate (TMM); RCOOH, 
R’COOH: mycolic acid. Adapted with permission from Verschoor et al., 2012. License Nº 3244830256376 
 
 




 Several slowly growing mycobacteria contain an array of waxes so called 
sulfolipids, they are formed by multi-acylated varieties of trehalose sulfate differing by the 
amount, composition and location of the acyl units (Goren et al., 1971). The major 
sulfolipid, SL-I, is characterized as a tetraacyl-trehalose-2-sulfate, acylated by two 
hydroxyphthioceranates (HPA), one phthioceranate (PA), and one palmitate (C16) or 
stearate (C18). They have been implicated in the pathogenesis of tuberculosis, but the 
function still remains unclear (Brennan and Nikaido, 1995; Converse t al., 2003; Layre et 
al., 2011). 
 
1.5.2.3 Phthiocerol dimycocerosate 
 PDIM, is a major lipid of M. tuberculosis and is related to its virulence ability. It is 
composed by 35 carbons as methyl or methylene groups and two hydroxy groups esterified 
with two mycocerosic acids (Goren and Brennan, 1980; Brennan, 2003). PDIM is also 
related to other lipids and methyl branched fatty acids, such sulfolipids where 
phthioceranic or hydroxy-phthioceranic acids are th major acyl constituents (Sirakova et 
al., 2001).  
 Recent studies in M. marinum have shown another structurally related group of 
molecules called phenolic glycolipids (PGLs). The structure of the carbohydrate domain of 
these compounds is highly variable and the genetic bases for these variations remain 
unknown. PGLs are, together with PDIMs, required for virulence and the lack of genes 
related to their biosynthetic pathways produces hypersensitive to antibiotics and negative 
effects in the cell wall such as higher permeability. I  has been demonstrated that PGLs 
play a major role in the virulence of some strains of M. tuberculosis complex and in M.  
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leprae (Málaga et al., 2008; Yu et al., 2012). Although most of the strains of M. 
tuberculosis do not produce PGLs due to a mutation in the polyketide synthase pks15/1, 
they still retain the ability to produce and secrete p-hydroxybenzoic acid derivatives (p-
HBADs) glycoconjugates which share with PGLs the same glycosylated aromatic nucleus 
(Constant et al., 2002).  
 
1.5.2.4 PIMs, LM, and LAM 
 Mycobacterial cell envelope contains high amounts of mannosylated molecules. 
These are ubiquitous mannosyl-phosphatidyl-m o-inositol based glycolipids and are 
metabolically-related lipoglycans, comprising PIMs, LM and LAM.  These are non-
covalently anchored to the cell envelope through their phosphatidyl-myo-inositol (PI) 
moiety (Besra et al., 1997; Hunter and Brennan, 1990; Pitarque et al., 2008). They promote 
the entry of M. tuberculosis inside phagocytic cells through mannose-specific C-type 
lectins, regulate phagosome maturation and modulate the host immune response (Briken t 
al., 2004; Kaur et al., 2009).   
 Structurally PIMs, LM and LAM are formed by a conserved PI backbone with 
mannosylation branch at the C-6 position of the myo-inositol.  The backbone is 
heterogeneous and the differences are based on the amount, position and type of the fatty 
acids. The PIMs include PI-dimannosides (Ac1PIM2 and Ac2PIM2) and PI-
hexamannosides (Ac1PIM6 and Ac2PIM6): Ac1PIM2 and Ac1PIM6 contain one fatty acid 
bound to the Manp attached to position 2 of myo-Ins in addition to a diacylglycerol moiety; 
on the other hand, Ac2PIM2 and Ac2PIM6 contain a fourth fatty acyl chain linked to 
position 3 of myo-Ins. LM and LAM are formed by a mannan core of approximately 20-25 
α(1→6)-linked Manp residues, sometimes showing substitution at C-2 by single Manp 
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units in all mycobacterial species investigated, except in M. chelonae where the branching 
occurs at C-3 (Guérardel t al., 2002; Kordulakova et al., 2003; Briken et al., 2004; Hsu et 
al., 2007; Kaur et al., 2009). The mannan core of LM varies in length and degree of 
branching depending on the species, the type of motifs capping the non-reducing extremes 
of the arabinan domain of LAM differs among mycobacterial species, finding mannose-, 
inositol phosphate-, phosphate- and non- capped LAM (Nigou et al., 2003). This feature is 
crucial since alterations in the lipoglycan compositi n and structure can be recognised 
differentially by the cells of the immune system, having an important effect on the 
resulting adaptive immune response (Mishra et al., 2012). Moreover, non-pathogenic 
species as M.smegmatis appears to be permissive to a variety of mutations affecting PIM, 
LM and LAM synthesis, the inability to generate mutants of M. tuberculosis deficient in 
the acylation of PIMs or LAM synthesis (Goude et al., 2008) indicates that these molecules 
probably play a more crucial role in the physiology pathogen rather than in the non-
pathogenic strain (Kaur et al., 2009).  
         
1.5.2.5 Glycopeptidolipids 
 GPLs are main constituent of the external layer of the cell wall, involved in 
different roles such as morphology of the cells, motility, biofilm development, immune 
response trigger and pathogenesis. They can be found in different non-tuberculosis-causing 
species of the Mycobacterium group, such as the saprophytic M. smegmatis and the 
opportunistic species of the Mycobacterium avium complex (MAC), such as M. avium and 
M. intracellulare. One specific feature of this group is the production of highly antigenic, 
typeable serovar-specific GPLs (ssGPLs) (Schorey and Sweet, 2008). GPLs are composed 
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of a glycosylated lipopeptide core and the type of glycosylations differs between infective 
and non-infective species (Chatterjee and Khoo, 2001; Patterson et al., 2000).  
 
1.5.2.6 Lipooligosaccharides  
 Lipooligosaccharides (LOSs) are a type of antigenic glycolipids present in some 
species of Mycobacterium such as M. canetti. LOSs compounds contain a α,α′-trehalose 
unit that is acylated and further glycosylated in a species-specific manner. Structural 
analyses demonstrated that LOS-I, -II, -III, and -IV share the same glycan core of acylated 
trehalose substituted by two β-D-Glcp residues and one 3-O-methylated α-L-Rhap 
(Rombouts et al., 2011). Studies using M. marinum have shown that LOSs are associated 




1.6 AIMS AND OBJECTIVES  
 
 The broad aim of this work is to identify components of metabolic pathways with 
potential role in the virulence of M. tuberculosis. In this research I plan to study both cell 
and non-cell envelope components by the use of genetic mutants, determining the effects 
of their respective deletions. While a vast majority of this work will be focused on cell 
envelope elements, part of the project also involves studies on intracellular metabolites as 
polyphosphate. Due to the fact that the study of M. tuberculosis constitutes a major 
technical challenge, the fast-growing and non-pathogenic organisms M. smegmatis mc2155 
and C. glutamicum ATCC13032 will be used in this work instead, as surrogate models. 
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They have been chosen because both share similar genomic organization and cell wall 
biosynthetic machinery than M. tuberculosis. Moreover, they can stand deletion of several 
genes that are essential in that pathogen. 
 In order to study cell envelope biosynthesis in mycobacteria, mutants will be 
generated, selected and used according to the criteria specified in each chapter. 
Summarising the approaches, the study will go as follows:  
1) Firstly, a strategy based on random transposon mutagenesis will be used to generate a 
M. smegmatis transposon-mutant library. The strains displaying altered colony morphology 
and increased sensitivity to the lipophilic drug rifampicin will be selected for further 
analysis as potential cell-envelope defective strains, trying to look for a link between the 
gene disrupted and the phenotype shown.   
2) Secondly, using bioinformatics tools, a group of genes will be selected in order to 
identify components involved in capsule and cell-wal biosynthesis in mycobacteria. 
Specifically, based on the homology to carbohydrate ABC-transporters, a list of putative 
genes involved in the transport of capsule components will be selected to construct 
knockout strains. On the other hand, the role of large membrane proteins encoded by 
mmpL genes in mycolic acid biosynthesis will be investiga ed using M. smegmatis specific 
mutant strains. Respectively, the strains will be analysed and tested for: a) changes in the 
capsule main component production and the effects of the deletion of the genes; b) effects 
of the deletion in biosynthesis and transport of the mycolic acids and the other “free lipids” 
of the mycobacterial cell wall mycolic acid biosynthesis. Additionally, C. glutamicum will 
be used as a model system of mycolic acid biosynthesis as well.  
3) Finally, in order to address the role of polyphosphate in the metabolism during 
phosphate-starvation condition in mycobacteria, knoc outs strains will be generated for the 
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exopolyphosphatases homologs in M. smegmatis. Polyphosphate consumption will be 
measured and effect in growth will be monitored in every strain. 
 The final objective of this study is to highlight t e role of several genes involved in 
cell envelope metabolism and the response under limiting conditions. Therefore, identify 















SCREENING OF TRANSPOSON LIBRARIES OF 

















Chapter 2 - Screening of Transposon Libraries of Mycobacterium smegmatis for Mutants with Cell Wall Alterations 
 
 37
2.1 INTRODUCTION  
 
 As highlighted in the introduction chapter, mycobacteria produce lipid-rich cell 
walls that have low permeability and high hydrophobicity. This distinct structure 
contributes to their pathogenicity and resistance to both therapeutic agents and host 
defence mechanisms (Brennan and Nikaido, 1995; Barry et al., 1998; Daffé and Draper, 
1998; Cox et al., 1999). It is composed of two segments, lower and upper. The lower 
consists on the cell wall core, located beyond the membrane, where the peptidoglycan (PG) 
covalently attached to arabinogalactan (AG), which is in turn esterified to the mycolic 
acids forming the mycolyl-arabinogalactan-peptidoglycan (mAGP) complex. This structure 
provides the template for insertion, in an interspeed way, of products such as cell-wall 
proteins and a number of free complex lipids: phthiocerol-containing lipids, trehalose 
mycolates, phosphatidylinositol mannans (PIMs) and glycosylated derivatives lipomannan 
(LM) and lipoarabinomannan (LAM) (Kaur et al., 2009; Pitarque t al., 2008). The upper 
segment is composed of free lipids, namely trehalose-based lipooligosaccharides (LOSs), 
phenolic glycolipids (PGLs) and also glycopeptidolipids (GPLs) with both short and long 
fatty acids. This unique arrangement produces an asymmetric bilayer of exceptional 
viscosity and width where fluidity and permeability are potentially low in the internal part 
of the bilayer and increased on the external face. Due to such a lipid rich structure, it can 
be envisaged that even lipophilic substances may face an exceptional barrier whereas the 
hydrophilic nutrients and inhibitors pass through channels like porins (Engelhardt et al., 
2002; Brennan, 2003; Rodrigues t al., 2011).  
 A number of studies in the past have reported functio al and structural changes in 
mycobacteria as a consequence of alterations in cell wal  composition. Therefore, the 
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integrity of morphological and structural features like biofilm pellicle or cording is the 
result of right interactions of the correct cell surface components and also between the 
healthy cells. A seemingly minor alteration as a reduction in the length of the mycolate 
chain by deleting kasB produces a drastic alterations in the morphology, loss of acid 
fastness and virulence of Mycobacterium tuberculosis (Bhatt et al., 2007). Glickman et al. 
also observed that the classic cord formation displayed in cultures of M. tuberculosis and 
Mycobacterium bovis was disrupted by the loss of proximal cyclopropane ri g of the major 
mycolic acid (Glickman et al., 2000). On the other hand, the loss of a reductase in the non-
virulent Mycobacterium smegmatis leads to the presence of a β-oxo rather than a β-
hydroxyl group in the mycolate unit that alters the morphology of the mutant and 
sensitivity to antibiotics, likely caused by the changes produced to the hydrophobic 
properties of the outermost part of the cells (Bhatt et al., 2008). Moreover, in the same 
species, the loss of GPLs and defects in LAM biosynthesis lead to important changes in 
both morphology, biofilm formation and structure of the colony (Billman-Jacobe t al., 
1999; Recht and Kolter, 2001; Kovacevic et al., 2006), altered growth and modulated 
immunology response when the deletion of the arabinofuranosyltransferase C (aftC) occurs 
due to the absence of AG alpha (1-->3)-linked arabinofuranosyl (Araf) residues (Birch et
al., 2008; 2010).  In the case of Mycobacterium marinum (a fish and amphibian pathogen) 
lipooligosaccharides play an important role in infection of host macrophages, biofilm 
formation and sliding motility an virulence (Ren et al., 2007), as well as it occurs in 
Mycobacterium avium when the glycopeptidolipids GPLs are loss (Miyamoto et al., 2008; 
Schorey and Sweet, 2008).  
 Therefore, alterations in its composition may affect the properties of the bilayer and 
could also be responsible for colony morphology changes, susceptibility to the host 
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immune response, phage resistance of different mycobacterial species, biofilm formation, 
loss of cording formation and the increased sensitivity to lipophilic inhibitors, which have  
demonstrated to be good indicators of cell wall disruption (Brennan and Nikaido, 1995; 
Gao et al., 2003a; Chen et al., 2009; Deshayes et al., 2010). 
 In the study of tuberculosis, the use of M. smegmatis as an experimental model has 
generated controversy and discussion (Reyrat and Kahn, 2001; Barry, 2001a; Tyagi and 
Sharma, 2002), due to its low pathogenicity as it survives poorly in macrophages (Anes t 
al., 2006; Jordao et al., 2008) and also because it exhibits no detectable virulence in mice 
(Bange et al, 1999). The composition of the M. tuberculosis cell wall presents a high level 
of similarity compared to M. smegmatis, in fact, in both organisms the synthesis of mycolic 
acids is carried out by the same set of enzymes namely FAS-I and –II systems, FabH, 
KasA, KasB, MabA and Pks13 (Takayama et al., 2005). Although, they exhibit different 
types of mycolic acids: while M. tuberculosis presents α-, methoxi- and keto- types, M. 
smegmatis shows α-, α’- and epoxy-. Another difference shown by M. tuberculosis cell 
wall compared to M. smegmatis corresponds to the nature of other lipids; for insta ce, its 
cell wall displays an unusual abundance of sulfolipids and produces LAM containing short 
mannose caps, unlike M. smegmatis (Brennan and Nikaido, 1995; Brennan, 2003; 
Mougous et al., 2004), these differences in the composition of the cell wall account for 
different metabolic and virulence features.  
 As a surrogate model, M. smegmatis is not as useful as M. bovis BCG when used in 
anti-tubercular drug discovery tests, since a significant percentage of M. tuberculosis 
targets are missing, making M. bovis BCG a more sensitive model in library screening for 
compounds active against M. tuberculosis (Altaf et al., 2010). The studies to determine its 
applicability in anti-tubercular drug discovery are rare and the reliability of M. smegmatis 
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as a model for the detection of inhibitors of M. tuberculosis could be controversial. 
Nevertheless, due to its shorter generation time, highly similar cell wall-lipids content 
compared to M. tuberculosis and the lack of complications on the handling, M. smegmatis 
has demonstrated to be useful as a surrogate model for study. For instance, this organism 
offers several advantages in order to decipher the s ructure and understanding how the 
biosynthesis of the cell wall occurs (Bhatt e  al., 2005), as well as the cytoplasmic 
functioning and regulation (Zahrt e al., 2001; O’Toole et al., 2003) because it can easily 
be genetically manipulated, obtaining viable mutants without losing the advantages to 
tolerate mutation that would be lethal in M. tuberculosis, as it occurs with single gene 
deletions of embA, embB or embC (Amin et al., 2008; Goude et al., 2008). The emb genes 
encode for key proteins in AG biosynthesis and the corresponding knockouts in M. 
smegmatis resulted in AG with reduced amount of arabinose content together with an 
increased amount of galactose, although the effect was less dramatic with embC (Escuyer 
et al., 2001; Zhang et al., 2003; Alderwick et al., 2011).  
 M. smegmatis is also known for showing less sensitivity towards the two frontline 
anti-TB drugs isoniazid and rifampicin (Chung et al., 1995; Quan et al., 1997; Li et al., 
2004), and its susceptibility is identical to that of MDR clinical isolates of M. tuberculosis. 
The stringency is not necessarily a disadvantage, since both drugs have shown a better 
activity against the pathogen not only in vitro but also in vivo, so in addition to their non-
pathogenic and fast-growing conditions, it turns M. smegmatis into a good surrogate when 
testing sensitivity to lipophilic antibiotics (Chaturvedi et al., 2007). The reduced 
susceptibility to these antibiotics shown by M. smegmatis remains not totally clear; in 
mycobacteria, the role of efflux pumps in antibiotic resistance has already been probed but 
it does not necessarily explain the difference with M. tuberculosis, since most of the 
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homologous pumps are present in both organisms and, specifically in the case of the efpA 
mutant, the lack of the efflux-pump gene increases th  resistance to rifamycins instead of 
reducing the susceptibility (Liu et al., 1996; Li et al., 2004). Perhaps, the difference in 
susceptibility is based on the fast-growing nature of M. smegmatis along with other 
unknown factors absent in M. tuberculosis, due to a greater genome with approximately 
3,000 more genes. 
 In this chapter a random transposon mutant library of M. smegmatis has been 
generated in order to use it as a source of strains w th altered cell wall. Transposon 
mutagenesis has been a powerful tool for the study of several biological aspects of M. 
tuberculosis, like genetic, pathogenesis and also to decipher mtabolic pathways, 
discovering new virulence factors and essential genes (Guilhot et al., 1994; Barry, 2001b; 
Sassetti et al., 2001; McAdam et al., 2002; Gao et al., 2003a; Gao et al., 2003b; 
Lamichhane et al., 2003). It has been shown that target sites are preferably the regions of 
the chromosome where transcription is inactive at the moment of transduction (Manna et 
al., 2004).  
 A mariner-based transposon has been used for mutagenesis in mycobacteria 
offering the advantage of being non-indigenous and having a high transposition frequency 
since its efficiency has been improved using a temperature sensitive phage delivery 
system. The recombinant phage phAE181 was used in this study, which is derived from the 
mariner-based Tn5371 and the lytic mycobacteriophage TM4 (Rubin et al., 1999 Kriakov 
et al., 2003). The phage can infect several species of both slow and fast growing 
mycobacteria as M. tuberculosis, M. smegmatis or M. marinum and replicates inside a 
mycobacterial host at 30°C as part of its lytic cycle, but not at 37°C. The hygromycin 
resistance gene (hyg) is then inserted by infection of the host at 37°C to be used as a 
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selection marker, the cassette disrupts the ORF imparing the transcription of the gene  
(Bardarov et al., 1997; Rubin et al., 1999; Sassetti et al., 2001; Rybniker et al., 2003).  In 
order to detect putative cell wall alterations, thephAE181 system was used to generate 
transposon mutant strains that were selected by visual criteria when loss of biofilm pellicle 
formation occurred (loss of the cell interface between the liquid media and the air, as 




2.2.1 Isolation of M. smegmatis Tn-mutants with altered growth patterns and 
 increased sensitivity to the lipophilic drug rifampicin 
 Following transposon mutagenesis using phAE181, a tot l of 1672 hygR 
transductants were obtained and inoculated into 96-well plates on duplicates. While a vast 
majority of strains showed normal growth patterns compared to the wild type control, some 
strains exhibited poor growth and/or alterations in the formation of pellicles on extended 
incubations (Fig. 2.1). These two types of strains amounted to a total of forty two Tn-
mutants, each of which was then tested for i) colony morphology alterations on solid 
media; ii) increased rifampicin sensitivity on agar plates using concentrations of the 
antibiotic lower than the minimal inhibitory concentration (MIC) previously reported of 30 
µg/ml (Chakravorty et al., 2008) and iii) cording in liquid media by optical microscopy. A 
total of fifteen strains displayed traits as small colony size, loss of cord formation, glossy 
texture or rifampicin sensitivity (Fig. 2.2). No spontaneous resistance was observed during 
the screening. 
 





Figure 2.1: Pellicle formation assay of different M. smegmatis strains. Picture showing a top view of the 
biofilm pellicles formed on the surface of TSB-cultures incubated in 96-well plates at 37°C for 5 days 
without agitation. Left well shows wild-type pellice pattern; center and right wells show defects in biofilm 
formation in two different Tn-mutants (Tn-mutagenesis using phAE181). The loss of the ability to form 
biofilm pellicle was used as one of the selection criteria. 
 
 
2.2.2 Identification of Tn-insertion sites and disrupted genes  
 Since the mutant strains contain the Tn5371 insertion, the transposon-disrupted 
genes were identified by DNA sequencing and the results obtained were analysed using the 
BLAST software (Altschul et al., 1990) and the MycoDB database 
(http://xbase.bham.ac.uk/mycodb/). Interestingly, two categories of biological processes 
were mainly represented amongst the insertions site. Whilst six genes encoded functions 
related to lipid metabolism, three were similar to genes involved in intermediate 
metabolism processes. Transposon insertions were also found in genes related to cell 











Table 2.1  
Transposon mutant library strains 
 
 
* Essential gene (Goude et al., 2008)  
‡ In vitro essential gene (Sassetti  al., 2003)  
† Non- essential gene (Sassetti t al., 2003) 
†† Non-essential gene (Lemichhane et al., 2003) 




Strain Gene Function M. tuberculosis 
H37Rv homologs 
Changes observed 
1 MSMEG_0472 putative lipoprotein No 
 





Rv3793 / embC * 
 
Small, RifS, loss of cord 
formation (6444823) 
23 MSMEG_5041 acyltransferase 
 
Rv1254 / 
acyltransferase  ‡ 
 
Small colony, RifS, loss cord 
formation (5136306) 
30A MSMEG_0147 C-5 sterol desaturase 
 
Rv1814 / erg3 † 
 




type I modular polyketide 
synthase 
Rv1661 / pks7 ‡ 
Glossy, small, loss of cord 
formation (482115) 
10F7B MSMEG_6599 LuxR regulator No 





Rv0118c /  oxcA ‡ 
 

















ABC transporter, ATPase 
subunit 
Rv2832c /  ugpC ‡ 




virulence factor mce 
family protein 
Rv1971 / mce3F † 
Glossy, small, loss of cord 
formation (2923473) 
56B MSMEG_3743 
Soj - SpoOJ regulator 
protein 
 
Rv1708 /  putative 
initiation inhibitor 
protein ‡ 






Rv1997 / ctpF † 
 






Rv3211 / rhlE †† 
RifS, loss of cord formation 
(2009180) 
109A MSMEG_4751 hypothetical protein No 
 
Normal size, loss of cord 
formation (4849186) 
 







Figure 2.2: Morphology of M.smegmatis Tn-mutants. Cultures grown until late-log phase in TSB were plated 
out on: (A) TSB-agar plates to display single colony formation. (B) 10µl drops of 10-5 serial dilutions from 
stationary phase cultures were spotted on TSB-agar plates with and without rifampicin 5µg/ml in order to check 
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 A set of the disrupted genes found in this library corresponded to genes previously 
described as involved in processes like biogenesis, structure or transport of cell wall 
components, validating the method and the selection riteria used. Among this group, the 
disrupted genes were: MSMEG_6387 (arabinosyltransferase A) and MSMEG_0408 (type-I 
modular polyketide synthase) which are involved in M. tuberculosis cell wall components 
biosynthesis; MSMEG_0147 (C-5 sterol desaturase) that has been described playing a role 
in membrane permeability in yeasts; finally, MSMEG_0157 (oxalyl-CoA decarboxylase) 
and MSMEG_4269 (glutamine-hydrolyzing) have been previously described as related to 
energy metabolism and aminoacid biosynthesis with implications in structural 
development of the cell wall as well. 
 A complete analysis of non-polar (system A, B, C, D) and polar lipids (system D, 
E) of the Tn-mutant strains was carried out using a 2D-TLC system to visualise the 
samples (Dobson et al., 1985). Neither the cell wall associated lipids nor the free lipids 
were considerably altered in any of the mutants analysed compared to the wild type strain 





























Figure 2.3: Lipid analysis of M. smegmatis Tn-mutants. Two dimensions-TLC analysis of [14C]-labelled 
lipids from mutant strains grown in 10 ml of TSB culture, cells were labelled during mid-log phase. 
Extracted lipids were separated using different solvent systems by spotting 20,000 cpm of each lipid sample 
(see General Materials and Methods chapter). Position  of known lipids from the wild-type are indicated by 
arrows. 1 and 2 indicate first and second dimension, respectively. Ac2PIM2 di- and monoacyl 
phosphatidylinositol dimannosides, Ac2PIM6 and AcPIM6 di and monoacyl phosphatidylinositol 
hexamannosides; GPLs–glycopeptidolipids; PI–phosphatidyl inositol; PL–phospholipids; TAG–
triacylglycerol; TMM–trehalose monomycolate; TDM–trehalose dimycolate.  
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2.2.3 Disruption of the parA homolog MSMEG_3743 causes growth inhibition, 
 impaired DNA segregation and delayed cell division of M. smegmatis 
 The ∆MSMEG_3743 Tn-mutant strain showed a severe impairment in its growth, 
forming clumping aggregates and a small amount of cells yield in both solid and liquid 
media even after long periods of incubation. Growth rate analysis was attempted by 
measuring optical density and counting viable cells, but the results were not reliable due to 
the way the cells clumped each other. Fluorescence microscopy was performed for 
visualisation of septa/membrane and nucleoids by staining with FM4-64 and DAPI, 
respectively. The majority of the wild-type cells clearly showed the midcell septa with 
well-segregated nucleoids in both halves of the cell. On the other hand, the mutants 
contained an asymmetric distribution of the septum (“spots-like”) along the cell surface 




 Given the fact that M. smegmatis possesses ~6500 genes, approximately 25% of the 
genes were, supposedly, disrupted from a pool of approximately 70,000 possible mariner 
insertion sites in a typical mycobacterial chromosome (Gao et al., 2003a).  The transposon 
insertion M. smegmatis mc2155 mutant library had been successfully developed according 
to the aim previously established, since the method used biased the results towards the 
selection of mutants where the genes disrupted wereinvolved in cell wall biosynthesis. The 
majority of the mutants showed loss of cord formation pattern when were grown on plates, 
revealing the lack of a normal structural organisation in the cell wall due to the gene 
disruption.  
 




Figure 2.4: Fluorescence micrographs of M. smegmatis cells. Both wild-type and ∆MSMEG_3743 strains 
were stained with (A) DAPI (DNA) and (B) FM4-64 (mebrane). DAPI staining revealed aberrant DNA 
chromosome distribution and localisation in the mutant cytoplasm. Membrane staining showed an abnormal 
septa organisation (membrane aggregates) as result of the transposon disruption of MSMEG_3743, unlike the 
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 Therefore, the selection of biofilm defective strains revealed colony morphology 
alterations and/or rifampicin sensitivity on plates, caused by the inactivation of genes 
mainly related to structural lipids metabolism and i termediate metabolism, but without 
changes in the lipid profile as it was expected from literature (Ojha et al., 2010) after 
losing the biofilm formation ability (i.e., loss of free mycolic acids or TDM pattern 
alteration). However, in the case of mutants who showed no alteration in lipids 
metabolism, changes could be related to slow growth r alterations in capsule or AG/LAM 
composition. 
 Fifteen Tn-mutant strains were identified and six out of them were annotated as 
genes related to cell wall biosynthesis or metabolism. Amongst them, MSMEG_6387 
encodes an arabinosyltransferase A termed embC, which along with its M. tuberculosis 
homolog Rv3793, have been extensively studied due to its role in the biosynthesis of the 
mycobacterial cell wall, since that it is essential for LAM synthesis and also as part of the 
embCAB operon whose the target of the ethambutol (EMB) (Telenti et al., 1997; Zhang et 
al., 2003; Alderwick et al., 2011). In contrast to the Rv3793, and as I have said in the 
introduction section, the ∆MSMEG_6387 strain yields viable. Consistently with previous 
results (Escuyer et al., 2001) the changes in morphology and cell wall permeability were 
expected but not drastic, therefore the TLC lipid analysis of the mutant did not show 
differences compared to the wild-type strain since the gene is involved in LAM synthesis 
(Alderwick et al., 2011), whose disruption leads to a structural deficiency, altering colony 
morphology and also increasing permeability of the cell wall that could explain the 
sensitivity to rifampicin. 
 Another gene disrupted was MSMEG_0408, which encodes for a type-I polyketide 
synthase.  A multi-domain fatty acid synthase-like enzyme that belongs to the polyketide 
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synthases (Pks) family, whose members are involved in complex fatty acyl components of 
the cell wall biosynthesis, such as glycopeptidolipids (GPL) in Mycobacterium genus 
(Tatham et al., 2012), surface-exposed lipooligosaccharides (LOS) in M. smegmatis 
(Etienne et al., 2005) or phthioceroldimycocerosates (PDIM) in M. tuberculosis (Jain and 
Cox, 2005). Therefore, polyketide synthases are related to virulence (Rousseau et al., 
2003; Matsunaga et al., 2004; Astarie-Dequeker t al., 2009). It was not surprising that this 
mutant displayed the above-described characteristics as previous studies on pks genes have 
reported major alterations in the cell wall compositi n. The BLAST analysis of the protein 
sequence against the M. tuberculosis H37RV protein data base showed high scores for 
several polyketide synthases such as Pks7, Pks12 or Pks2, while the search for equivalent 
regions in both M. smegmatis and M. tuberculosis genomes did not show synteny. 
Moreover, TLC-analysis of the mutant strain did notreveal any detectable change in the 
lipid pattern compared to the wild-type strain. These apparently negative results are still 
consistent with previous reports, were the cell envelope of pks-mutant strain is similar to 
that of the wild-type strain, despite the altered phenotype displayed (Rousseau et al., 
2003).  
 A group of genes related to lipid metabolism were disrupted. In first place, 
MSMEG_0147 was found to have a potential link to the cell envelope. Its closest homolog 
has been described as a sterol desaturase related to membrane-sterols production in yeast, 
where the mutants showed increased permeability and sensitivity to antifungal drugs 
(Smith and Parks, 1993; Brumfield et al., 2010). Although no synteny with a M. 
tuberculosis cluster was found, the role of the erg3 gene must be considered for further 
studies. Regarding the ∆MSMEG_6599 mutant strain obtained, in Mycobacterium avium, a 
luxR gene have been described as regulator of several gnes related to cell wall-associated 
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lipids, lipid metabolism and host cell invasion, thus controlling the envelope composition 
(Alonso-Hearn et al., 2010). In this case, the disrupted luxR gene contains a frame shift 
showing no M. tuberculosis homologous gene, then it is still possible to have  different 
biological effect over the same genes. On the other hand, even though MSMEG_0472 has 
no homologs in M. tuberculosis and the cluster that belongs to showed no synteny, 
lipoproteins have shown to have a role in the composition and structure of the cell wall as 
well as in virulence (Crellin et al., 2008; Brülle et al., 2010). Finally, the acyltransferase 
gene is located downstream an ATP-dependent RNA-helicas  of unknown function, more 
detailed study is necessary in order to elucidate the specific role it has, since rifampicin 
sensitivity was observed most likely as an increased permeability of the envelope.  
 Regarding the disrupted genes related to intermediary metabolism, previous 
screenings in M. smegmatis have shown that TCA cycle crucial enzymes are related to 
colony morphology alterations as a result of an impaired growth rate (Chen, 2010), and 
also crucial enzymes in glyoxylate metabolic pathway, both isocitrate lyase and malate 
synthase, have been previously reported as related in pathogenesis of M. tuberculosis 
(Muñoz-Elias and McKinney, 2005; Dunn et al., 2009; Quartararo and Blanchard, 2011). 
In this study, a transposon mutant strain was found carrying a disruption in the gene 
encoding for the oxalyl-CoA decarboxylase, an enzyme which is part of the glyoxylate 
cycle. Moreover, a disruption in MSMEG_3641 was found, this gene encodes for a 
conserved hypothetical protein that is likely to be related to malate synthase expression. 
Then, further studies are necessary in order to elucidate the role of MSMEG_3641 in the 
rifampicin sensitivity shown by the mutant and its link to the glyoxylate cycle. 
 The MSMEG_4269 gene encondes for the AsnB protein that has been rported as 
protector factor against several antibiotics since the disruption of asnB gene increases the 
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sensitivity to drugs in M. smegmatis. The protein is the only putative asparagine synthetase 
present in the Mycobacterium genus, and yet the knockout strain does not seem to be an 
asparagine auxotroph (Ren and Liu, 2006). The C. glutamicum homolog ltsA, encodes a 
glutamine-dependent amidotransferase is related to the cell wall structure formation and in 
the L-glutamate production (Hirasawa, 2000). Interestingly, in this study, the colony 
morphology analysis also showed a change in the colony edges and rifampicin sensitivity 
when the strain was exposed to Tween. These facts, long with the high degree of synteny 
of the clusters found when compared with M. tuberculosis, suggest asnB gene as a good 
drug target. Due to the fact that the changes in the morphology can be the result of a slow 
growth rate instead of a structural or biochemical alteration in the cell wall, it was not 
surprising to have found no alterations in the lipid analysis. Nevertheless, AG, LAM and 
capsular components remained to be analysed.  
 The ∆MSMEG_3743 mutant strain was chosen for further analysis due to the 
unique phenotype shown and the importance of the cell cycle control as a vital function, 
whose mechanisms still remain unknown. Normal wild-type strains of M. smegmatis 
stained to visualise the septum show a normal midcell septum with two segregated 
chromosomes (Errington et al., 2003). In this study, the traits shown by the MSMEG_3743 
mutant indicated that the cell division process was severely delayed, since the strain 
exhibited an abnormal amount of nucleoids and also defective DNA segregation, 
suggesting a DNA structural scaffold role for the Soj- SpoOJ regulator protein protein, a 
ParA-like homologous (Jakimowicz et al., 2007; Maloney et al., 2009). The presence of 
multinucleoids or granules phenotypes could be just an effect of spotting cells at different 
cellular stages. The results showed that there is no fu ctional redundancy between the parA 
homologous since the presence of two other ones doe n t rescue the cell from the altered 
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condition, this result was expected since the overexpression of each of them also produced 
DNA segregation defects and cell progression impairment, probably as the effect of the 
lack of an optimal ratio of ParB/ParA (Maloney t al., 2009). Nevertheless, recent studies 
have shown very similar segregation and DNA distribu ion patterns in parA knockout M. 
smegmatis cells, suggesting similar functions for both genes (Ginda et al., 2013). In this 
study, anucleate cells were not possible to be found in the mutant cells, as it could be 
expected from the literature (Bignell and Thomas, 2001). Complementation assay was 
attempted several times using the vector pMV261 withou  success, it is likely that the 
impaired partitioning function of the disrupted gene MSMEG_3743 prevents the correct 
replication of the plasmid; therefore, I suggest performing the complementation assay 
using an integrative vector as pMV306 bearing the promoter of the gene in order to avoid 
the potential loss of the plasmid and to allow the transcription under native conditions.  
The putative role in coordination and/or regulation of the cell cycle given to the ParA-like 
homolog shows it a potential candidate for drug taret.  
 
2.4 MATERIALS AND METHODS 
 
2.4.1  Phages, bacterial strains and growth conditions 
 The bacterial strains, plasmids and bacteriophages us d in this screening are listed 
in Table 2.2. M. smegmatis strain was grown in TSB liquid media containing, 0.05% 
Tween-80 (surfactant agent to avoid clumping effect of he lipid cell wall) and on TSB-
1.5% agar plates at 37°C; Escherichia coli was grown in LB broth and on LB-1.5% agar 
plates at 37°C. Hygromycin B was added at concentrations of 50 or 100 µg/ml for M. 
smegmatis and 150 µg/ml for E. coli. The transposon is a mariner variant with a 
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hygromycin resistance cassette and carried an origin of replication in E. coli which allows 
the transposon along with the insertion site to be rescued from the genomic DNA, as a 
plasmid replicating in E.coli C118 λpir, to be sequenced. High titre bacteriophage lysate 
was prepared as explained in the General Materials and Methods chapter (Larsen t al., 
2007). 
 
Table 2.2: Phages and bacterial strains used 
Phage/ Bacteria Genotype or description Reference 
   




Temperature-sensitive derivative of 
mycobacteriophage TM4 containing the 
Himar1-derived transposon Tn5371. HygR 
 
 
Rubin et al., 1999 
Kriakov et al., 2003 
   





CC118 lysogenized with λpir phage 
 
Manoil and Beckwith, 1985 







Parental strain, ept-1 mutation conferring 
high efficiency of plasmid transformation 
Snapper et al., 1990 
 
 
2.4.2 Transposon mutagenesis and isolation of mutants 
 M. smegmatis culture was grown in 50 ml of TSB-0.05% Tween-80 to an OD600 
value of 1. Tween is a non-ionic surfactant added as an emulsifier between the liquid 
media and the lipidic surface of the cells. The cells were harvested by centrifugation at 
room temperature, washed twice with 50 ml MP buffer (50 mM Tris/HCl pH 7.6, 150 mM 
NaCl, 10 mM MgCl2 and 2 mM CaCl2) and then resuspended in 1ml of MP buffer. An 
aliquote of 0.5 ml was mixed with high titre phage lysate 1010 to 1011 pfu/ml at a 
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multiplicity of infection (MOI) of 10, a control sample was prepared adding 0.5 ml of MP 
buffer instead. After incubation at 37°C for 3 hours without agitation, the cells were 
harvested and resuspended in 1 ml TSB plus 0.05% Tween-80. Cells were recovered at 
37°C overnight, plated on TSB-Hyg50 agar and then incubated at 37°C for 4 to 5 days.  
 Hygromycin resistant strains were selected and inoculated in 96-well plates 
containing TSB-Hyg100 media without Tween-80 in order to allow the biofilm pellicle 
formation. Rifampicin increased sensitivity was tested by plating on TSB-agar plates with 
and without rifampicin by using a spike replicator from cultures grown in 96-well plates 
and incubated at 37°C for 4-5 days, the concentrations of antibiotic used were 5 and 7.5 
µg/ml (from stock solutions 50 mg/ml dissolved in dimethyl sulfoxide) which were lower 
than the 30 µg/ml previously reported for M. smegmatis mc2155 (Chakravorty et al., 2008), 
additionally, a MIC of 20 µg/ml was obtained for the wild type strain used in this study. 
The hygromycin resistant colonies showing loss of the biofilm pellicle formation in 96-
well plates, defective colony morphology or rifampicin sensitivity were selected for 
sequencing and further analysis. Selected strains were grown until late-log phase in TSB-
broth containing 0.05% Tween-80 in order to observe cording and colony morphology. For 
cording, 1 ml of culture was spun for 10 s to remove cell aggregates, 10 µl were loaded on 
microscope slides, air-dried out and observed at magnification 1000x using immersion oil; 
colony morphology was observed on TSB-agar plates plating 10 µl drops of serial dilutions 
(10-2 to 10-6) and also streaking agar plates in order to obtain single colonies. 
 
2.4.3 Isolation and sequencing of transposon insertion sites 
 Genomic DNA was extracted from the transposon mutant strains (see General 
Materials and Methods chapter), digested with BssHII and then ligated with T4 ligase. The 
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resulting ligated fragments were used to transform E. coli CC118λpir by heat shock 
procedure and selecting the self-ligated fragments that contained the Tn5371 with the 
hygromycin cassette and the R6K ori. The colonies ristant to hygromycin were 
inoculated into LB broth with hygromycin to obtain plasmid DNA that was sequenced 
using the primers marinerKMN1 (Tn5371-L) 5’-AGTGCCACTAAATTGTAAGC-3’ 
and marinerHyg (Tn5371-R) 5’-TAGACAGATCGCTGAGATAGG-3’ to obtain the 
sequences of the regions flanking the insertions. Since the disruption of the gene by the 
transposon includes the insertion of a hygromycin resistance cassette, the RNA 
transcription of the disrupted genes was not checked by RT-PCR or any other method. 
Downstream effects of the disruptions were expected for genes forming part of an operon. 
 
2.4.4 Fluorescence microscopy 
 M. smegmatis mc2155 10 ml culture was grown to stationary-phase in tryptic soy 
broth at 37ºC and agitation. The cells were collected by centrifugation. Prior to DAPI 
staining, the cells were permeabilized by exposure to toluene 0.3% for 20 min at 37ºC and 
then washed twice in phosphate-buffered saline PBS (10 mM sodium phosphate, 150 mM 
NaCl, 15 mM KCl, pH 7.4). Vectashield containing DAPI 1.5 µg/ml was added and 
incubated for 20 min. For membrane visualisation, the cells were incubated with the 
membrane dye, FM4-64 at a final concentration of 0.5 µg/ml for 1h and 10 µl of sample 
were mounted on poly-L-lysine coated slides. 
 The cells were visualized by brightfield and fluorescence microscopy using a 
Nikon Eclipse TE-300 microscope, capture and image nalysis was conducted using 
Analysis (Olympus) and a Nikon super high-pressure mercury lamp. A Nikon filter set 
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(Ex528-553/Em600-660) was used for FM4-64 stained cells and DAPI-stained cells were 






























ADDRESSING THE ROLE OF MMPL GENES IN MYCOLIC 


















 Mycolic acids (MA) are major cell wall components of the genus Mycobacterium 
and are required for viability and virulence (Bhatt et al., 2005, 2007; Dubnau et al., 2000; 
Glickman et al., 2000; Vilchèze et al., 2000). As discussed in Chapter One, MA are very 
long chain α-alkyl, β-hydroxy fatty acids (C60 to C90) that can be found associated with 
the cell wall in two different ways: 1) Covalently attached to arabinogalactan (AG) which 
is also bound to the peptidoglycan of the cell wall by phosphodiester bond on the internal 
region of the outer membrane and 2) Present as a part of the interspersed glycolipids in the 
form of simple monomycolyl glycerol (MMG), glucose monomycolate (GMM), trehalose 
monomycolate (TMM) and trehalose dimycolate (TDM) (Besra et al. 1994; Andersen et 
al., 2009).  
 MA confer important features to mycobacteria, which include resistance to 
chemicals such as hydrophobic antibiotics and dryness, low permeability of the cell wall, 
the ability to stain acid-fast and form biofilms. In Mycobacterium tuberculosis, mycolates 
are also critical for virulence and the persistance i side the host (Daffé and Draper, 1998; 
Yuan et al., 1998; Dubnau et al., 2000; Glickman et al., 2000; Ojha et al., 2005; Bhatt et 
al., 2007). Moreover, chain modifications such as cyclopropane rings, keto and methoxy 
groups play an important role in immunomodulation si ce mutant strains that exhibit 
altered MA subtypes have shown hypersusceptibility to the host immune response, 
alterations in cell wall permeability and also resulted in virulence attenuation (Glickman et 
al., 2000; Rao et al., 2005, 2006; Bhatt et al., 2007).  
 In mycobacteria, the biosynthetic pathway of MA involves two enzymatic systems. 
The type-I fatty acid synthetase (FAS-I), a multidomain peptide found in eukaryotes 
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(mammals and fungi) and prokaryotes; and also the typ -II fatty acid synthetase (FAS-II), 
which is found in plants and bacteria. The FAS-I synthase, who also provides the fatty 
acids for phospholipids, synthesises the precursors for MA elongating a growing fatty acid 
chain by two-carbon units, using acetyl-CoA and malonyl-CoA as substrates to produce 
C16 and C26 fatty acids. The C16 acyl-CoA is the prcu sor for the production of 
meromycolic acids via FAS-II elongations where a protein called FabH acts as the link 
between the two systems by catalysing the condensation of the FAS-I-derived acyl-CoAs 
with malonyl-acyl carrier protein (ACP) (Choi et al., 2000; Brown et al., 2005, 2007). The 
product of the condensation is then incorporated by FAS-II as a substrate for the synthesis 
of the very long mero chain of α-, methoxy- and keto- mycolic acids while the C26 fatty 
acid unit corresponds to the short α-branch of the resulting MA. The latter steps involve 
four enzymes that act successively elongating the fatty acid to meromycolates (C56), the 
condensing KasA and KasB, the keto-reductase MabA, the hydroxyacyl-dehydratase and 
the enoyl-reductase InhA. The final step is catalysed by the polyketide synthase Pks13, 
which condensates the α-branch and the meromycolate to produce MA (Quemard et al., 
1995; Schaeffer et al., 2001; Kremer et al., 2002; Gande t al., 2004; Portevin et al., 2004; 
Takayama et al., 2005; Bhatt et al., 2007; Brown et al., 2007).  
 Although steps implicated in the biosynthesis of MA have been described, the 
components that are involved in mycolate transport and deposition in the cell wall still 
remain unidentified. A hypothetical pathway has been proposed that involves the transfer 
of a mature mycolate to an isoprenoid carrier, forming MycPL (6-O-mycolyl-β-D-
mannopyranosyl-monophospho-heptaprenol) (Besra et l., 1994), and subsequently to 
trehalose inside the cell to yield TMM (Takayama et al., 2005). TMM is then proposed to 
be transported by a yet unknown mechanism outside the cell, where it is the substrate of 
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the mycolyltransferases of the Ag85 complex (Belisl et al., 1997; Puech et al., 2002), 
transfering the mycolate unit to either the AG complex, or to another TMM resulting in 
formation of TDM (Fig. 3.1). Alternatives to this hypothetical pathway may involve 
intracellular synthesis of TDM prior to transport, or the flipping of Myc-PL outside the cell 
to be used as substrate for extracellular formation of TMM.  
 
 
Figure 3.1: Schematic diagram of putative 
steps in MA biosynthesis and transport in M. 
tuberculosis. Hypothetical pathway proposed by 
Takayama et al., 2005. Inside the cell, a mature 
mycolate would be transferred to a carrier (PL: 
mannophospho-heptaprenol) and subsequently to 
trehalose to yield TMM, which would be 
transported outside by an unknown mechanism. 
Alternative steps are shown by hatched or dotted 




As it is clear from the literature already 
cited, the MA metabolism is critical for 
viability and virulence, therefore the 
understanding of MA transport will open 
new options for discovering targets and 
developing new drugs against it. In this 
chapter, I describe the potential role of a 
class of transmembrane (TM) proteins, designated MmpL (mycobacterial membrane 
protein large), as the transporter of MA in mycobacteria. 
 The genomes of M. tuberculosis H37Rv and other mycobacteria contain genes 
encoding proteins that belong to a family of multidrug resistance pumps called RND 
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proteins (resistance, nodulation, and division), normally contain 12 TM domains and two 
non-TM loops (Cole et al., 1998; Domenech et al., 2005). Due to the efflux pump nature of 
MmpL proteins, the genes encoding them have become of high interest to understand drug-
resistance mechanisms; nevertheless, only MmpL5 has been hypothetically described as a 
drug-efflux system for azoles, clofazimine and bedaquiline, where a transcriptional 
regulator encoded by Rv0678 has been shown to be implicated in resistance to the 
compounds via upregulation of mmpL5 in M. tuberculosis (Milano et al., 2009; Hartkoorn 
et al., 2014). So far, none of the other mycobacterial MmpLs studied appears to play any 
role in drug resistance even though when some of them ave shown to share transcriptional 
regulation systems with mmpL5, like in the case of mmpL2 and mmpL4 (Radhakrishnan et 
al., 2014). In fact, recently, mmpL4 and mmpL5 have been described as part of an novel 
siderophore export system which is essential in the virulence of M. tuberculosis (Wells et 
al., 2013). The gene mmpL7 conferred resistance to isoniazid when overexpressed in 
Mycobacterium smegmatis but the M. tuberculosis mmpL7 mutant did not display altered 
sensitivity to the drug (Pasca et al., 2005). Instead, many mmpL genes are associated with 
clusters involved in the biosynthesis of cell wall-associated glycolipids like sulfolipids, 
polyacylated trehalose (PAT), glycopeptidolipids, lipooligosaccharides and other complex 
lipids like phthiocerol dimycocerosate (PDIM) where th y are required as scaffolds for the 
biosynthetic machinery, allowing localized synthesis of a cell wall associated lipid together 
with ABC-transporter or smaller MmpS protein to facilitate transport (Cole et al., 1998; 
Converse et al., 2003; Cox et al., 1999; Domenech et al., 2004, 2005; Sondén et al., 2005; 
Deshayes et al., 2010; Rombouts et al., 2011). In the case of PDIM biosynthesis, a two 
hybrid screening using the non-TM domains of the PDIM transporter MmpL7 revealed 
interactions with enzymes implicated in later stages of biosynthesis of the phthiocerol 
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moiety (Jain and Cox, 2005). On the other hand, MmpL8 has been found involved in 
sulfolipid SL-1 biosynthesis as part of a protein complex that translocates either the final 
lipid or an intermediate to the extracytoplasmic side (Converse et al., 2003; Domenech et 
al., 2004), as well as the case of MmpL10, whose functio  has been associated to 
diacyltrehalose/polyacyltrehalose (DAT/PAT) biosynthesis (Rodríguez et al., 2013). 
 Given that MmpLs proteins are predominantly involved in the transport of different 
glycolipids, it seemed likely that one of them could a so be involved in the translocation of 
a mycolate-containing glycolipid such as TMM, TDM, or Myc-PL to the outside of the 
bacterial cell for subsequent use as a substrate for cell wall mycolylation. 
 Mycobacterium leprae, contains a high degree of genetic decay and has an int ct 
cell wall containing MA, therefore, it is a valuable organism to use when considering 
essential candidate genes for functions related to the cell wall, like MA metabolism. Only 
five out of fourteen homologs of mmpL genes from M. tuberculosis are present in M. 
leprae, where only mmpL3 was predicted to be an essential gene (Domenech et al., 2005). 
Due to the essentiality of MA for viability of mycobacteria (Vilchèze et al., 2000; Portevin 
et al., 2004; Bhatt et al., 2005; Parish et al., 2007), it was likely that mmpL3 was involved 
in mycolate transport in M. tuberculosis.  
 In this study, I have investigated the role of mmpL3 in MA transport and 
biosynthesis by generating and characterising a conditi al mutant of MSMEG_0250, the 
homolog of the M. tuberculosis mmpL3 (Rv0206c) in the fast growing and non-pathogenic 
M. smegmatis. In parallel, to overcome the complications of gene essentiality, I also 
compared and contrasted the potential role of mmpL genes in mycolate transport in 
Corynebacterium glutamicum. In this organism, the MA biosynthesis associated g nes are 
not essential and thus viable mycolate-less mutants can be generated. Its cell wall is similar 
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to mycobacteria but with a less complex structure and composition level since 
corynebacteria only synthesises trehalose monocorynom colates (TMCM) and trehalose 
dicorynomycolates (TDCM) as extractable lipids, apart from the membrane inserted 
lipoglycans. For instance, members of the genus Corynebacterium has been previously 
used as model for the study of MA metabolism and a mutant for an ABC-transporter 
produces altered mycolates as an indirect effect of an impaired lipoglycan biosynthesis 
(Mishra et al., 2008; Wang et al., 2006).  
  In this context, a complete characterisation of the strains was performed in order to 





3.2.1 mmpL3 is an essential gene in mycobacteria 
 In M. tuberculosis, mmpL3 was first proposed to be an essential gene by Domenech 
et al. (2005) on the basis of the inability to obtain an mmpL3 knockout mutant. While the 
gene is not located near any known MA biosynthesis gene, the gene cluster surrounding 
mmpL3 shows a high level of synteny with other mycobacterial species including M. 
leprae. This includes the presence of three putative membrane associated proteins and a 
second mmpL gene, mmpL11, situated downstream of mmpL3 (Fig. 3.2), whose mutant 
strain have been reported as attenuated in the mouse model of infection by Domenech et al. 
(2005), on the other hand, the M. smegmatis mutant strain has shown reduced membrane 
permeability and also altered biofilm formation (Purdy et al., 2009; Pacheco et al., 2013).   
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 A knockout phage was designed to delete MSMEG_0250, the M. smegmatis 
homolog of mmpL3, and consistently with findings from previous studies (Domenech et 




Figure 3.2: Map of the mmpL3-mmpL11 region in different mycobacteria genomes. Homologous genes 
are indicated by similar arrows. Hatched borders indicate genes found exclusively in M. smegmatis and a 




 Subsequently, CESTET (Conditional expression–specialized transduction 
essentiality test), a tool designed to test gene ess ntiality in M. smegmatis, was used to 
obtain a conditional mutant of the gene MSMEG_0250 (Fig. 3.3). The technique consists in 
the generation of a merodiploid strain carrying a second copy of a putative essential gene 
under the control of the acetamidase promoter, the replacement of the target gene with a 
selection marker using a phage that contains an allelic-exchange substrate and finally the 
growth of the strain in the presence or absence of acetamide (Bhatt et al., 2005; Bhatt and 
Jacobs, 2009).  
 




Figure 3.3: Schematic diagram of CESTET in Mycobacterium smegmatis mc2155. Left side: The 
recombinant phage is transduced into a merodiploid strain and homologous recombination produces allelic 
exchange deleting the native copy of the putative essential gene (MSMEG_0250). Right side: The 
transductants strains are selected on hygromycin-containing medium with or without acetamide. When the
gene tested is essential the growth is only observed on plates containing acetamide. kan and hyg resistance 
cassettes; Pac, inducible acetamidase promoter; dotted and solid arcs represent the integrative vector and the 




 In this study, the strain ∆MSMEG_0250 was constructed containing a recombinant, 
integrated copy of mmpL3 under the control of the inducible acetamidase promoter, while 
the native copy of the gene was replaced with a hygromycin resistance cassette, the strains 
generated were confirmed by Southern and used in the study. They were spotted in two 
different agar-plates with and without acetamide, showing that the viability of 
∆MSMEG_0250 was dependent on the addition of the inducer in the growth medium, 
confirming that MSMEG_0250 was an essential gene (Fig. 3.4). Growth analysis in liquid 
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media was not performed since the conditional mutant lysis in absence of acetamide was 
clearly easy observed after the depletion of the remaining MmpL3 protein. 
 
 
Figure 3.4: Essentiality of MSMEG_0250 in M. smegmatis mc2155. Growth of the conditional mutant 
∆MSMEG_0250 and parental merodiploid strain (mc2155::pMV306-mmpL3) on TSB-agar with or without 
the inducer acetamide. 10 µl of 10-fold serial dilutions of cultures were spotted on the agar plates and 
incubated for 5 days at 37ºC. (Varela t al., 2012. License Nº 3244880310622 ). 
 
 
3.2.2 MmpL3 is involved in mycolic acid transport in mycobacteria 
 In order to address the putative role of MmpL3 in MA transport, the effects of 
depletion of MSMEG_0250 on lipid metabolism in the M. smegmatis conditional mutant 
were tested. Cultures of the ∆MSMEG_0250 conditional mutant were grown in broth in the 
presence or absence of acetamide and labelled with [14C]-acetate at different time points. 
Using a three stage extraction procedure the lipids were collected and analysed as follows: 
1) Petroleum ether extraction of the cell pellet noaffecting the integrity of the cells, but 
extracting the surface-exposed, noncovalently bound cell wall lipids; 2) Extraction of 
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apolar and polar lipids from the previously treated pellet; and 3) Extraction of AG-bound 
mycolic acids from the resultant delipidated cells. For cultures grown in the presence of 
acetamide, TMM was predominantly found in the apolar lipid extract from cell pellets and 
TDM in both the petroleum ether extract and in the apolar lipid extract. Nevertheless, an 
earlier examination performed using M. smegmatis cell pellets extracted with consecutive 
treatments of petroleum ether, indicated that no further TDM was extracted from cells after 
the third consecutive extraction. Each petroleum ether extract of the ∆MSMEG_0250 
conditional mutant represent a pool of five consecutive extractions of the same sample and 
thus the presence of TDM in the subsequently processed cell pellet was not due to 
insufficient petroleum ether extraction. The exact lo ation of these cell-associated TDM 
molecules that resist petroleum ether extraction is unknown, but it is possible that they 
represent newly synthesized TDM that is closer to the inner membrane and thus 
inaccessible to petroleum ether extraction. In contrast to the cultures of the conditional 
mutant grown in the presence of acetamide, [14C]-labeled cultures grown in the absence of 
acetamide showed an increasing amount of TMM in cell pel ets, which was accompanied 
by decrease in TDM levels both in the petroleum ether extracts and in the apolar fraction 
from cells. Conditional depletion of MSMEG_0250 also resulted in a decrease in 
mycolylation of AG. The accumulation of TMM in the cells over time following 
conditional depletion suggested that loss of MSMEG_0250 function affected TMM 





















Figure 3.5: Lipid analysis of the ∆MSMEG_0250 conditional mutant.  
Cultures were grown and labeled in TSB, (–) or (+) acetamide and the samples were collected at the indicate  
times. 
(A) 2D-TLC analysis of [14C]-labelled lipids from ∆MSMEG_0250 strain. Fraction-I: petroleum ether 
extracts; Fraction-II: intracellular apolar lipids. Fractions were separated in two directions, Direction 1 using 
chloroform:methanol:water (100:14:0.8) and Direction 2 using chloroform:acetone:methanol:water 
(50:60:2.5:3). TMM and TDM are indicated by dotted and solid arrows, respectively.  
(B) TLC analysis of methyl esters of [14C]-labelled cell wall bound mycolic acids. MAMES were separated 
using petroleum ether:acetone (95:5) as the solvent system. Methyl esters of the different subclasses of 
mycolic acids are indicated by arrows as well as the origin and the direction of the moving phase. 
(C) TMM and TDM levels (%) from TLC (A) measured bydensitometry. (-) and (+): acetamide (Figure by 
A. Singh). 
(Varela et al., 2012. License Nº 3244880310622 ) 
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3.2.3 Bioinformatic analysis of potential mmpL genes in corynebacteria 
 As it was previously described, the cell wall of crynebacteria is similar to the cell 
wall of mycobacteria, containing TMCM and TDCM as the outer non-covalently bounds 
glycolipids. Due to the existing similarities, a parallel study in corynomycolate 
biosynthesis was conducted, also assuming that an MmpL-like protein was involved in its 
transport. Therefore, using the BLAST, a search in the C. glutamicum genome was carried 
out in order to find mmpL genes, with the amino acid sequence of the M. tuberculosis-
MmpL3 protein as a query sequence. Additionally, a cluster analysis was performed, 
comparing the C. glutamicum genome with the mmpL3-mmpL11 region from M. 
tuberculosis as query sequence using the MycoDB database.  
 The C. glutamicum ATCC13032 genome was found to contain four mmpL-like 
genes, including NCgl0228, NCgl0599, NCgl0887 and NCgl2769. BLAST results details 
were NCgl0228: Id 25%, E=5e-47; NCgl0887: Id 37% and 25% for the main alignment 
segments and E=4e-30 for the whole sequence; and NCgl2769: Id 43% E=8e-159. On the 
other hand, the search revealed that there is no corynebacterial region equivalent to the 
mycobacterial mmpL3-mmpL11 cluster. Although, NCgl0887 is situated in a cluster that 
contains NCgl0885, a putative trehalose corynomycolyl transferase; while NCgl2769 is 
present downstream of the corynomycolate condensase gene, pks13 (which encodes Pks13, 
the enzyme catalysing the condensation of the meromyc late and α-chains) and two 
putative esterases genes: NCgl2777 and NCgl2779 (Fig. 3.6). Given both, the genetic 
context of NCgl0887 and NCgl2769, and the far lesser complexity of the cell wall of C. 
glutamicum, it was likely that any of these three mmpL genes were involved in 
TMCM/mycolate processing and transport. The gene NCgl0599 has been previously found 
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related with a cluster of a carotenoid/lycopene pigment biosynthesis, thus was not consider 




Figure 3.6: Diagrammatic representation of the genomic map of the putative mmpL genes of Corynebacterium 
glutamicum ATCC 13032.  The regions surrounding the three RND superfamily drug-exporter genes do not show 
synteny unlike it was seen for the Mycobacterium genus region mmpL3-mmpL11. Grey boxes indicate genes 
encoding for hypothetical proteins. Fragment size: 10kb. 
 
   A topology prediction was carried out using the MmpL3 sequence showing that the 
protein contains 12 TM domains and 2 non-TM loops, named L1 and L2 of sizes 151 and 
142 amino acids, respectively. On the other hand, in silico analysis of the MmpL3-like 
amino acid sequences showed a similar topology with bo  loops and TM-domains present 
as well. NCgl0228 and NCgl2769 amino acid sequences revealed predicted topologies 
similar to the M. tuberculosis-MmpL3 (12 TM domains and two non-TM loops), while 
NCgl0887 predicted topology was 11 TM and the L1-loop facing the cytoplasm. The non-
TM loops could be, potentially, involved in interactions with the mycolic acid biosynthesis 
machinery. (Fig. 3.7). 
 




Figure 3.7: Predicted topology of MmpL3 and corynebacterial MmpLs. TM regions are indicated by 
cylinders and are numbered while the non-TM loops of MmpL3 are indicated as L1 and L2. The carboxy- 
and amino- termini are indicated by C and N, respectiv ly. Topology predictions were done using the 
Mobyle@Pasteur server and the TopPredII tool. (Varela et al., 2012. License Nº 3244880310622). 
 
3.2.4 Redundant mmpL functions in Corynebacterium glutamicum 
 As corynomycolic acid biosynthesis is a non-essential process, it is possible to 
generate viable mutants of corynebacteria that do not produce corynomycolates and the 
loss of corynomycolic acids from the cell envelope results in poor growth rates leading to 
smaller colonies (Gande t al., 2004). To probe the role of mmpLs in corynomycolate 
transport, individual in-frame deletion mutants were generated for the genes NCgl0228, 
NCgl0887, and NCgl2769 from C. glutamicum ATCC13032. None of the three mutant 
strains ∆NCgl0228, ∆NCgl0887, and ∆NCgl2769 showed any alterations in colony size or 
appearance. To investigate potential functional redundancies between the three C.
glutamicum mmpL genes, double and triple mutant strains were constructed. While the 
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colony sizes and appearance of the double mutants, ∆NCgl0228-∆NCgl0887 and 
∆NCgl0887-∆NCgl2769, remained unaltered, the ∆NCgl0228-∆NCgl2769 mutant formed 
smaller colonies and showed clumpy pattern growth in broth. A similar growth defect was 
observed for the triple mutant ∆NCgl0228-∆NCgl0887-∆NCgl2769. Thus, while single 
deletions of NCgl0228 or NCgl2769 did not have any effect, the concurrent loss of 
NCgl0228 and NCgl2769 severely affected the growth patterns of the mutant strain, 
indicating potential alterations in the cell wall (Fig.3.8). 
 
 
Figure 3.8: Growth characteristics of the C. glutamicum mmpL-mutants. Strains were grown at 30ºC 
using BHI media (agar plates and broth cultures). The pictures show healthy strains when at least one of 
NCgl0228 and NCgl2769 genes is present; on the other hand, the mutation of both genes severely impaires 
the grown in liquid and solid media as shown in thelast two strains on the right. Healthy strains were 
incubated for 48 h, while the defective ones were incubated for 5 days. Scale bar represents 1 mm. (Varela et 
al., 2012. License Nº 3244880310622). 
 
 
3.2.5 NCgl0228 and NCgl2769 play a role in corynomycolate metabolism 
 To determine whether the altered growth phenotype observed for some of the C. 
glutamicum mmpL mutants were linked to defects in corynomycolate transport, petroleum 
ether extracts of surface exposed lipids, and subsequent, remaining total lipids were 
extracted from [14C]-acetate-labelled cell pellets. TLC analysis showed that the parental 
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strain and most mutant strains produced TMCM and TDCM, with the latter found 
predominantly in the petroleum ether extracts containing surface-exposed lipids (Fig.3.9 
A-B). Furthermore, levels of AG-bound corynomycolic a ids for most mutant strains were 
the same as the parental, wild-type strain C. glutamicum. The two exceptions were the 
∆NCgl0228-∆NCgl2769 and ∆NCgl0228-∆NCgl0887-∆NCgl2769 mutant strains, in which 
no TMCM or TDCM were detected in the petroleum ether extracts or in the cell pellets. 
Additionally, no AG-bound corynomycolic acids were observed in the ∆NCgl0228-
∆NCgl2769 and ∆NCgl0228-∆NCgl0887-∆NCgl2769 strains (Fig.3.9 C). The absence of 
any TMCM, TDCM, and AG-bound corynomycolates suggested either that there was a 
complete cessation of corynomycolic acid biosynthesis in the double and triple mutants or 
that corynomycolates were being transported in an altern te (carrier-bound) form that was 
used as substrate for TMCM, TDCM, and AG-bound coryn mycolate synthesis. However, 
the latter seemed less likely as no intermediates wre seen to accumulate in the 
∆NCgl0228-∆NCgl2769 and ∆NCgl0228-∆NCgl0887-∆NCgl2769 mutants. These results 
also indicated a functional redundancy between NCgl0228 and NCgl2769 with regards to 
corynomycolate metabolism. No additional alterations i  lipid profiles were observed in 
the triple mutant suggesting that NCgl0887 did not play any apparent role. 
Complementation of the double mutant with either plasmid-borne NCgl0228 or NCgl2769 
restored corynomycolate biosynthesis, though in case of the latter gene, the 
complementation was partial since neither TDCM nor TMCM appear clearly in the TLCs. 
In order to elucidate the presence of corynomycolates in that strain, the total lipids sample 
was purified using an anion exchange column which allows collecting apolar lipids 
fractions. The purification showed the presence of small amounts of both TDCM and 
TMCM as an effect of the complementation with pVWEx2-NCgl2769  (Fig.3.10). 
 





Figure 3.9: Lipid analysis of the C. glutamicum mmpL mutant strains. 
 
A and B: TLC analysis of [14C]-labelled lipids extracted from C. glutamicum mmpL mutant strains, using 
CHCl3:CH3OH:H2O (60:16:2) as the solvent system. A: petroleum ether extracts, B: total lipids from 
petroleum ether-treated cells. 
C: TLC analysis of [14C]-labelled fatty acid methyl esters (FAMES) and coryn mycolic acid methyl esters 
(CMAMES) extracted from delipidated cells, using petroleum ether:acetone (95:5) as the solvent system; 
pks13 null mutant does not produce corynomycolic acids, was used as a control. The trend observed in panels 
A and B for the TDCM band correspond to an artifact produced by solvent who runs faster through the 
matrix on the extremes of the silica plate, the effect is increased due to the large width of the plate used  
(Varela et al., 2012. License Nº 3244880310622). 
 
 





Figure 3.10: Complementation of the C. glutamicum mmpL double-mutant strain. TLC analysis of A: 
total lipids and B: AG-bound corynomycolates, from complemented C. glutamicum ∆NCgl0228-∆NCgl2769 
double-mutant strains. 
* lanes showing purified apolar lipids samples from wild-type and double mutant complemented with 
pVWEx2-NCgl2769 strains (same samples loaded in A), after removing polar lipids, more clear bands 
appeared as evidence of TDCM and TMCM presence. Conditi s as stated in fig. 3.9. (Varela et al., 2012. 





 To understand the corynomycolates biosynthetic pathw y is paramount to identify 
the transport step once the trehalose molecule has been transferred to the mature mycolate 
inside the cell. It has been demonstrated that when t  condensation step is impaired, C. 
glutamicum does not produce MA and exhibits an altered cell envelop. Moreover, the same 
process is vital for survival in Mycobacterium (Gande et al., 2004; Portevin et al., 2005; 
Gavalda et al., 2009). The deletion of both Rv0206c homologous NCgl0228 and NCgl2769 
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in C. glutamicum ATCC13032 produced a similar effect, which is lack of both TMCM and 
TDCM in the cell wall, together with a deficient growth phenotype.  
 This study has demonstrated that mmpL3 plays a role in MA transport. The 
intracellular accumulation of TMM in the ∆MSMEG_0250 mutant following conditional 
depletion suggested that TMM was the likely carrier for the MA moiety. The exported 
TMM is presumably used as substrate by the enzymes of the Ag85-complex for 
mycolylation of the cell wall AG and the formation f cord factor (TDM). These findings 
were complemented by the recent studies of La Rosa et al. (2012) and Tahlan et al. (2012) 
who used a drug-to-target approach, with the latter demonstrating that treatment with a 
compound that targeted MmpL3 resulted in a phenotype identical to what we observed 
with the M. smegmatis conditional mutant. Additionally, at the moment this study was 
performed, Grzegorzewicz et al. (2012) reported that AU1235, an adamantyl urea inhib tor 
of M. tuberculosis, also targeted MmpL3. Notably, the authors observed a decrease in the 
TDM and AG-bound mycolates content in M. tuberculosis cells treated with AU1235, and 
higher levels of TMM inside. Additionally, they were also able to reproduce the effects of 
AU1235 in a M. smegmatis conditional mmpL3 mutant; showing similar results to that 
obtained for the ∆MSMEG_0250 mutant described in this study.  
 Recent studies have reported that spontaneous resitance observed to the 
antitubercular compounds BM212 and SQ109 occurs as the result of mutations in mmpL3 
gene. Furthermore, cells exposed to SQ109 have displayed accumulation of intracellular 
TMM, strongly suggesting that the MmpL3 transporter function should be the efflux of 
TMM (LaRosa et al., 2012; Tahlan et al., 2012). Interestingly, in a recent unpublished 
study, I have observed that the C. glutamicum mutant strain ∆NCgl0228 exhibits a lower 
MIC to SQ109 even though the strains showed a normal corynomycolates production 
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suggesting the transporter could be acting as an efflux pump for SQ109 with high 
specificity (unpublished results).   
 The complex nature of mycolic acids biosynthesis leads to the idea that the 
transport mechanism of TMM may not be solely carried out by MmpL3. Previous studies 
in glycolipids transport of mycobacteria have shown that MmpL proteins may require the 
concerted action of several proteins forming complexes; in M. smegmatis, the biosynthesis 
of GPL is carried out by a membrane-bound megacomplex where MmpL4a and MmpL4b 
act as scaffold along with MmpS4, a third transmembrane protein termed Gap, a 
polyketide synthase and several other proteins (Deshayes et al., 2010; Sondén et al., 2005). 
In this context, the existence of a membrane-bound protein complex involved in mycolic 
acids transport was proposed and blue native polyacrilamide gel electrophoresis (BN-
PAGE) technique was performed in order to find protein-protein interactions involving 
MmpL3. Native membrane fractions from C. glutamicum strains where analysed, 
unfortunately, the isolation of native protein complexes from clumped cell pellets of 
growth-defective mutants was unsuccessful.  
 The region downstream of mmpL3 encodes two TM proteins, Rv0204c and Rv0205, 
which may form part of a complex involved in the transport of TMM. Additionally, the 
biosynthetic clusters for PDIM also contain ABC transporters and thus the role of ABC 
transporters in mycolates transport (acting in conjunction with MmpL3) remains a 
possibility. A recent study by Tullius et al. (2011) has suggested a role for the mmpL3-
mmpL11 gene cluster in heme transport; interestingly, both mmpL4 and mmpL5 have been 
described as part of siderophore export systems (Wells et al., 2013), perhaps the iron-
uptake function remains as an ancient role between th  paralogs of the mmpL family after 
the speciation process. A dual function seems also be a fact for MmpL5, as mentioned 
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before, the protein has been hypothesised to be the fflux-pump for azoles that affect the 
biosynthesis of sterol in mycobacteria (Milano et al., 2009); therefore both iron- and sterol-
metabolism appear to be connected via mmpL5 and its tran criptional regulator, a similar 
situation has also been described in Cryptococcus neoformans, where sterols biosynthesis 
and iron homeostasis are linked via the regulator Sre1p under stress conditions (Chang et 
al., 2007). The authors reported that they were also ble to delete a region of the M. 
smegmatis genome that included MSMEG_0250. In this study, it was not possible to 
generate an individual null mutant of MSMEG_0250 in M. smegmatis mc2155 despite 
repeated attempts, consistently with results observed for the M. tuberculosis homolog by 
Domenech et al., 2005. Specifically for mmpL11, previous studies did not report any 
alteration in the lipid profile of the mutant; nevertheless, a recent study has shown 
intracellular accumulation of the mycolic acid-precursor MycPL and also the inability to 
export monomeromycolyl diacylglycerol (MMDAG) and mycolate ester wax in M. 
smegmatis mutant (Pacheco et al., 2013), revealing the crucial role of this conserved 
cluster in the cell wall biogenesis. However, the essentiality of the gene MSMEG_0250 
was demonstrated using CESTET and it was also showed that conditional depletion caused 
a loss of TDM and of cell wall AG-mycolylation, along the intracellular accumulation of 
TMM, downstream effects should not have been occurred as result of the disruption of 
MSMEG_0250 since the orientation of MSMEG_0249 indicates that the gene is under the 
control of a different promoter, moreover, the MSMEG_0250 gene was enough to restore 
the function via CESTET. In contrast to mycobacteria, I observed several differences in the 
role of mmpL genes in corynomycolate transport in C. glutamicum. First, there was no 
equivalent corynebacterial cluster exhibiting synteny with mycobacterial mmpL3-mmpL11 
region. Instead, a functional redundancy was observed between NCgl0228 and NCgl2769 
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located in two distinct regions of the C. glutamicum genome. Individual deletion of either 
of these mmpL genes did not have any effect, but simultaneous deletion of both genes led 
to complete loss of TMCM, TDCM and AG-bound corynomycolates. This was in contrast 
to the M. smegmatis conditional mutant where conditional depletion of MSMEG_0250 led 
to loss of TDM and AG mycolylation, but intracellular accumulation of TMM. As 
mentioned above, while this result raised the possibility that corynomycolate transport may 
involve a carrier other than TMCM, this seemed highly unlikely, given the absence of any 
accumulating intermediate in the C. glutamicum ∆NCgl0228-∆NCgl2769 and ∆NCgl0228-
∆NCgl0887-∆NCgl2769 mutant strains. Instead, variations in the phenotypes of the 
mycobacterial and corynebacterial mutants may be a reflection of fundamental differences 
in mycolic acid biosynthesis in the two genera. Mycobacterial mycolic acid biosynthesis 
requires several components including a multidomain FAS-I, a multienzyme FAS-II 
complex, modifying enzymes and Pks13 (Radmacher et al., 2005; Takayama et al., 2005). 
Corynomycolate biosynthesis on the other hand requis two type-I FAS and Pks13. 
MmpLs are also envisaged to act as scaffolds for the localized biosynthesis on the cell 
membrane, facilitating concerted biosynthesis and transport. In mycobacteria, due to the 
far larger number of components involved, mycolate biosynthesis may be delinked from 
transport. Instead, MmpL3 could form a complex with ot er proteins involved in TMM 
transport. As a result, loss of MmpL3 would not cause a direct cessation of mycolate 
biosynthesis. In contrast, in C. glutamicum, where corynomycolate biosynthesis requires 
fewer enzymatic components, late-stage enzymes such as Pks13 may depend on interaction 
with an MmpL complex to ensure that corynomycolate biosynthesis is coupled to 
transport. Thus, a concurrent loss of NCgl0228 and NCgl2769 would lead to not just the 
loss of a transport complex, but also disrupt the lat stages of corynomycolate biosynthesis.  
 
 Chapter 3 - Addressing the Role of mmpL Genes in Mycolic Acid Metabolism in Mycobacteria and Corynebacteria 
 
 83
 Describing the mmpL3 gene as essential and involved in mycolate transport confers 
it vital importance as a target for development of new drugs, fact that it is as well 
supported by the recently published literature, where MmpL3 has been identified as the 




3.4 MATERIALS AND METHODS  
 
3.4.1 Bacterial strains, growth conditions and generation of C. glutamicum mmpL 
mutant strains 
 Corynebacterium glutamicum ATCC 13032 was grown on the complex medium 
Brain Heart Infusion at 30ºC. Deletion vectors using the nonreplicable system 
pK19mobsacB containing inserts synthesized by GeneArt and crossover PCR were used 
(Schäfer et al. 1994). The inserts contained 12 nucleotides of the 30 end of the target gene 
along with 300 bp of the upstream sequence, and 36 nucleotides of the 50 end together 
with 300 bp of the downstream sequence. The non-replicative construct was introduced 
into C. glutamicum ATCC 13032 using kanamycin resistance as indicator of the 
chromosomal integration. Clones displaying sucrose-re istance were selected during a 
second step of selection in order to indicate loss of the vector-encoded sacB function. After 
the second recombination event about half of the recombinants contained the desired 
deletion, as verified by PCR, and one strain each was termed C. glutamicum ∆NCgl0228, 
∆NCgl0887 and ∆NCgl2769, respectively. The double-mutant ∆NCgl0887-∆NCgl2769 
was generated using ∆NCgl0887 and using the appropriate pK19mobsacB construct. In-
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frame deletion of NCgl0228 in a single or double mutant background was not possible 
despite repeated attempts. As an alternative, we used pK19mobsacB-NCgl0228, containing 
an internal fragment of NCgl0228 amplified by primer pairs 5’-
CATAGAATTCGTGGCTGTGCTCATTGCGTTGAC-3’ and 5’-
GTACGTCGACCTCTGCCATCAAATCAGCCGACTG-3’. This vector was used to 
disrupt NCgl0228 in C. glutamicum ∆NCgl0887, ∆NCgl2769 and in ∆NCgl0887-
∆NCgl2769 to generate the double-mutants C. glutamicum ∆NCgl0228-∆NCgl0887 and 
∆NCgl0228-∆NCgl2769, and the triple mutant ∆NCgl0228-∆NCgl0887-∆NCgl2769 
respectively. C. glutamicum mutants were generated by Dr Eggeling’s group at the 
Institute for Biotechnology 1 of the Research Centr Jülich, Germany (Eggeling and Bott, 
2005). Growth of all mutants was characterized on the complex medium brain heart 
infusion broth at 30ºC, with 25 µg/ml kanamycin when appropriate. Extractions of [14C]-
labelled of lipids and corynomycolic acids from all strains were done as described 
previously (Gande t al., 2004, 2007).  
 
3.4.2 Complementation of C. glutamicum ∆NCgl0228-∆NCgl2769  
 NCgl0228 was amplified using primer pairs F0228 5’-
CTCATTTGTCGACAAGGAGATATAGGTGGCGAAATTGCTATTCAGG-3’ and 
R0228 5’-GGTGGGATCCCTAACGTGCAGCCTGCTTCTCC-3’; and NCgl2769 using 
the primer pair F2769 
5’ACAATTGTCGACAAGGAGATATAGGTGTTTTCTAAATGGGGCCAC-3’ and 
R2769 5’-TCCTCGCGGATCCTTAATCTAGATCCTCAAGCCTGC-3’, using C. 
glutamicum ATCC13032 chromosomal DNA as template. PCR products were cloned in 
pVWEx2 to yield pVWEx2-NCgl0228 and pVWEx2-NCgl2769, respectively. The inserts 
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in the plasmids were verified by sequencing, and subsequently used to transform C. 
glutamicum ∆NCgl0228-∆NCgl0887 to tetracycline resistance 5 µg/ml. Complemented 
strain were generated by Dr Eggeling’s group at the Institute for Biotechnology 1 of the 
Research Centre Jülich, Germany (Eggeling and Bott,2005). 
 
3.4.3 Generation and characterization of a M. smegmatis MSMEG_0250 conditional 
mutant 
 The conditional mutant ∆MSMEG_0250 was generated using CESTET (Bhatt et 
al., 2005). A merodiploid strain was previously generat d by introducing an integrating 
vector pMV306-mmpL3 by electroporation into M. smegmatis mc2155 (Snapper et al., 
1990). pMV306-mmpL3 consists of mmpL3 cloned downstream of the acetamidase 
promoter into the integrative vector pMV306 (Stover et al., 1991). The merodiploid strain 
mc2155::pMV306-mmpL3 was used to perform specialized transduction (Bardarov et al., 
2002; Larsen et al., 2007) using ph∆MSMEG_0250 to replace MSMEG_0250 with a 
hygromycin resistance cassette. The transductants were selected at 37ºC on plates 
containing 100 µg/ml hygromycin and the gene replacement of MSMEG_0250 was 
confirmed by Southern blot. Conditional depletion of MSMEG_0250 in the strain 
∆MSMEG_0250 to visualize [14C]-labeled mycolic acids and other lipids was carried out as 
described before (Bhatt e al., 2005).  
 
3.4.4 Extraction and analysis of [14C]-labelled Lipids 
 Labelled C. glutamicum lipids were extracted from 10 ml of BHIS medium cultures 
grown at 30ºC until OD600 0.4, at which point, 5 µCi/ml [
14C] acetate (50 mCi/mmol) were 
added and the culture incubated overnight. 
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 Free lipids samples were obtained by two consecutive rounds of extraction using 2 
ml of CHCl3/CH3OH/H2O (10:10:3, v/v/v) for 3 h at 50 °C. Amounts of 1.75 ml of CHCl3 
and 0.75 ml of water were added to the lipid extracts, mixed and centrifuged. The lower 
organic phase was collected and washed two times using 2 ml of CHCl3/CH3OH/H2O 
(3:47:48, v/v/v), the organic phase obtained was dried and resuspended later using 200 µl 
of CHCl3/CH3OH/H2O (10:10:3, v/v/v). An amount of 20,000 cpm was used from each 
strain to perform the TLC technique using CHCl3/ H3OH/H2O (60:16:2, v/v/v) as mobile 
phase. Autoradiograms were obtained by 3-day exposure to film to reveal [14C] -labeled 
lipids (Gande et al., 2004). Supelco LC-SAX anion exchange 3 ml columns were used to 
separate polar and apolar lipids fractions, a CHCl3/CH3OH (2:1, v/v) solution was used as 
eluent. Firstly, the column was washed with 2 volumes of eluent and then 200 µl of total 
lipids sample were loaded and the eluate containing the apolar lipids fraction was collected 
with 3 volumes of eluent. Finally, the polar lipids fraction was collected using 3 ml of 
ammonium acetate 1 M dissolved in eluent solution. Samples were dried out and analysed 
by TLCs as mentioned in General Materials and Methods section.  
 
3.4.5 Fatty acid methyl esters (FAMEs) and mycolic acid methyl esters (MAMEs) 
 extraction from delipidated cells and whole cells  
 The delipidated [14C]-labelled cells were subjected to alkaline hydrolysis reaction 
with 5% tetrabutylammonium hydroxide at 100°C overnight. CH2Cl2 (4 ml), CH3I (300 µl) 
and water (2 ml) were added to the reaction and mixed for 30 min. After discarding the 
upper aqueous phase, the organic phase was washed two times using water and dried out 
by evaporation. The dried MAMEs were resupended in iethyl ether and centrifuged to 
sediment insoluble material. The supernatant was collected in a new tube and evaporated to 
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dryness. The dried extract was dissolved in 200 µl of CH2Cl2 and 5 µl were used for liquid 
scintillation counting. The mixture (10,000 cpm) was subjected to TLC developed in 
petroleum ether (b.p. 60°C-80°C): acetone (95:5, v/v). [14C]-labelled FAMEs/MAMEs 
were visualised on an X-ray film following overnight exposure to the TLC plates. 
 
3.4.6 Bioinformatic analysis 
 MmpL3 homologs were searched using the BLAST function (Altschul et al., 1990) 
from the NCBI database; while the trasmembrane domains were predicted using TopPredII 
(Claros et al., 1994). Cluster analysis was performed using the MycoDB database. 
 
3.4.7 Southern-blot confirmation 
 The mutant strains obtained were confirmed by PCR and also by Southern-blotting 
technique using a DIG probe as described in General Materials and Methods section. In 
this case, probes of the genes NCgl0228, NCgl0887 and NCgl2769 were developed using 
PCR product that later were used to hybridise the genomic DNA of every strain that was 
previously digested using restriction en enzymes flanking the genes. The following picture 








Figure 3.11: Southern-blot confirmation. The picture displays the hybridisation between the digested 
genomic DNA (from wild-type and mutant strains) and the probes for the genes NCgl2769, NCgl0887 and 
NCgl0228 (top, centre and bottom, respectively). First four red circles from the left to the right show the lack 
of hybridisation in the the mutant and the last red circle on the right side shows the probe.  
P1, P2 and P3 indicate the probe used in each case and the numbers indicate the combination used for single 
(1,2,3), double (12, 23, 31) and triple mutant (123). Southern blot and picture by A. Singh. 
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 As described in the Introduction Chapter, the cell envelope of Mycobacterium 
tuberculosis and Mycobacterium smegmatis, possess three structural components: the 
plasma membrane, the cell wall containing mycolic acids and the outermost capsule, with 
the last two structures forming a Gram-negative-lik outer membrane (Daffé and Draper, 
1998; Sani et al., 2010). The capsule appears as an electron transparent region that 
surrounds the mycobacterial cell envelope in transmis ion electron microscopy 
preparations (Chapman et al., 1959). It is non-covalently bound and is composed of a small 
amount of proteins and species or type-specific lipids. However, the major constituent of 
the mycobacterial capsule is a glycogen-like α-glucan, representing more than 80% of the 
extracellular polysaccharides, whereas between 10 to 20% of the composition correspond 
to (lipo)-arabinomannan, PIMs and ESX-1-secreted proteins in some species like 
Mycobacterium marinum (Sani et al., 2010; Roy et al., 2013). 
 Mycobacterial α-glucan is made up of repeated elements of either fiv  or six α-D-
(1→4)-glucosyl core branched every five or six residues with oligo-glucosyl side chains of 
glucosides at position 6-OH. Its molecular mass has been estimated to be about 100 kDa 
and, along the glycogen, is considered a highly branched glucan (Fig. 4.1) (Ortalo-Magne 
et al., 1995; Lemassu et al., 1996; Dinadayala et al., 2008; Sani et al., 2010). 
 In Mycobacterium tuberculosis, like in the majority of bacteria, the capsule is a 
protective structure; its presence seems to be an ad ptive response to stressful conditions 
and also plays an important role in the successful colonisation of the host, inhibiting the 
immune response and immunomodulation (Cywes et al., 1997; Daffé and Ettiene, 1999; 
Geurtsen et al., 2009, Giovannini et al., 2012). Its role in pathogenicity is key since during 
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the infection process the capsule components are the first to interact with the immune 
system.  
 
Figure 4.1: Structure of α-glucan. Model for the repeating unit of the α-glucan of Mycobacterium bovis 
BCG based on the data from MALDI-TOF spectrometry. Adapted with permission from Dinadayala et al., 
2004. 
 
 Studies have shown α-glucan induces monocytes to differentiate into an altered 
form of dendritic cells by blocking CD1 expression a d dampening pro-inflammatory 
cytokine response by suppressing IL-12 production, which allow mycobacteria the evasion 
of the immune system (Gagliardi et al. 2007; Sani et al., 2010).  
 Although the structure and composition of the mycobacterial capsule has been well 
studied (Daffé and Ettiene, 1999; Dinadayala et l., 2008), the genetics and biochemistry 
of both assembly and transport of its high molecular weight components are not well 
understood. Due to the structural correspondences shown by capsular α-glucan and 
glycogen, it is likely that both polymers share common biosynthetic pathways. Different 
glycogen biosynthesis routes have been described in bacteria: the classical GlgC-GlgA 
pathway which is glucose dependent, where GlgC activates glucose 1-phosphate to 
generate glucose nucleotide-diphosphate which is subsequently used by GlgA to 
polimerise the linear glucan; and the non-classical GlgE pathway that produces glycogen 
from maltose and also trehalose as precursor. The latt r has been hypothesised as the 
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putative route for capsular glucan biosynthesis (Fig. 4.2) (Chandra et al., 2011; Park et al., 
2011). 
 In M. tuberculosis, the disruption of the glgA gene (Rv1212c) results in a 
significant reduction in the amount of capsular α-glucan without affecting the glycogen 
content. However, capsular glucan production in the Rv1212c mutant could be restored not 
only by complementation with Rv1212c, but also the overexpression of Rv3032, suggesting 
functional redundancy between both genes. Moreover, failures to disrupt both genes 
indicated that the function encoded by these genes was critical for bacteril growth. The 
presence of more than one functional glgA orthologue does not occur in all mycobacterial 




Figure 4.2: Model of mycobacterial α-glucan pathways.  The classical glycogen pathway is shown in blue, 
the Rv3032 pathway is associated with methylglucose lipopolysaccharide (MGLP) biosynthesis. In red, the 
GlgE pathway may contribute to cytosolic glycogen, capsular glucan and/or MGLP. Glucans degradation 
either to glucose-1-P by GlgP or to trehalose by TreX-TreY-TreZ in green, generating potential intermediates 
for glucan reassembly or other metabolic purposes. Taken from Chandra et al., 2011. 
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 Carbohydrate uptake has been a paradox in M. tuberculosis because even though 
there appear to be no exogenous sugars available to transport (and therefore no precursors 
for capsule biosynthesis), the sugar uptake systems have been shown to be critical during 
the infection, where transporter systems are necessary for growth in macrophages and mice 
while facing restricted access to host sugars. For instance, a trehalose-recycling ATP-
binding-cassette (ABC) transporter has been found to be required for M. tuberculosis to 
establish infection in mice systems (McKinney t al., 2000; Sassetti and Rubin, 2003; 
Kalscheuer et al., 2010). 
 In bacteria, operons for carbohydrate-specific ABC-transporters have shown to bear 
a gene that encodes a sugar-specific periplasmic binding protein or permease (Bertram et 
al., 2004). In silico analyses in Mycobacterium smegmatis genome sequences revealed 
twenty eight putative carbohydrate permeases, which consist of nineteen ABC-
transporters, three belonging to the phosphotransferase system (PTS) group, one to the 
major intrinsic protein (MIP) group, four to the major facilitator superfamily (MFS) and 
one to the sodium solute superfamily, while all thegenes encoding for ABC-type sugar 
binding proteins were adjacent to ABC permease genes. On the other hand, M. tuberculosis 
appears not having the necessary carbohydrate transport ystems unlike M. smegmatis; 
only five sugar permeases were present (four associated to the ABC-type group and the 
other one to the MFS), with only two of them present in M. smegmatis and lacking the 
genes encoding for the PTS group. Since the identity of hese four ABC systems to other 
previously identified transporters not present in mycobacteria is less than 25%, the 
substrates of these transporters are difficult to predict (Titgemeyer et al., 2007).  
 As it was explained, components of the glycogen biosynthetic pathways that have 
been already described should be useful in the identification of factors involved in the α-
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glucan biosynthesis; additionally, using a combination of comparative genomics and 
bioinformatics tools, Titgemeyer et al (2007) have shown a complete analysis of the 
carbohydrate-uptake systems of M. smegmatis and M. tuberculosis. Hypothetically, the 
systems described for M. tuberculosis should contain the sugar-transporters necessaries fo  
the α-glucan biosynthesis; therefore, several genes from the M. tuberculosis H37Rv 
genome were identified and selected as potential candid tes involved in α-glucan 
biosynthesis routes and listed in Table 4.1.  
Table 4.1  
Candidate genes proposed to be involved in α-glucan transport 




























O-antigen/lipopolysaccharide ABC transporter RfbD 
 
 The aim of the study described in this chapter was to investigate pathways involved 
in the transport of α-glucan in M. smegmatis. More specifically, I have looked at the role of 
predicted sugar specific ABC transporters in this process, using candidate genes from M. 
smegmatis and generating deletion mutants for each of them by specialised transduction 
(Bardarov et al., 2002).  
  
4.2 RESULTS 
4.2.1 Selection of candidate ABC-transporters of M. smegmatis   
 Using the list of candidate genes shown above, M. tuberculosis homologs were 
searched in the M. smegmatis genome using BLAST (Altschul et al., 1990). Due to the 
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ABC-type nature of all the genes selected, several m tches were found and only the 
highest scores and identity percentages obtained were chosen for further analysis. 
Additionally, respective genomic regions from the species were analysed in order to find 
synteny between putative clusters, thus improving the selection criteria of the candidate 
genes. Only the genes Rv2039c and Rv2040c showed low scores and identity through 
BLAST analysis with the M. smegmatis genome; moreover no synteny was found 
compared to M. smegmatis sequences (Fig. 4.3 A), unlike the rest of the query s quences 
analysed (Fig. 4), which did show high scores and identities, beside the synteny between 
genomic regions compared. Although no homology was found for MSMEG_0505 in the M. 
tuberculosis genome, still was chosen to generate a deletion mutant since it was part of a 
major operon composed by MSMEG_0506 and MSMEG_0507 as well. Genes selected are 
listed on Table 4.2. 
Table 4.2  
Selected genes from M. smegmatis proposed to be involved in α-glucan transport. 
In order to identify potential candidate genes in M. smegmatis mc2155, BLAST was performed using the genes 
from the M. tuberculosis H37Rv genome listed in table 4.1 as query sequences. The score and identity values 
found for each gene are shown as well as the description. Selected genes were deleted by specialised 
transduction. 
 
M.tuberculosis H37Rv Score Identity M.  smegmatis mc2155 Description 




Rv2040c 139 33% MSMEG_0506 
 
ABC-transporter, permease protein 
 
Rv2039c 125 33% MSMEG_0507 
 
Probable sugar ABC-transporter 
 
Rv1237 367 85% MSMEG_5059 
 
ABC-transporter, permease protein SugB 
 
Rv1236 412 79% MSMEG_5060 
 
ABC-transporter, permease protein SugA 
 
Rv2316 397 83% MSMEG_4466 
 
ABC-transporter, permease protein UspA 
 
Rv2317 353 79% MSMEG_4467 
 
ABC-transporter permease protein UspE 
 
Rv3783 418 80% MSMEG_6369 
 









Figure 4.3: Alignment view of the genomic regions of M. tuberculosis H37RV (above) and M. smegmatis 
mc2155 (under). Sequences were aligned using the promer algorithm fro  the xbase database in order to  
find synteny between selected clusters. A- Rv2039c-Rv2039c M. tuberculosis region did not show co-
localisation of genetic loci in the M. smegmatis genome. B, C and D show, respectively, Rv1236- Rv1237, 
Rv2316- Rv2317 and Rv3783 compared regions showing high level of synteny.  
 
 
4.2.2  MSMEG_6369 is an essential gene in Mycobacterium smegmatis 
 The generation of knockout strains by specialised transduction was attempted and 
all the mutants obtained were confirmed by Southern blot, except for MSMEG_6369. In 
that case, several transduction attempts were carried out but no mutant was observed, 
suggesting that MSMEG_6369 was essential. In order to demonstrate that, I used 
conditional expression–specialized transduction essentiality test (CESTET), a genetic tool 
designed to prove gene essentiality in M. smegmatis (Bhatt et al., 2005; Bhatt and Jacobs, 
2009). Basically, the native copy of MSMEG_6369 could be deleted in a merodiploid 
strain containing a second copy of the gene integrad in the genome under the control of a 
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promoter inducible by acetamide. The conditional mutant generated was viable only in the 
presence of 0.2% of acetamide in the media-agar plates (Fig. 4.4 A) demonstrating that 
MSMEG_6369 is essential for viability. Furthermore, the strain was unable to grow after 






Figure 4.4: Essentiality test for MSMEG_6369 in M. smegmatis mc2155. Growth of the conditional mutant 
on A- Sauton agar plates with or without acetamide (%), plates incubated at 37ºC for three days, and  B- 
inducing the expression with acetamide in TSB cultures + and – acetamide, incubated at 37ºC for 48h. 
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4.2.3 Analysis of extracellular α-glucan levels in candidate ABC-transporter 
 mutants 
 All the ABC-transporter mutants were screened using a spotblot analysis to detect 
surface-exposed capsule α-glucan. Briefly, the technique allows detection of surface-
exposed α-glucan in a colony-blot assay using an antibody-filter-screen, assessing altered 
production of α-glucan. Interestingly, all the mutants for capsule transporters candidates 
showed high levels of extracellular α-glucan and normal levels of intracellular glycogen in 
comparison with the wild-type strain (Fig. 4.5). The positive control used was the ∆pstS 
strain; pstS genes encode high-affinity phosphate binding proteins forming the Pst complex 
which is a membrane-associated complex that belongs to the superfamily of ABC-
transporters. The strain is already known for its α-glucan overproduction and the lack of 
the gene is related to phosphate uptaking deficiency in M. tuberculosis (Peirs et al., 2005).  
The negative control results shown correspond to samples from ∆glgB strain, known to 
produce reduced levels of both capsular α-glucan and intracellular glycogen due to the 
disruption of the biosynthetic pathway (Fig. 4.2). The technique consists in the detection of 
α-glucan directly on cell samples and also cells treated with 0.5% Tween-80 as a mild 
detergent in order to remove the capsule material fom the outermost layers without 
disrupting the cells. The results in figure 4.5 show that the wild-type strain produces an 
amount of capsule exposed outside and also capsule mat rial tightly attached to the 
mycomembrane structure which can not be removed by a mild detergent as Tween-80; as it 
was expected the ∆glgB strain does not produced capsular material able to interact strongly 
with the mycomembrane and to organise a capsular structure in the way the wild-type 
strain did. The α-glucan amounts produced by the mutant strains were similar that the 
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positive control used and every fraction analysed showed overproduction of capsular 
material as result of the deletions. 
 
 
Figure 4.5: Spotblot analysis detecting α-glucan in knockout strains. An antibody-filter-screen was used 
to detect α-glucan production in samples from: A) Non-treated c lls; B) Cells treated with 0.5% Tween-80 as 
a mild detergent in order to remove the capsule; C) Supernatant from treated cells; D) Intracellular glycogen. 
MSglgB and MSpstS lanes are positive and negative controls respectively. Numbers indicate the dilution 
from – to +. Results show overproduction of α-glucan in the mutants tested not as result of an alteration of 
the production of intracellular glycogen. Assay carried out in collaboration with Dr Jeroen Geurtsen at the 
VU University Medical Centre in Amsterdam, Netherlands. 
   
 
4.2.4 Growth of mutant strain in different carbohydrate-based carbon sources  
 It was likely that the selected ABC-transporter genes could be involved in the 
uptake of external sugars rather than function as exporters of the capsule or its precursors. 
Thus, the ability of the strains of growing in fifteen different sugars as the sole carbon 
source was tested, in order to correlate transporter function and metabolite. As shown in 
Fig. 4.6 the growth of all mutant strains was similar in every carbon source provided 
except in 10 mM trehalose, where the mutant ∆MSMEG_5059-5060 failed to grow. 
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Although it was not considerable, this strain showed growth ability when using glycogen 
as carbon source. This fact could be interesting since both trehalose and glycogen 




Figure 4.6: Mycobacterium smegmatis strains growth in defined media. Every strain was grown in 
defined Sauton media testing different unique carbon sources and a bar chart was plotted showing the optical 
density reached by each strain measured at 600nm after 48 hours of incubation at 37ºC. ∆MSMEG_5059-
5060 strain was unable to grow using trehalose as unique carbon source but showed growth in glycogen 
unlike the rest of the strains. Assay carried out in collaboration with Dr Jeroen Geurtsen at the VU University 
Medical Centre in Amsterdam, Netherlands.  
 
4.3 DISCUSSION  
 The analysis of MSMEG_6369 protein sequence by BLAST showed that the gene is 
the homolog of rfbD, previously reported to be involved in the synthesis of TDP-rhamnose 
that forms the O-antigen subunit of the lipopolysaccharide (LPS), a major constituent of 
the outer membrane in several Gram-negative (Burns and Hull, 1998; Cuthbertson et al., 
2007). Therefore, in mycobacteria, RfbD could have n important role in the biosynthesis 
of extracellular polysaccharides like arabinomannan or glucan, predominant constituents 
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on the surface of M. tuberculosis (Schwebach et al., 2001; 2002). Due to the conditional 
gene expression in the strain, which depends on the acetamide supply, a different time 
course experiment needed to be designed to determin the glucan level production under 
acetamide depletion.  
 The strain ∆pstS was used as positive control for high levels of extracellular 
capsular α-glucan and perhaps, due to the mutation, the strain encounters a phosphate 
limiting condition which could trigger a stress response overproducing protection factors 
like the capsule. Similar results have been found by others with an isocitrate 
dehydrogenase ∆icd mutant, who showed high levels of capsular glucan (Chen and Bhatt, 
unpublished results). In this case a breakdown in the TCA-cycle could induce anaplerotic 
pathways or glyoxylate cycle in order to re-establishing the homeostasis, ending up on 
accumulation of capsular material. The high levels of extracellular capsular α-glucan found 
in the mutant strains could probably be due to two reasons: either an overproduction of the 
polysaccharide as a result of the stress response or an accumulation because of the 
breakdown on the sugars recycling system. 
 While these experiments were carried out, Kalscheuer t al. showed the system 
MSMEG_5058-MSMEG_5061 to be a high-affinity permease specific for trehalose that 
plays a major function in the recycling system for cell wall-released trehalose and also 
confirmed the inability of the mutant to grow using trehalose as sole carbon source 
(Kalscheuer et al., 2010). Any imbalance in sugar metabolism (like th inability to recycle 
trehalose) could probably have severe consequences on α-glucan levels and considering 
that mycobacteria use the non-mammalian trehalose as a precursor for essential cell-wall 
glycolipids and other metabolites (Swarts e  al., 2012), its high levels could be due to an 
accumulation rather than an overproduction of capsul r material, produced by a broken 
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recycling pathway. It is interesting that ∆MSMEG_5059-5060 mutant showed the ability to 
metabolise glycogen as unique carbon source; perhaps not being able to recycle the 
trehalose due to the mutation induces and activates the ability to use glycogen which could 
be used as a sugar storage that need to be activated und r specific conditions, perhaps the 
stringent response or the carbon starvation. On the o r hand, a very detailed study is 
required in order to check the growth dynamic, since in some cases the impaired growth 
shown may be the effect of a long lag-phase required to adapt the metabolism to that 
specific carbon source, which is not possible to detect after only 48 hours of incubation. A 
recycling system of metabolites synthesised by the pathogen appears as an adaptation 
mechanism to either unfavourable conditions or different types of nutrients. In that context, 
the determination of changes in gene- and protein- expression profiles via microarrays or 
proteomics analysis is necessary along with the growth kinetics assays. The growth of the 
strains in defined media could probably show that te rest of the transporters are either 
redundant or involved in the uptake of molecules that were not tested in this study. A 
complete test would require the generation of double, triple or even quadruple mutants.  
 In summary, while changes in α-glucan production were seen in the mutants, the 
effects were not likely related to the transport of α-glucan and thus the genes involved in 
its transport and biosynthesis remain unidentified. 
 
4.4 MATERIALS AND METHODS 
 
4.4.1  Candidate genes, plasmids, phages, bacterial strains and growth conditions 
 As it was stated in the introduction, ABC-transporter homologs genes from M. 
smegmatis were selected in order to generate knockout strain for the genes 
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MSMEG_0505-0507, MSMEG_5059-5060, MSMEG_4466-4467 and MSMEG_6369. 
Table 4.1 and 4.2 outline the putative functions and the respective M. tuberculosis 
homologous for candidate genes while vectors and bacteri l strains used in this study are 
listed in Table 4.3. The strains were grown in different liquid media at 37ºC, namely, TSB 
as culture media and both 7H9 and Sauton as defined media, adding acetamide or different 
carbon sources when it was required. 
 
4.4.1.1 α-glucan assay  
 In order to detect α-glucan by colony-blot assay, M. smegmatis strains were grown 
at 37ºC in Middlebrook 7H9 media supplemented with 10% oleic acid-albumin-dextrose 
catalase (OADC) and 0.05%  Tween-80 until an ODA600 of ~1, hygromycin was added at 
100 µg/ml concentration into mutant strains cultures. Cells were diluted 100 times in 7H9 
with neither supplement nor Tween-80 (in order to obtain an intact capsule), adding 0.2% 
dextrose and grown to exponential phase. Then were ha vested by centrifugation and 
washed thrice and resuspended in phosphate buffered saline solution. Detection of α-
glucan was performed before and after an incubation of the cells in the mild detergent 
Tween-80 (0.5%) by agitation for 30 min at room temp rature in order to remove the 
capsule. Treated cells were collected by centrifugation and separated from the extracted 
fraction ready to perform blot analysis. These assays were carried out in collaboration with 
Dr Jeroen Geurtsen at the VU University Medical Centre in Amsterdam, Netherlands. 
 
4.4.1.2 CESTET  
 A conditional mutant strain was generated by CESTET (Bhatt and Jacobs, 2009) 
integrating the MSMEG_6369 gene into the M. smegmatis mc2155 under the control of the 
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acetamidase promoter (primers used to amplify the gene using BamHI and ClaI sites: 
MS_6369F 5’-CATGGATCCATGACGTTCACCGACGCG-3’ and MS_6369R 5’-
CATATCGATTCAGACCCAGTAGGGCAC-3’) and the chromosomal MSMEG_6369 
replaced by a hygromycin resistance cassette afterwards. Cultures were grown either in 
TSB and Sauton media with 0.2% acetamide and also on 1.5% agar plates using 
hygromycin at 100 µg/ml and kanamycin at 30 µg/ml to select the conditional mutant 
strain.  
 
4.4.1.3 Different unique carbon sources test 
 In order to test growth ability in defined media, 10 mM of different carbon sources 
were added to Sauton media and the strains grown at 37ºC for 48h. These assays were 
carried out in collaboration with Dr Jeroen Geurtsen at the VU University Medical Centre 
in Amsterdam, Netherlands. 
 
4.4.2 Generation of mutant strains 
 Individual mutants were generated using allelic exhange constructs designed to 
replace the selected genes from M. smegmatis proposed to be involved in α-glucan 
biosynthesis and transport. Sequences flanking the left and right of the genes were PCR 
amplified using the primers and restriction sites (Van91I) listed on Table 4.4 following the 
procedure described in General Materials and Methods section to generate knockout 
phages. Allelic exchange constructs were designed to replace the selected genes with a 
hygromycin resistance cassette. Each mutant was validated as bona fide by Southern blot 
analysis as described in General Materials and Methods section. 
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Table 4.3  
Phages, plasmid vectors and bacterial strains used and generated in this study. Generation of phages, 
vectors and strains is fully described in General Material and Methods section. 
 
Vectors and Bacterial 
Strains Description Reference 
 
Phage   
phAE159 
Conditionally replicating shuttle phasmid 
derived from the lytic mycobacteriophage TM4 
(TM4ts::pYUB328) 
Kriakov et al., 2003 
ph∆MSMEG_4466-4467 
Derivative of phAE159 obtained by cloning 
p∆MSMEG_4466-4467 into its unique PacI site. 
This work 
ph∆MSMEG_0505-0507 
Derivative of phAE159 obtained by cloning 
p∆MSMEG_0505-0507 into its unique PacI site. 
This work 
ph∆MSMEG_5059-5060 
Derivative of phAE159 obtained by cloning 
p∆MSMEG_5059-5060 into its unique PacI site. 
This work 
ph∆MSMEG_6369 
Derivative of phAE159 obtained by cloning 
p∆MSMEG_6369 into its unique PacI site. 
This work 




   
 p0004s 
Cosmid for cloning allelic-exchange substrates. 
Used for specialized transduction. Contains 
λphage cos site and HygR-sacB cassette.  
Bardarov et al., 2002 
pSD26 Escherichia coli-mycobacterial shuttle plasmid 
with acetamidase promoter KanR 
Parish and Brown, 2008 
pMV306 
Single-copy-integrating vector; inserts into the 
phage L5 chromosomal integrating site attB in 
many mycobacteria KanR, 
Stover et al., 1991 
pMV306-6369 MSMEG_6369 cloned into pMV306 . KanR. This work 





M. smegmatis  mc2155 
 
Parental strain, ept-1 mutation conferring high 
efficiency of plasmid transformation 




Chromosomal copy of MSMEG_4466-4467 in 
mc2155 was replaced by a HygR cassette 
This work 
∆MSMEG_0505-0507 
Chromosomal copy of MSMEG_0505-0507 in 
mc2155 was replaced by a HygR cassette 
This work 
∆MSMEG_5059-5060 
Chromosomal copy of MSMEG_5059-5060 in 
mc2155 was replaced by a HygR cassette 
This work 
mc2155::6369 
MSMEG_6369 under the control of the 




Chromosomal copy of MSMEG_6369 in 
mc2155::6369 was replaced by a HygR cassette 
This work 
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Table 4.4 
Primers used for generation of allelic exchange substrates and sequencing 
Sequences flanking the left and right sides of the genes were amplified using the following primers and 














5' AGGATCCAGGACCTGCCAAT 3' 
5' CTTCACCGATCCGGAGGAAC 3' 
5' CGGCCGATAATACGACTCA 3' 
5' CTGACGCTCAGTCGAACGAA 3' 
 
MS0505-0507-LL   
MS0505-0507-LR   
MS0505-0507-RL  
MS0505-0507-RR   
 
 
5' TTTTTTTTCCATAAATTGGGCTGAGGCTCGCCAGCGCCTGC 3' 
5' TTTTTTTTCCATTTCTTGGATCTGCTGTGCGGCTTTGAGCGAC 3' 
5' TTTTTTTTCCATAGATTGGACCGAGGCGTTCATCATCCC 3'  








5' TTTTTTTTCCATAAATTGGAAGTCCAGCGACGCCGGATAGTTC 3' 
5' TTTTTTTTCCATTTCTTGGGAAGGATCGGTGAGCCACTCGATG 3' 
5' TTTTTTTTCCATAGATTGGTGACCGTGGTGCCGCTGTATCTG 3' 
5' TTTTTTTTCCATCTTTTGGTCCGGCGAAGTATCCGTTGGAG 3' 
 
MS5059-5060-LL   
MS5059-5060-LR   
MS5059-5060-RL   
MS5059-5060-RR   
 
 
5' TTTTTTTTCCATAAATTGGAGCGGCTCGTCCATGAGAAAC 3' 
5' TTTTTTTTCCATTTCTTGGGCTGGTCACACCGATCTTCAAC 3' 
5' TTTTTTTTCCATAGATTGGCATGAACGGCGTGGTCTTCC 3' 








5' TTTTTTTTCCATAAATTGGTCGTCGTCGACAACGACAAC 3' 
5' TTTTTTTTCCATTTCTTGGTGGCGATGGTGATCCAGAAC 3' 
5' TTTTTTTTCCATAGATTGGATCAGGAACTTCGGCACTGG 3' 
5' TTTTTTTTCCATCTTTTGGTCCGCGCATCGCAGATCAAC 3' 
LL forward primer for left flank, LR reverse primer for left flank, RL forward primer for right flank, RR reverse primer for right flank. 
HL, HR, OL and OR: sequencing primers used to check flanks cloned into p0004s. 
 
 
4.4.3 α-glucan detection by colony-blot assay 
 Serial dilutions of the samples (5 µl) were spotted on nitrocellulose membrane, the 
membrane was dried for 1 h at 80ºC, blocked, immuno-labelled using an anti-α glucan 
monoclonal antibody overnight (1:5) and washed with PBS plus 0.05% Tween-80. Then, 
incubated with peroxidase-labelled goat anti-mouse IgM (1:1000) and developed using 
3,3-diaminobenzidine tetrahydrochloride (Baba, 1993). The M. smegmatis ∆glgB and 
∆pstS mutant strains were chosen as negative and positive control for α-glucan production, 
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respectively. These assays were carried out in collab ration with Dr Jeroen Geurtsen at the 
VU  University Medical Centre in Amsterdam, Netherlands. 
 
4.4.4 Southern-blot confirmation 
 The mutant strains obtained were confirmed by Southern-blotting technique using a 
DIG probe as described in General Materials and Methods section. The following pictures 
show a diagram representing the digestion pattern of genomic DNA from wild-type and 
mutant strains on the left side. The right side of the pictures display the films obtained by 












Figure 4.7:  Southern-blot confirmation. The left sides of the pictures display the digestion pattern 
diagrams of genomic DNA from wild-type and mutant strains. Right sides display the films obtained by 
hybridisation between the probes and the digested genomic DNA. The diagrams include the restriction 
enzyme used and the expected sizes for each strain after the digestion; the films display the digestion pattern 
obtained for each strain tested and the probe was also used as molecular-weight size reference. The strain  
that showed the expected pattern were choosen to perf rm the experiments described in this chapter. L and R 
indicate the flanking regions, hyg: hygromycin resistance cassette. A- ∆MSMEG_0505-0507, B- 















DECIPHERING THE ROLE OF EXOPOLYPHOSPHATASES 















 Inorganic polyphosphate (polyP) is an ubiquitous long polymer of tens or hundreds 
of orthophosphate (Pi) units linked by phosphoanhydride bonds, widespread in every 
single organism: bacteria, archaea and eukaryotes (Fig. 5.1) (Kulaev et al., 1999). The 
molecule has several functions e.g., phosphate and energy storage, role regulating the 
levels of nucleotides like ATP, maintenance of cell homeostasis, regulation of gene 
expression, storage of inorganic cations, membrane transport, etc (Kornberg et al., 1999). 
In prokaryotes, it has been demonstrated that polyP metabolism is involved in bacterial 
virulence, sporulation, motility, cell division and response to both stress and stringency 
(Rao et al., 1998; Brown and Kornberg, 2004; Zhang et al., 2005a, Sureka et al., 2009; 
Varela et al., 2010). 
 
 
Figure 5.1: Schematic diagram of inorganic polyphosphate molecule. polyP molecule made up of tens to 
hundreds of phosphate residues linked by phosphoanhydride bonds. (Adapted with permission from 
Kornberg et al., 1999. Confirmation Nº 11129104). 
 
  
 The polymer is synthesised reversibly by the enzyme Polyphosphate kinase 1 
(Ppk1) that adds the γ-phosphate of an ATP molecule to the polyP chain extreme (Ahn and 
Kornberg, 1990). This enzyme is highly conserved in several bacteria and archaea, 
including some main pathogens, whilst in eukaryotes only Dictyostelium discoideum 
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(DdPPK1) has been demonstrated to have a Ppk1 homologue (Zhang et al., 2005b). PolyP 
biosynthesis can also be produced by other enzymes such as Polyphosphate kinase 2 
(Ppk2), a nucleoside diphosphate kinase (NDK) which syntesises polyP from GTP and is 
responsible for the 20% of the normal polyP cellular amount shown by ppk1 Pseudomonas 
aeruginosa mutants strains, despite the fact the NDK-activity is 75-fold greater (Rashid et
al., 2000; Ishige et al., 2002; Zhang et al., 2002); additionally, Polyphosphate kinase 3 
(Ppk3) reversibly utilises inorganic polyP as a donor to produce CTP from CDP. Activity 
assays have shown that while Ppk2 and Ppk3 are able to utilise 100% of the polyP amount, 
but Ppk1 only utilises 30%, leading to the idea that Ppk1 function is mainly the polyP 
synthesis for phosphate and energy storage, while the other two enzymes consume polyP 
(Nahalka et al., 2009).  
 Studies in prokaryotes have demonstrated that ppk1 is an important factor in 
bacterial survival, stringency, long-term cell survival, nutrient limitation and virulence 
including pathogenic bacteria, moreover is an interesting candidate for drug development 
since is not present in humans (Rao et al., 1998; Kuroda and Kornberg, 1997; Hengge-
Aronis, 2002; Zhang et al., 2005b; Brown and Kornberg, 2004). Specifically, in 
Mycobacterium tuberculosis, results show that downregulation of either ppk1 or ppk2 
causes the failure of survival in macrophages, proving its role as key factor in the 
intracellular life (Sureka et al., 2007; Sureka et al., 2009). 
 PolyP degradation is accomplished by an exopolyphos atase, designated Ppx that 
belongs to the Ppx/GppA family. The enzyme acts by breaking down the polymer from the 
end of the chain into inorganic phosphate units and contributes to maintain the dynamic 
balance of polyP and phosphate levels in the cell (Akiyama et al., 1993; Miyake et al., 
1999).  Interestingly, bacteria lacking Ppx exhibited increased resistance to complement-
 
Chapter 5 - Deciphering the role of exopolyphosphatses in mycobacterial biology 
 
 112
mediated killing in Neisseria meningitidis (Zhang et al., 2010). Ppx is also required for 
survival inside the necrotic lung lesions produced by M. tuberculosis (Thayil et al., 2011). 
The genome of Corynebacterium glutamicum ATCC13032, encodes two ppx genes: 
NCgl0396 (ppx1) and NCgl0938 (ppx2), but Ppx2 is the major exopolyphophatase with 
substrate specificity toward short-chain polyP (Lindner et al., 2009). In the case of M. 
tuberculosis H37Rv, the genome also contains two genes encoding putative Ppxs, namely 
Rv0496 and Rv1026. While the Rv0496 encoded protein has shown to possess Ppx activity, 
the role of Rv1026 remains unknown since its product has not been able to degrade polyp 
in vitro, although both proteins have low ATPase and ADPase activities that can be 
inhibited by the hyperphosphorylated guanine nucleotid  alarmone (p)ppGpp (Thayil et al., 
2011; Choi et al., 2012). Previous studies suggested that Rv1026 may be involved in an 
adaptive response to amino acid starvation and its up-regulation might reflect the adaptive 
response to stress within the macrophage (Srivastav e  al., 2007). It has been classified as 
an essential gene by Himar1-based transposon mutagenesis of M. tuberculosis (Sassetti et 





Chapter 5 - Deciphering the role of exopolyphosphatses in mycobacterial biology 
 
 113
 In Escherichia coli, polyP plays an important role in cell physiology during the 
stringent response which is regulated principally by (p)ppGpp, the effector, synthesized by 
RelA and SpoT in response to limiting conditions (Magnusson et al., 2005; Braeken et al., 
2006). In several species of the genus Mycobacterium, polyP accumulation results in the 
appearance of visible granules under certain stress conditions (Ward et al., 2012). In M. 
tuberculosis, which is able to survive and replicate within thehostile environment inside 
macrophages and can lie dormant in humans for years, polyP has been implicated in the 
persistence. It has also been demonstrated that the Rel protein catalyzes the synthesis and 
hydrolysis of (p)ppGpp, regulating its intracellular evels and consequently the ability to 
survive long-term starvation in culture (Primm et al., 2000; Avarbock et al., 2005). 
 In E. coli, the amount of polyP is regulated by a coordinated ctivity between Ppx 
and Ppk and increments of polyP levels following stress, as a result of the suppression of 
Ppx activity by the effect of the alarmone (p)ppGpp and the expression of ppk1 in 
stationary phase. This leads to an accumulation of the polymer due to a boost in its 
biosynthetic rate (Kuroda and Kornberg, 1997; Manganelli, 2007; Achbergerová and 
Nahálka, 2011; Choi et al., 2012). On the other hand, in mycobacteria, polyP acts on a 
signalling path way where polyP is key for the induction of rel and the biosynthesis 
(p)ppGpp during stationary phase, acting upstream of (p)ppGpp, unlike other bacteria such 
as E. coli and Streptomyces lividans where it occurs downstream and the deletion of ppk1 
does not provoke variations in either the expression of rel gene or the biosynthesis 
(p)ppGpp (Chouayekh and Virolle, 2002; Sureka et al., 2007). Thus, in M. tuberculosis, 
the induction of rel gene during the stationary phase is regulated by the sigma factor σE, 
which is related to the response under stress conditi s, growth in macrophages and 
pathogenesis (Rodrigue et al., 2006; Donà et al., 2008). Moreover, it has been shown that 
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the two-component system MprAB modulates the transcription of sigE during stress where 
MprB phosphorylates MprA using polyP as phosphate donor, activating mprAB and sigE 
expression (Fig. 5.2). Interestingly, the activation does not occur in ppk mutants but only in 
wild-type strains, and down-regulation of ppk1 impairs the ability of growing inside the 
cytoplasm of the macrophage which is a phosphate-lacking environment (Manganelli et 
al., 2001; He et al., 2006; Pang et al., 2007; Sureka et al., 2007). Recent studies have 
demonstrated that low levels of phosphate activate the ppk1 transcription via two different 
regulator factors that could bind its promoter: the p osphorilated response regulator RegX3 
(from another two-components system, the SenX3-RegX3) and SigE; forming a regulated 
network where ppk1 connects a pair of two-components systems during phosphate scarcity 
(Sanyal et al., 2013).  
 
Figure 5.2: Schematic representations of the signalling cascades where polyP is involved in bacteria. 
A.- Pathway of stringent response development in E. coli showing polyP role. B.- Stress-induced signalling 
pathway in mycobacteria starting from polyP. (Adapted with permission from Manganelli, 2007 and Sureka 
et al., 2007. Licence Nº3244860716435). 
 
 Understanding the basis of M. tuberculosis persistence is an important step in 
tackling latent tuberculosis infection, where polyP should play a crucial role. The majority 
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of the studies available in polyP metabolism have be n focused in the biosynthesis of the 
polyP, and therefore the role of polyphosphate kinases, rather than the degradation of 
polyP by the exopolyphosphatases.  So far, studies have shown pleiotropic effects as result 
of the lack of Ppk function, which is perhaps not strongly relevant on phosphate usage 
during active growth of the cell because, as it has been said, the organisms are still able to 
overcome the condition and accumulate polyP regardless the mutation, therefore focusing 
in polyphosphate kinases role might not be the right strategy. On the other hand, 
exopolyphosphatases and its importance in persistence have not been studied, and then 
little is known about the cellular and molecular functions of mycobacterial Ppxs. 
Considering that M. tuberculosis faces a harsh intracellular environment in macrophages 
where the essential phosphate supply is extremely poor, the role of the exopolyphosphatase 
activity in persistence and infection appears as an interesting topic to be studied. 
 The study described in this chapter aimed to determine the potential role played by 
exopolyphosphatases and polyP in phosphate metabolism during phosphate starvation in 
mycobacteria. Two exopolyphosphatases homologs were found in the genome of 
Mycobacterium smegmatis mc2155, namely MSMEG_0939 and MSMEG_5413; deletion 
mutants of each gene were generated by specialised transduction and the strains were 




5.2.1 Identification of putative M. smegmatis exopolyphosphatases 
 Using BLAST, two putative exopolyphosphatases homolg us genes were 
identified in Mycobacterium species genomes. The Ppx protein sequence from Escherichia 
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coli K-12 (NCBI Reference sequence NP_416997.1) was used as a query. In M. 
tuberculosis H37Rv, Rv0496 (score 57.8, Id 23%, E-value 6e-10) and Rv1026 (score 70.5, 
Id 27%, E-value 4e-14) were predicted to encode exopolyphosphatases; meanwhile, in M. 
smegmatis mc2155, MSMEG_0939 (score 70.9, Id 24%, E-value 5e-14) and MSMEG_5413 
(score 70.1, Id 28%, E-value 1e-13) showed to be, respectively, the identified homologs. 
 
5.2.2  Deletion of both MSMEG_0939 and MSMEG_5413 genes produces slower 
growth rate in M. smegmatis  
 Using allelic exchange substrates, the apramycin and hygromycin antibiotic 
resistance cassettes were transduced into M. smegmatis mc2155 strain in order to replace 
regions of the exopolyphosphatase genes, MSMEG_0939 and MSMEG_5413, respectively. 
Three mutant strains were generated, namely ∆MSMEG_0939, ∆MSMEG_5413 and 
∆MSMEG_0939-5413 depending either on the single or double gene disruption caused. 
Each deletion was checked by Southern blot analysis, also confirming the introduction of 
the resistance cassettes and discarding any possible leaking RNA transcription. As it is 
mentioned in the methods, serial dilutions were spotted on both TSB and Sauton agar 
plates in order to check colony morphology alterations, the deletions of the genes did not 
produce alterations in any of the mutants grown on the media mentioned above compared 
to the wild-type strain used as control (Fig. 5.3 A). No clumping effect was observed in 
liquid media either, although, the double mutant strain showed a slower growth rate and 
reached lower OD value at stationary phase compared to the wild-type and single mutants 
strains (Fig. 5.3 B). Since the morphology does not show any change between the strains, 
the OD values shown by the strains are reliable in t rms of the growth rate, which is also 
consistent with the data obtained by cell-counting (Fi . 5.4). 
 





Figure 5.3: Growth characteristics of ppx mutants of M. smegmatis mc2155. A- Colony pictures from 10 
µl of culture spots on different media, left and centr  columns: 10-1 dilutions on Sauton and TSB-agar, 
respectively, right column: 10-6 dilution on TSB-agar. Cultures were grown in Sauton and TSB liquid media 
at 37ºC until stationary phase, spotted on respective solid media and incubated for 3 days until colonies were 
visible. B- Growth curves for control and mutant strains grown in 50 ml of TSB media at 37ºC and 180 rpm
of agitation. Values and error bars shown were obtained from experiments performed in duplicates. 
 
 
Chapter 5 - Deciphering the role of exopolyphosphatses in mycobacterial biology 
 
 118
5.2.3 MSMEG_0939 and MSMEG_5413 genes have a crucial role in phosphate 
supply from intracellular polyP during phosphate starvation 
  
 As it was mentioned in the introduction, polyP metabolism is involved in stress and 
stringency response. Several studies carried out in E. coli and Pseudomonas aeruginosa 
have been focused in the function of ppk1 in bacterial survival within harsh environments 
(Rao and Kornberg, 1996; Kuroda et al., 1999) and, specifically, nutrients starvation and 
oxidative stress (Sureka et al., 2007); although, the role of the exopolyphosphatase activity 
in phosphate metabolism has not been carefully studied. In order to decipher the effect of 
ppx genes deletion in phosphate metabolism, mutant strain  were subjected to phosphate 
starvation assays. The strains were grown until station ry phase in rich TSB media and 
later transferred into a defined minimal Sauton were phosphate was not added. Details are 
described in materials and methods section. 
 In order to test the growth dynamic, optical density (OD) measurements and cell-
counting were carried out. During phosphate starvation reatments, the single mutant 
strains ∆MSMEG_0939 and ∆MSMEG_5413 did not seem to suffer major effects in the 
growth dynamic due to the lack of one of the exopoly hosphatases. The OD values 
demonstrated that the the single mutants were able to grow in the absence of phosphate   
showing a similar growing pattern than the wild-type strain under the same conditions. A 
slighty reduced growth was shown by single mutants in the absence of phosphate, which 
was not larger than one order of magnitude in terms of cell viability, and their growth 
seemed to be only limited by the amount of phosphate available. On the other hand, the 
lack of both putative exopolyphosphatases produced a negative effect under the conditions 
tested, the OD values obtained showed that cells were not able to grow when phosphate 
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was removed from the environment; surprisingly, the same effect was observed even when 
the double mutant strain was grown in the presence of phosphate (3 mM KH2PO4 in 
Sauton medium), where apparently the uptake or the utilisation of the extracellular 
phosphate available was impaired. Moreover, while th  OD measurements showed no 
growth for the strain (Fig. 5.4), the viability tess demonstrated that the lack of both genes 
produced a lethal effect undergoing growth in Sauton minimal media (Fig. 5.5). The 
presence of at least one of the putative exopolyphos atases genes suffices to survive 
under phosphate scarcity, strongly suggesting that intracellular polyP was degraded and 
used by the wild-type and single mutant strains to overcome the starvation, while the 
double mutant was not able to use polyP via another pathway. 
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Figure 5.4: Optical density measurements for ppx mutant strains of M. smegmatis mc2155 during 
phosphate starvation. Cells previously grown in TSB medium until stationary phase were washed two times 
with Sauton medium without phosphate and diluted until OD600nm=0.4 where the starvation experiment 
started. Strains were grown in Sauton media with (control +Pi) and without (-Pi) phosphate supply during 48 
hours at 37ºC in agitation and growth was monitored by optical density. OD was measured every 24 hours in 
order to test the effect of gene deletions. The lack of both exopolyphosphatases produced a lethal effect in 




















































Figure 5.5: Viability test for ppx mutant strains of M. smegmatis mc2155 during phosphate starvation.  
Cells previously grown in TSB medium until stationary phase were washed two times with Sauton medium 
without phosphate and diluted until OD600nm=0.4 where the starvation experiment started. Strains were grown 
in Sauton media without (A) and with (B) phosphate supply during 48 hours at 37ºC in agitation and viability 
was monitored by cell counting on TSB plates by plating 25 µl of -3, -4, -5 and -6 dilutions. Viable cell 
counting was performed at the end of the incubation in TSB, the beginning of the starvation and every 24 
hours in order to test the effect of gene deletions. Wild-type and single mutant strains were able to survive 
while undergoing Pi starvation and showed similar growth patterns. The lack of both exopolyphosphatases 
produced a lethal effect in Sauton medium even in the presence of Pi. Values and error bars taken from three 
experiments carried out independently.  
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5.2.4 Deletion of MSMEG_0939 and MSMEG_5413 genes induce polyP 
accumulation during phosphate starvation 
 
 Inasmuch as intracellular levels of free phosphate r  limited and must be 
maintained at a concentration close to 10 mM (Rao et al., 2009), the results shown in 
section 5.2.3 suggested that the phosphate consumption and usage during the starvation 
should be dependent on polyP, thereby the double mutant strain should exhibit high levels 
of polyP as result of the inability to degrade the polymer; on the other hand, wild-type and 
single mutant strains should exhibit similar levels of polyP due to the usage of polyP as 
phosphate source. In order to test this hypothesis and to determine whether the genes 
MSMEG_0939 and MSMEG_5413 play a role in the utilisation of polyP, the cellular polyP 
contents of every strain were measured by a DAPI-based assay. Levels were quantified at 
each stage were growth and viability was tested, the amounts of polyP quantified were 
normalised in terms of the protein content, as a ratio between polyP and protein amounts. 
The results showed that deletions did not seem to have a significant effect in the amounts 
of polyP displayed by the strains when they were incubated in a rich-media as TSB and 
abnormal polyP accumulation or depletion were not observed (Fig. 5.6 A).  
 As it was mentioned, polyP levels were quantified during the incubation in Sauton 
medium with and without phosphate (0, 24 and 48 hours). The results showed that whereas 
the wild-type and the single mutant strains exhibited similar levels of polyP, the lack of 
both exopolyphosphatases produced an accumulation of approximately 5-fold at the end of 
the incubation (Fig. 5.6 B); those polyP values compared to the ones found at the 
beginning of the starvation suggested that the phosphate used by the wild-type and single 
mutants must come from the degradation of polyP, since the strains were actively growing 
and dividing without any other source of phosphate available rather than the polyP. On the 
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other hand, the double mutant strain showed similar levels of polyP than the initial 
condition, indicating that the cells did not use polyP as a source of phosphate and, as it has 
been shown by cell counting, they underwent cellular death. 
 The wild-type and single mutant strains tested under control conditions (Sauton 
media with phosphate) contained similar amounts of polyP than after growing in TSB, 
since these strains were actively growing and dividing it is valid to assert that new polyP 
was synthesised from the polyP available in the medium, keeping the ratio polyP/mass on a 
relatively constant level. Interestingly, the double mutant strain displayed a higher content 
of polyP even though cell-death was observed.  
 These results demonstrate that the uptaken phosphate from the medium has been 
directed to the synthesis of polyP but without the ability to be degraded and used in the 
case of the double mutant strain, which is likely the cause of the lethal effect observed 
(Fig. 5.6 C); moreover, the experiments also showed differences in the polyP levels 
between the single mutant strains. While the ∆MSMEG_5413 content was similar to the 
wild-type strain one in every condition tested, thelevels shown by ∆MSMEG_0939 strain 
where approximately 1.5-fold higher, confirming previously published results where 
different activities and/or functions were ascribed and hypothesised to each 
exopolyphosphatase (Thayil et al., 2011; Choi et al., 2012). Although, these results 
suggested a redundant effect for the genes, since the presence of one of them suffices for 
the survival of the organism and the use of phosphate units from the polyP during the 
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Figure 5.6: Effect of ppx genes deletions in polyP content during Pi starvation in M. smegmatis strains. 
Bar chart showing polyP levels of wild-type, ∆MSMEG_0939, ∆MSMEG_5413 and ∆MSMEG_0939-5413    
strains during incubation in TSB (A) and Sauton media without (B) and with phosphate (C). Cells previously 
grown in TSB were washed and incubated in fresh Sauton media –Pi and +Pi during 48 hours at 37ºC. 
Samples were taken at 0, 24 and 48 hours of the incubation and polyP levels were measured using a DAPI-
based fluorescence method. Data collected from three independent experiments. 
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  In order to avoid the lethal effect of the double mutation, gene complementation 
attempts were carried out by introducing the multicopy-replicating plasmid pMV261, 
carrying either MSMEG_0939, MSMEG_5413, Rv0496 or Rv1096 into the double 
knockout mutant; additionally, a control recombinant strain was developed carrying only 
the vector without any of the genes. The double mutant strains bearing the constructs were 
incubated under the conditions already described, but the initial incubation in TSB was 
extended up to sixty hours due to the slow-growth pattern shown by complemented strains. 
OD values were measured during the experiment in the same way described above and the 
polyP levels were quantified after 48 hours of starvation. Surprinsingly, the polyP levels 
shown by the double mutant after 48 hours of incubation in Sauton medium were 
approximately 10-folder and 5-folder (Sauton without and with phosphate, respectively) 
higher compared to the levels found in the previous experiment, while the complemented 
strains showed similar or even higher levels of polyP than the double knockout mutant 
(Fig. 5.7). Moreover, the complementation assays were not successful, since the OD 
measurements showed that the complemented strains were not able to survive the 
incubation in Sauton media (Fig. 5.8).  
 
5.3 DISCUSSION  
 Using the E. coli K-12 exopolyphosphatase sequence already described as query 
(Akiyama et al., 1993; Zago et al., 1999), I identified two putative exopolyphosphatases in 
the M. tuberculosis HRv37 genome, namely Rv0496 and Rv1026, as it was predicted by 
previous studies (Lindner et al., 2009). At the time when this work was carried out, Thayil 
et al. and Choi et al. attempted to determine exopolyphosphatase functions in these two 
putative exopolyphosphatases and showed each as having distinct biochemical activities: 
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only Rv0496 was found able to degrade polyP (preferable short chains) but Rv1026 had no 
detectable exopolyphosphatase activity in vitro. The M. smegmatis mc2155 homologues, 
MSMEG_0939 and MSMEG_5413, were chosen in order to check their roles in bacterial 
survival under phosphate starvation and the in vivo polyP degradation by generating single 
mutants and a double mutant strain. Surprisingly, even though Rv1026 was predicted to be 
essential in M. tuberculosis, I was able to generate a MSMEG_5413 knockout in M. 
smegmatis. My results showed a high degree of redundancy between both M. smegmatis 
putative exopolyphosphates since the presence of either gene was enough to rescue the 
double mutant strain from cell death while growing  Sauton medium. Additionally, these 
data strongly suggested that polyP is the only source of inorganic phosphate while growing 
in minimal medium like Sauton, which is available by the action of exopolyphosphatases. 
 















 - Pi + Pi
 
Figure 5.7: polyP content during Pi starvation in complemented ∆MSMEG_0939-5413 strains. Bar 
chart showing polyP levels during incubation in Sauton media without (-Pi) and with phosphate (+Pi). Cells 
previously grown during 60 hours in TSB were washed an  incubated in fresh Sauton media during 48 hours 
at 37ºC. Samples were taken at the end of the incubation (48 hours) and polyP levels were measured using a 
DAPI-based fluorescence method. Complementation was carried out using the vector pMV261, where the 
genes MSMEG_0939, MSMEG_0939, Rv0496 and Rv1026 were cloned. ∆2: double mutant, pMV261: only 
vector control, c: complemented strains. Data shown collected from three independent experiments. 
 















































Figure 5.8: OD values for the growth of complemented ∆MSMEG_0939-5413 strains during phosphate 
starvation. Cells previously grown in TSB medium during 60 hours were washed two times with Sauton 
medium without phosphate and diluted until OD600nm=0.4. Later, the strains were grown in Sauton media 
with (+Pi) and without (-Pi) phosphate during 48 hours at 37ºC in agitation and growth was monitored by 
optical density. OD was measured every 24 hours in order to test the effect of the complementation which 
was carried out using the vector pMV261 where the genes MSMEG_0939, MSMEG_0939, Rv0496 and 
Rv1026 were cloned. ∆2: double mutant, pMV261: only vector control, c: complemented strains. Data shown 
collected from three independent experiments. 
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 Nevertheless, single mutants clearly exhibited different physiological roles for each 
gene, judging by the difference in polyP content described. The data support the idea that 
each gene has a different function but still retaining exopolyphosphatase activity in vivo 
since the double mutant was not able to survive in Sauton medium even in the presence of 
phosphate. The strains present no colony morphology alterations and parallel analysis of 
capsule α-glucan and total lipid profile in the ∆MSMEG_5413 strain did not show, at least, 
any change attributable to the cell envelope (data not shown). In the case of 
MSMEG_5413, the genetic context shows that the gene is downstream MSMEG_5414, 
both forming part of the same operon. This gene encodes for a septum formation initiator 
protein DivIC, whose function and link with the exopolyphosphatase encoded by 
MSMEG_5413 need to be elucidated, due to the nature of DivIC it is likely that the 
function of this exopolyphosphatase could be related to cell division, perhaps doning 
phosphate groups. On the other hand, the genetic context of the gene MSMEG_0939 
reveals a close distance to the genes that encode for the two component system SenX3-
RegX3, MSMEG_0936 and MSMEG_0937, respectively. Therefore, a function directly 
related to the regulation of phosphate-uptake, -useand -store could be hypothesised for 
MSMEG_0939, where the degradation of polyP should be the most important one, and now 
supported by the activity described in the literatue (Thayil et al., 2011; Choi et al., 2012).  
In this case, it is likely that the exopolyphosphatases are under the strict regulation of the 
SenX3-RegX3 system, perhaps a minimal medium like Sauton triggers a stringent response 
where the phosphate uptake is completely directed to the synthesis of polyP and the 
phosphate supply relies exclusively on the exopolyphos hatase activity (not present in the 
double mutant), independently of the phosphate available in the media, which the double 
mutant used in this study was not able to use. If the regulation of the exopolyphosphatase 
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activity was simple, a normal complementation assay hould rescue the double mutant 
from the death while growing in Sauton medium; since the expression using the pMV261 
vector is constitutive, a stress condition could be generated that either prevents the activity 
of the exopolyphosphatases via (p)ppGpp or the organism undergoes a general metabolic 
dysregulation. 
 Due to the diversity of metabolic processes in which polyP is involved (Brown and 
Kornberg, 2008) and considering that representative genomes of the Actinomycetales in 
general contain both ppx genes, it seems very likely that their functions had reached a high 
level of specialisation where each exopolyphosphatase could have a specific role at 
different stages, under different conditions or having substrate specificity as it has been 
said for polyP-length and Ppx2 (Lindner t al., 2009). For instance, a BLAST analysis 
showed a high degree of identity between Rv1026 and NCgl0938 (52% of identity, E=2e-
102), but functionally the enzymes have not shown to possess similar exopolyphosphatase 
behaviour in vitro (Lindner et al., 2009; Choi et al., 2012), likely suggesting that the 
activity in vivo is regulated by additional factors and under different environmental 
conditions or stages that could be biasing the results and might have not been considered 
when in vitro reaction are performed, like protein complexes or reaction involving several 
proteins. This study has shown that in M. smegmatis the polyP degradation by Ppxs 
consists in the only source of inorganic phosphate during starvation, an interesting point, 
since that could also be the scenario that M. tuberculosis could face as an intracellular 
pathogen and during dormancy as well. Additionally, it supports the idea of both 
homologous exopolyphosphatases having different biological functions, but showing signs 
of redundancy under certain conditions that must be studied in great detail since gene 
expression is highly regulated and critical in this pathway (Manganelli, 2007). Then, the 
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next goal in this context must be to determine substrate specificity, expression conditions 
and gene regulation for each exopolyphosphatase.  
  
 
5.4 MATERIALS AND METHODS 
 
5.4.1  Bacterial strains and growth conditions 
 M. smegmatis mc2155 strain was used in all experiments as wild-type control and to 
generate mutant strains for the exopolyphosphatase homologous genes MSMEG_0939 and 
MSMEG_5413. Using specialised transduction, three strains were generated, namely 
individual single mutants and double mutant strain (Table 5.1). Antibiotics concentrations 
used for selection in each case were hygromycin 100 µg/ml, apramycin 50 µg/ml and 
kanamycin 30 µg/ml. Colony morphology of the mutant strains was ob erved on both TSB 
and Sauton 1.5%-agar plates by spotting 10 µl of 10-1 to 10-6 dilutions from M. smegmatis 
cultures previously grown in TSB and Sauton media, respectively, until stationary phase. 
Plates were incubated at 37ºC until colonies were visible (3-6 days). The growth of the 
strains was measured in duplicates by optical density at 600 nm, 50 ml of TSB liquid 
cultures were grown at 37ºC, 180 rpm of agitation, a d started using 1/1000 dilutions of 
previously grown cultures adding antibiotics according to the concentrations mentioned 
above. Sauton medium contains 0.05% (3.7 mM) KH2PO4, 2% glycerol, 0.4% L-
asparagine, 0.2% glucose, 0.2% citric acid, 0.05% magnesium sulfate, 0.005% ferric 
ammonium citrate, at pH 7.0.  Phosphate starvation assays were performed using Sauton 
medium prepared using Milli-Q water with no monopotassium phosphate added; in order 
to avoid traces of phosphate, the flasks were previously washed with acetic acid and all the 
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chemicals used were analytical grade, with no levels of phosphate detected. Liquid media 
were prepared adding 0.05% Tween-80 as surfactant age t. 
 
5.4.2  Generation of mutant strains 
 Individual mutants were generated using allelic exhange constructs designed to 
replace the MSMEG_0939 and MSMEG_5413 genes with apramycin and hygromycin 
resistance cassettes, respectively. Sequences flanking the left and right of the genes were 
PCR amplified using the primers listed on Table 5.2 and Van91I restriction sites, following 
the procedure described in General Materials and Methods chapter to generate knockout 
phages. The double mutant strain was generated from the ∆MSMEG_5413 mutant, using 
the phage designed to delete MSMEG_0939, to obtain ∆MSMEG_0939-5413, a double 
Apra-Hyg resistant strain. Each mutant was validate as bona fide by Southern blot 
analysis as described in General Materials and Methods section. 
 
5.4.3  Phosphate starvation    
 Phosphate starvation assays were performed as it follows. Firstly, the strains were 
grown during 30 hours until stationary phase in 50 ml of TSB culture in aeration at 37ºC 
and 180 rpm. Each culture was split into two similar volumes and the cells collected by 
centrifugation and washed twice with Sauton media without phosphate. Cells were 
transferred into 20 ml of Sauton media with and without phosphate, diluting the cells until 
approximately an OD=0.4 and continuing the incubation for 48 hours in the same 
conditions. Samples of 1 ml were collected at the end of the incubation in TSB and every 
24 hours during incubation in Sauton media in order to determine polyphosphate content. 
In addition, at the same stages, cell couting was carried out by plating 25 ul of cell 
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dilutions 10-3, 10-4, 10-5 and 10-6 on TSB-agar plates in duplicates. Phosphate starvation 
assay was carried out in triplicates, starting from independent cultures. 
 
5.4.4  Complementation of mutant strains  
 The open reading frames for MSMEG_0939, MSMEG_5413, Rv0496 and Rv1026 
were PCR-amplified from M. smegmatis mc2155 and M. tuberculosis H37Rv genomic-
DNA, respectively, using the primers pairs Ms0939F/Ms0939R, Ms5413F/Ms5413R, 
pMV261-Rv0496F/pMV261-Rv0496R, pMV261-Rv1026F/pMV261-Rv1026R (Table 
5.2). Amplified genes were cloned into the pMV261 vector using the primer-incoporated 
BamHI and HindIII cloning sites and the constructs generated were used to transform 
Top10 chemically competent E. coli cells using kanamycin for selection. Recombinant 
plasmids were purified, checked by DNA-sequencing ad used to transform M. smegmatis 
strains by electroporation.  
 
 
5.4.5  Polyphosphate extraction 
 PolyP extraction was performed using the method described by Ault-Riché et al., 
(1998). Samples of 1 or 2 ml of culture were taken and cell pellets collected by 
centrifugation for 3 min at 13,000xg and discarding the supernatant. Each pellet was 
resuspended in 0.3 ml of the a mix solution containing 4 M guanidinium thiocyanate 
(GITC), 50 mM Tris/Cl, pH 7 (or QG buffer, QIAGEN) and 50 µl of the suspension were 
used for protein amount determination using the BCA Protein Assay by Pierce (Biuret’s 
method-based) as an indicator of amount of bacterial mass per sample. The suspension was 
incubated at 95ºC for 3 min, and 30 µl of 10% SDS  was added. The mix was incubated at 
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95ºC for 2 min. Next, 300 µl of 100% ethanol and 5 µl of Glassmilk suspension were 
added to the tubes, which were then mixed by vortexing and incubated for 30 s at 95ºC. 
The mix was centrifuged at 13,000xg for 2 min and the supernatant was discarded. The 
pellet was resuspended in 200 µl of cold New Wash solution (5 mM Tris/Cl, pH 7.5, 0 
mM NaCl, 5 mM EDTA, 50% ethanol) and centrifuged at 13,000xg for 30 s. The pellet 
was resuspended in 100 µl of a solution containing 50 mM Tris/Cl, pH 7, 5 mM MgCl2, 5 
µg/ml DNAase and 5 µg/ml RNAase and incubated at 37ºC for 30 min. The suspension 
was centrifuged and the supernatant discarded. The pellet containing the polyP was washed 
twice with 200 µl of cold New Wash solution, centrifuged and supernata t discarded.  
 Finally, the polyP was collected two times by resuspending the pellet by vortex in 
50 µl of water, incubating the sample for 2 min at 95ºC, centrifuging at 13,000xg, and 
saving the supernatant containing the polyP. The polyP samples were stored at -20Cº for 
no longer than 10 days. 
 
5.4.6  Polyphosphate quantification assay 
 A DAPI (4’,6-diamidino-2-phenylindole)-based assay was carried out for polyP 
quantification doing modifications to a protocol previously described by Aschar-Sobbi et 
al. (2008) and Díaz and Ingall (2010). Reactions of 250 µl volume were prepared in 96-
well black microplates containing 125 µl HEPES (20mM final concentration), 1 µl DAPI 
(10 µM final concentration), 119 H2O and 5 µl of each sample of polyP on triplicates. In 
order to standarise the quatification, each plate that was read included wells with known 
amounts of commercial polyphosphate (KeraFast, High MW P700) from 0-20 µM and 
these readings were used to plot standard curves. The amounts of polyphosphate were 
finally expressed as weight [µg], assuming that 1 µg of polyP in a volume of 2 ml 
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corresponds to 6.3 µM of orthophosphate, using the -PO3 group as a monomeric unit 
(Aschar-Sobbi et al., 2008). The shift in fluorescence was measured using a PHERAstarFS 
microplate reader (BMG LABTECH) at 415 nm (excitation) and 525 nm (emission) 
wavelengths.  Blank reactions were prepared using 5 µl of water instead of polyP. Diluted 
polyP samples 1/10 and 1/20 were also measured using the same method when signals 
were saturated. The amount of polyP obtained in µg from each sample was divided by the 
amount of proteins present in the same sample, and a ratio between amount of polyP and 










































Table 5.1  












Cosmid for cloning allelic-exchange substrates. 
Used for specialized transduction. Contains 
λphage cos site and HygR-sacB cassette.  
Bardarov et al., 2002 
p∆MSMEG_0939 
 
Derivative of p0004s designed for allelic exchange 




Derivative of p0004s designed for allelic exchange 




Escherichia coli-mycobacterial shuttle vector, 
aph from Tn903, hsp60 gene promoter from M. 
tuberculosis. KanR. 






























Conditionally replicating shuttle phasmid derived 
from the lytic mycobacteriophage TM4. 
Bardarov et al., 2002 
ph∆MSMEG_0939 
 
Derivative of phAE159 obtained by cloning 




Derivative of phAE159 obtained by cloning 






M. smegmatis  mc2155 
 
Parental strain, ept-1 mutation conferring high 
efficiency of plasmid transformation. 





Null mutant of MSMEG_0939 in mc2155  




Null mutant of MSMEG_5413 in mc2155 (replaced 




Double mutant of mc2155 in which chromosomal 
copies of MSMEG_0939 and MSMEG_5413 were 









Table 5.2  
List of primers used in this study  
 
 








5' TTTTTTTTCCATAAATTGGCTCGAGGTAGCCCTTCTTGCCC 3' 
5' TTTTTTTTCCATTTCTTGG GGACAGCTCCAGCGAACCGCCG 3' 
5' TTTTTTTTCCATAGATTGGCTGGCTCGCCACCGAGCTCGCCG 3' 







5' TTTTTTTTCCATAAATTGGCGACGGCACCAACTACCGCGCACTG 3' 
5' TTTTTTTTCCATTTCTTGGCGAATACGATCCCGAGCAGATCCAC 3' 
5' TTTTTTTTCCATAGATTGGCGATCATCAACGCGACGTAG 3' 
5' TTTTTTTTCCATCTTTTGGACGGCTGGGTTTCGTGATGC 3' 
 
LL forward primer for left flank, LR reverse primer for left flank, RL forward primer for right flank, 
RR reverse primer for right flank 
 












5' GACCCGTGCGGGATCCTGTGCTCGATGTGG 3' 
5' GGCTAGAAGCTTCTTATCGTCCGGCGTCGC 3' 
5' CTGGAGCGGATCCCATGGGTGTGAACGACC 3' 
5' CCGTTCGCTTTAAGCTTTCAGCTGATCG 3' 
5' CACGGTCCAGGATCCGGTGGTCGATG 3' 
5' GGTGTGAAGCTTTCATGGTTTGCTGCC 3' 
5' CTGGTGGGGATCCAGTGGCGCTAACCCG 3' 
5' TGTGGCAGAAGCTTCTTATCCGGCCAG 3' 
 







5' CCAGTGGCAGCGAGGACAAC 3' 
5' TGTGCAATGTAACATCAGAG 3’ 
 
 
5.4.7 Southern-blot confirmation 
 The mutant strains obtained were confirmed by Southern-blotting technique using a 
DIG probe as described in General Materials and Methods section. The following pictures 
show a diagram representing the digestion pattern of genomic DNA from wild-type and 
mutant strains on the left side. The right side of the pictures display the films obtained by 












Figure 5.9:  Southern-blot confirmation. The left sides of the pictures display the digestion pattern 
diagrams of genomic DNA from wild-type and mutant strains. Right sides display the films obtained by 
hybridisation between the probes and the digested genomic DNA. The diagrams include the restriction 
enzyme used and the expected sizes for each strain after the digestion; the films display the digestion pattern 
obtained for each strain tested and the probe was also used as molecular-weight size reference. The strain  
that showed the expected pattern were choosen to perf rm the experiments described in this chapter. L and R 
indicate the flanking regions, hyg-apra: hygromycin a d apramycin resistance cassette, respectively.  A- 
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 Despite the major progresses achieved in the care and control of Tuberculosis (TB) 
since the mid-1990s, the development and identification of new diagnostics, drugs and 
vaccines is still a priority against the disease as well as better, shorter and cheaper 
treatments for all forms of TB, especially due to drug resistance and persistence. In this 
context, the efforts of molecular microbiology must be focused, firstly, on a good 
understanding of the molecular basis involved in the structure and biosynthesis of the cell 
envelope, and also on decipher the molecular mechanisms of bacterial survival in harsh 
conditions and dormancy.  
 The main objective of this study was to explore novel areas inside the proposed 
fields by using different strategies, in order to tackle topics mainly unexplored, “forgotten” 
or unproductive during the previous years. Surprisingly, during the course of my project, 
several publications appeared in the topics chosen, complementing my results and also 
supporting the criteria behind the choice taken. Summarising, four projects were carried 
out: three regarding the mycobacterial cell envelop and one regarding the survival in 
order to find new genetic determinants (i.e., transposon mutant library) and to study topics 
not yet fully explored (i.e., capsular α-glucan biosynthesis, mycolic acid transport and the 
role of exopolyphosphatases). In this project, searching for defective cell-cell interactions 
(as the lack of biofilm formation) or the selection of strains with visual defective 
morphologies have demonstrated to be an effective tool to use in order to look for key 
genes related to cell wall metabolism. The selected or “randomly”-discovered genes 
studied in this project were related to functions as different as transport or division, and 
also to metabolites as different as lipids, sugars or phosphate; but finally all of them 
genetically or metabolically related to cell wall biosynthesis, a key structure in the survival 
of mycobacteria. 
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 The first strategy chosen to tackle the objectives proposed was based on random 
transposon mutagenesis, using Mycobacterium smegmatis as surrogate model for 
generating a Tn-mutant library, looking for colony morphology alterations and antibiotic 
resistance and using them as selection parameters of the screening. Although the lipid 
analysis performed did not display evidences of alter tion in chemical composition in the 
strains as it was expected, since no changes regardin  noncovalently bound 
glycoconjugates like PDIMs, PGLs, free mycolic acids, PIMs or SL were found by TLC 
analysis. Nevertheless, structural changes and increased sensitivity to rifampicin were 
associated to several diferent genes, for instance, MSMEG_6387 (arabinosyltransferase A) 
and MSMEG_0408 (type I modular polyketidesynthase), which are involved in lipid 
metabolism and whose homologous genes in Mycobacterium tuberculosis have been 
related to cell wall components (Escuyer et al., 2001; Alderwick et al., 2011), validating 
the technique used at the same time. Therefore, further projects should focused in 
elucidating, accurately, what are the chemical changes occurred and the factors involved in 
the alterations. In the specific case of the disruption of MSMEG_3743, previously describe 
to be part of a group of genes related to cell cycle and DNA segregation (Jakimowicz et 
al., 2007; Maloney et al., 2009), new structural changes were discovered in terms of DNA 
distribution and cell partitioning, adding precious information in a field which is still no 
deeply investigated. Moreover, a recently published study has shown similar results 
involving its homologs in M. smegmatis (Ginda et al., 2013), and also started to speculate 
about how the genes involved in cell division could be related to persistency, which is the 
other field that I tried to focus this project on ad also showing that is a field which needs 
to be explored. Nevertheless, the mutant strains obtained in this project yet need to be used 
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to perform a sugar analysis in order to find a correlation between the chemical composition 
and the structural/functional defects found. 
  Regarding mycolic acid biosynthesis, at the beginning of this project its transport 
remained completely unclear and only hypothetical pathways were proposed (Takayama et 
al., 2005). Based on the known functions of a group of r teins belonging to the RND 
family called MmpL, the gene mmpL3 was predicted to encode a glycolipid transporter and 
it was chosen as a candidate to transport trehalose monomycolate. As it was previously 
described by Domenech et al. (2005), in this project the gene was confirmed to be essential 
in M. smegmatis by developing a conditional expression system. Additionally, trying to 
obtain stronger results and a broader panorama of its function, the role of mmpL3 in 
mycolic acid biosynthesis was addressed using two organisms who present mycolic acid as 
component of the cell wall, both belonging to the order Actinomycetales, namely M. 
smegmatis and Corynebacterium glutamicum. Using the conditional mutant and a set of 
mmpL mutants for the three orthologs present in C. glutamicum, the results showed mmpL 
to be involved in mycolic acid transport in both organisms. In the conditional M. 
smegmatis mutant, loss of the MmpL3 function produced a decrease of trehalose 
dimycolate (TDM) levels and also reduced mycolylation of arabinogalactan (AG); on the 
other hand, the complete loss of trehalose monocorynom colates (TMCM), trehalose 
dicorynomycolates (TDCM) and AG-bound corynomycolates was observed in one of the 
C. glutamicum double mutants (∆NCgl0228-NCgl276). These results were published 
(Chemistry and Biology, 2012; 19(4):498-506) and surprisingly, while the paper was under 
revision, three new studies were published regarding MmpL3 functions, identifying it as 
the target of three drugs and one of them showing similar results (La Rosa et al., 2012; 
Tahlan et al., 2012; Grzegorzewicz et al., 2012). This is remarkable, due to the fact that 
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eleven out of twelve publications related to MmpL3 have been published only in the last 
twenty months, proving that the topic has become important and this project has been part 
of that process. Regarding the different publications, the characterisation of mmpL3 as a 
gene involved in heme group transport in M. tuberculosis (Tullius et al., 2011) opened 
another door in order to delucidate the real function of the transporter, since it could be 
involved in more than one vital function and displaying two completely different roles with 
a high degree of promiscuity. That fact does not seem to be completely well understood 
and still need to be elucidated, since some results eemed to be contradictory. Therefore, 
MmpL3 remains as a key transporter and it keeps adding reasons to be consider as a good 
drug target candidate since several changes in the ratios of mycolic acids species occur 
during infection and also because it connects the metabolisms of two important virulence 
factor as TMM/TDM and trehalose, a key sugar during i fection and nutrient scarcity, 
topic which has also been tackled in this project.  
 The project related to the capsule α-glucan transport did not accomplish its main 
objective, since the candidate genes selected did not show to be involved in the transport of 
α-glucan in M. smegmatis under the conditions tested. Nevertheless, the essntiality of 
MSMEG_6369 was demonstrated by generating a conditional expression system for the 
gene, and also the mutant ∆MSMEG_5059-5060 showed not to be able to grow using 
trehalose as a unique sole carbon, as it was proved by Kalscheuer et al. (2010) while these 
experiments were carried out, validating the methods and techniques used as strong tools to 
obtain new data, despite the fact that the main objectives were not accomplished. In the 
case of the ∆MSMEG_5059-5060 strain, an interesting fact was observed, since the 
mutation seemed to activate the route to metabolise glycogen as unique carbon source 
when it was unable to recycle trehalose; it is know that some organisms accumulate 
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glycogen (glycogen accumulating organisms, GAO) in order to use it under certain 
conditions (e.g., anaerobic), even though mycobacteria do not belong t  that group (in fact 
they accumulate polyphosphate) the metabolic repertoir  could include the ability to 
induce the use of glycogen under stress conditions. Perhaps a genetic comparison between 
mycobacteria and GAO organisms could open a door to a better understanding of glycogen 
metabolism in the Mycobacterium genus. This topic yet have to be expanded due to the 
role that capsule plays in pathogenicity via the facilit tion of the interaction with 
macrophages, the modulation of the induction of cytokines or its components acting as 
major polysaccharides antigens. The genetic and molecular bases underlying those 
processes need to be described and elucidated in orer t  find more drug targets. 
 Finally, considering the survival and dormancy as crucial processes in 
mycobacterial virulence, the role of inorganic polyphosphate (polyP) in survival under 
harsh condition was tested using a point of view not considered before. The majority of the 
publications and studies available at the beginning of this project were focused on the role 
and on the function of the enzyme polyphosphate kinase (Ppk) in virulence and stringent 
response (Brown and Kornberg, 2008), obtaining pleiotropic effects when generating 
knockout mutants. In this project, I decided to address the role of polyP in survival when 
the cells face absence of phosphate, but focusing in the two exopolyphosphatases (Ppx) 
present in mycobacteria instead of Ppk. The role of x polyphosphatases in mycobacteria 
has also started to become an important area and a couple of publications appeared during 
the progress of this project, showing different in v tro activity for each Ppx among other 
functions (Thayil et al., 2011; Choi et al., 2012), supporting the data obtained and showing 
that further analysis are necessary in a nascent resea ch topic.  
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  The results obtained have shown that the polyP is the unique source of inorganic 
phosphate during phosphate starvation and it is supplied by the activity of the 
exopolyphosphatases, which seems to have a protective role during stress and likely having 
different physiological functions. As it was explained, the polyP and exopolyphosphatases 
are involved in complex signalling pathways related o the transcription of several genes 
and, undoubtedly, needing a very accurate regulation in terms of the levels of metabolites 
and depending on the stage of expression. The genetic context of both genes reveal 
interesting information about their potential functions; as it was stated, the gene 
MSMEG_0939 must be related directly to the use of phosphate groups as a result of the 
degradation of polyP by removing the last phosphate residue. On the other hand, a very 
careful insight of the genetic context of MSMEG_5413 reveals that downstream effects 
were likely to happen since it forms part of an oper n and it must be transcribed as a 
polycistronic mRNA unit, since the gene overlapped with MSMEG_5414, involved in cell 
division and sporulation processes (Katis and Wake, 1999; Bennett et al., 2007), thus, 
analysis by fluorescence microscopy is needed in order to determine changes in the 
division function. The alignment of its genomic region with the equivalent one in the 
genome of M. tuberculosis reveals high level of synteny, and also shows that a nucleoside 
triphosphate pyrophosphohydrolase (encoded by Rv1021) seems to be transcribed as part 
of the same operon. In this case, the function is likely to be related to the synthesis (or 
degradation) of signalling molecules using the exopolyphosphatase as a phosphate donor 
and probably related to the stringent response. Moreover, the genome of M. tuberculosis 
shows a very close distance between Rv1026 and genes related to the donation of 
phosphate groups to sugar and that could be related to the biosynthesis teichoic acids, 
where phosphate is a major component (Schneewind and Missiakas, 2014). Therefore, 
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even though no morphology alterations were found, a complete analysis of peptidoglycan, 
arabinogalactan and lypoglycans must be perform in the ∆MSMEG_5413 strain in order to 
reveal the function of the gene, where the effect of the deletion could have not resulted in 
structural changes, but maybe in an impaired regulation of other genes. In this sense, 
MSMEG_5413 is possible to be related to the cell wall biosythesis as a phosphate-donor to 
molecules involved in cell-shaping and cell wall composition; membrane-staining assays 
like the one performed with the ∆MSMEG_3743 (Chapter 2) strain would also be suitable 
in order to find alteration in the shape or the septum formation at cellular level. As it has 
been explained, the exopolyphosphatases transcription and activities seem to be tighly 
regulated, and also forming part of operons susceptibl  to suffer polar effects as result of 
their deletions. A similar situation occurs with the gene MSMEG_3743 that is upstream of 
an operon composed by six genes; thus, successful complementation assays necessarily 
require the use of an integrative vector that allows the transcription of the genes under 
native conditions, reducing the effect of gene overexp ession and plasmid replication. The 
deletion of genes without disrupting the open reading frames of the other members of the 
operon does also appear as an effective tool to avoid polar effects as result of the deletions. 
 This summary shows that the strategies chosen in order to achieve the objectives 
proposed at the beginning of this study were appropriate, since each project carried out was 
prolific in terms of the amount and quality of the data obtained, and also opening the 
possibilities to continue future experiments in order to discover new drug targets and a 
better understanding of the metabolism of mycobacteria. 
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7.1 Genomic DNA extraction  
 Cells from a 10 ml bacterial culture were collected by centrifugation and 
resuspended in 450 µl of resuspension buffer (50 mM Tris/Cl pH 8.0, 10 mM EDTA,100 
µl/ml RNaseA), 10 mg/ml lysozyme were added and incubated overnight at 37ºC. After the 
incubation, 100 µl of 10% SDS and 50 µl  of 10mg/ml Proteinase K were added,  the 
suspension was mixed gently and incubated for 4 hours at 55ºC. 200 µl of 5 M NaCl were 
added and the mix was incubated at 65ºC for 15 min.Later 500 µl CHCl3 were added 
mixing for 5 min and centrifuged at 13,000 rpm for 5 min. The aqueous layer was 
transferred to a new clean tube and 350 µl isopropanol (~0.7x of the volume obtained) 
were added and the tube gently mixed by inversion until DNA precipitated out of the 
solution. The reaction was centrifuged at 13,000 rpm for 10 min (or more if necessary). 
Supernatant was aspired and 1 ml 70% ethanol was added, the tube was gently inverted 
and spun in microfuge for 5 min. Supernatant was removed and the DNA dried out for 15 
min. Finally, 50 µl of water or TE buffer (10 mM Tris/Cl, 1 mM EDTA, pH 8) were added, 
the DNA sample was quantified by absorbance at 260 nm and stored at -20ºC.  
 
7.2 PCR, DNA-ligation and DNA-digestion 
 Polymerase chain reactions were carried out using Phusion® HF PCR kit from 
NEB, DNA-ligation reaction using T4-DNA ligase kit from NEB and DNA-digestion 
using NEB restriction enzymes. Every reaction was performed according to protocols 





Chapter 7 – General Materials and Methods 
 
 147
7.3 Preparation of competent cells 
 Chemically competent cells were prepared starting from an overnight culture of 
Escherichia coli that was used to inoculate 100 ml of LB medium with 20 mM MgSO4. 
Cells were grown until OD600 of 0.6 at 37ºC and then centrifuged at 4,500xg for 5 min at 
4ºC. The pellet was gently resuspended in 0.4 ml of ice-cold TFB1 solution (30 mM 
potassium acetate, 10 mM CaCl2, 50 mM MnCl2, 100 mM RbCl, 15% glycerol) and 
incubated on ice for 5 min. The cells were centrifuged at 4,500xg for 5 min at 4ºC and the 
pellet gently resuspended in 2.5 ml of TFB2 solution (10 mM MOPS, 75 mM CaCl2, 10 
mM RbCl, 15% glycerol, pH 6.5). Finally the cells were incubated on ice for 15-60 min 
and 200 µl aliquots were stored at -80ºC. 
Mycobacterium smegmatis electrocompetent cells were prepared from 50 ml of 
7H9+OADC+0.05% Tween-80 culture grown until OD600 ~ 0.5-1.0 at 37ºC. The culture 
was incubated on ice for 90 min and then centrifuged at 2,000xg for 10 min at 4ºC. The 
pellet was washed two times with 40 ml of sterile ic cold 10% glycerol. Finally the cells 
were resuspended in 5 ml of ice cold 10% glycerol and liquots of 200 ul stored at -80ºC. 
 
7.4 Transformation of competent cells 
 E. coli top10 competent cells were thawed on ice and 5µl of p asmid DNA were 
added (< 5% of cell volume or < 50 ng in 10 µl or less). The tube was gently swirl and mix 
by finger flicking. The reaction was incubated on ice for 20 min, then placed at 42°C for 
45 sec and back on ice for 5 min. Later 1 ml of LB was added and incubated for 60 min at 
37°C with agitation 150 rpm. Finally, 50, 100 and 200 µl of reaction were spread on 
different LB-agar plates containing the selection marker and incubated overnight at 37ºC. 
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 M. smegmatis competent cells were transformed by electroporation. Aliquots of 
200 µl of cells were thawed on ice and poured in a 1 mm gap electroporation cuvette 
previously frozen, 5-10 µl of plasmid DNA were adde and the mix was subjected to a 
single pulse using an Eppendorf Electroporator 2510 (2.5kV), 1 ml of TSB was added and 
cells were recovered at 37ºC for 4 hours. Finally, cells were plated on TSB-agar solid 
media adding the selection marker. 
 
7.5 Generation of mutants strains by specialised transduction 
 
7.5.1 Construction of the allelic exchange substrate (AES) plasmid 
 Approximately 1 kb of upstream (left) and downstream (right) flanking sequences 
of each gene were PCR amplified from M. smegmatis mc2155 genomic DNA using the 
primers listed on each chapter (LL-LR and RL-RR, respectively). Amplified fragments did 
not have restriction sites for the enzymes used to ligate and included between 100 to 400 
bp of the 5’ end of the gene in the left flank and 100 to 400 bp of the 3’ end of the gene in 
the right flank.  
 Then, 10 µl of purified PCR product were digested with the appropriate restriction 
enzyme while 50 µg of plasmid p0004s were digested with Van91I. The top two vector 
fragments of size 3.68 kb and 1.60 kb (containing both the hyg/sacB and oriE fragments) 
were cut out from agarose gel. The digested vector fragments from p0004s were mixed 
with the digestions from the left and right flanking sequences and purified using the 
Qiagen gel extraction kit following the user guide protocol. Then, 30 µl of mixed 
fragments were collected and ligated using T4 DNA ligase from NEB using 5 µl of ligation 
mix and 100 µl E. coli Top10 chemically competent cells. Transformants were selected 
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and the plasmids obtained were checked by digestion w th the previous enzymes and PacI 
and sequenced using the primers HL, HR, OL, and OR.This protocol describes the 
exchange between the target gene and the hygromycin cassette, but in this study the 
apramycin cassette was also used as selection marker. 
 
7.5.2 Phasmid Construction 
 Sequence-confirmed plasmids and the phAE159 DNA where digested with PacI, 
using 1 µg each in 20µl of reaction. Approximately 2-4 µl of the phage and 4-6 µl of the 
plasmid were used for a T4 ligase reaction of 10 µl. An in vitro packaging was carried out 
by adding 5 µl of ligation mixture directly to the MaxPlaxTM packaging extract tube and 
incubated for 1.5 h. The reaction was stopped with 200 µl MP buffer (50 mM Tris/HCl 
pH 7.6, 150 mM NaCl, 10 mM MgCl2 and 2 mM CaCl2) and incubated at room 
temperature for 30 min, 100 µl of HB101 host cell suspension were added directly to the 
packaging tube and incubated at 37ºC for 1 h. The cells were collected by centrifugation, 
the supernatant removed and the pellet resuspended with 1 ml of fresh LB media. The cells 
were plated on LB-hyg 150 µg/ml and incubated at 37ºC overnight. The hygromycin 
resistant colonies were selected to look for potential phasmids, which were purified and 
checked by digestion with PacI enzyme. The right digestion pattern consists in a ph ge 
genomic ~40kb band and a linearised band of allelic exchange plasmid of ~7kb. 
 E. coli HB101 was previously prepared for transduction from a 50 ml LB culture 
supplemented with 10 mM MgSO4 and 0.2% maltose incubated at 37°C until OD600 0.8-
1.0. Cells were collected by centrifugation at 3000 rpm, 4°C for 10 min and resuspended  
in 500 µL of MP buffer and stored for no longer than a week at 4°C.  
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7.5.3 Generation of knockout phage 
 An amount of 5-10 µl phasmid DNA was electroporated into 200 µl 
electrocompetent M. smegmatis cells, 1 ml of LB media was added and the mix incubated 
at 30ºC (not 37ºC) for 1 h. Aliquots of 100, 200 and 400 µl were mixed with 500 µl of 
actively growing culture of M. smegmatis. The dilutions were mixed separated and added 
to 4 ml of molten top agar (at 50°C) in a snap cap tube and mixed gently by inverting the 
tube and poured onto pre-warmed 7H9 basal agar plates. The plates were incubated at 30ºC 
until plaques were observed. Plaques were picked and soaked in 200 µl of MP buffer to 
recover the phage.   
 
7.5.4 High titre phage lysate 
 Firstly, plates containing 7H9 basal agar were overlaid with 4 ml of top agar 
containing 500 µl actively growing M. smegmatis culture. 10-fold dilutions of the phage 
were prepared using MP buffer. 10 µl of each dilution were spotted on the above overlaid 
plate and the plate incubated at 30ºC for 3 days until plaques were observed in the spot 
zones. The plaques on every spot were counted and the amount of plaque forming units 
(PFU) per ml of phage suspension was calculated. Phages were overlaid in triplicate on 
7H9 agar basal plates with top agar containing 500 µl actively growing M. smegmatis 
culture giving approximately 1000 plaques per plate, incubation at 30ºC until plaques 
displayed the typical lysis pattern. Each plate was soaked with 4ml of MP buffer and 
incubated at room temperature for 5 h (or overnight at 4°C).  The suspension containing 
the bacterial debris and phages was taken, filtered using a 0.22 µm PVDF filter, the filtrate 
containing a high density of phage particles was stored at 4°C until further use. Ideal titre 
for transduction should have at least 1010 PFU per ml. 
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7.5.5 Specialized transduction 
 A 50 ml M. smegmatis culture was grown in TSB + 0.05% Tween-80 at 37ºC until 
OD A600 of 0.8 to 1. The culture was collected and cells were span down for 15 min at 
4,000 rpm. The pellet was resuspended in 5 ml of MP buffer obtaining an even consistency 
and 45 ml of buffer were added and mixed well. Cells were washed twice following the 
same way. Finally, the cells were resuspended in 5 ml of MP buffer and 1 ml of cell 
suspension was mixed with 1 ml high titre knockout-phage lysate. A negative control 
reaction was set using only 1 ml of MP buffer and cells suspension. Reactions were 
incubated at 37ºC (non-permissive temperature for phage replication) for 1 h to allow 
infection. Tubes were centrifuged for 15 min at 4,000 rpm, supernatants were decanted, 
and the pellet resuspended in 3 ml of TSB + 0.05% Tween-80 and incubated for 3 h at 
37ºC. After incubation, the pellet was collected anresuspended in 400 µl of TSB + 0.05% 
Tween-80 and 100 µl spread on each TSB-agar plate containing 100 µg/ml hygromycin 
and incubated at 37ºC until transductants colonies appeared. Selected colonies were 
verified by Southern blot. 
 
7.6  Southern blot analysis 
 Gene knock-out mutant strains were confirmed by Southern blot analysis using 
digested genomic DNA, appropriate restriction enzymes and DIG-High Prime (ROCHE) 
labelled probes. Basically, a selected restriction enzyme was used to digest genomic DNA 
from wild-type and mutant M. smegmatis strains and the digested DNA was separated by 
agarose gel electrophoresis producing a laddering effect. Each mutant showed a different 
digestion pattern compared to the wild-type (due to the hygromycin cassette incorporated) 
and PCR products of approximately 1 kb of the flanking regions were used as probes. 
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 The agarose gel containing digested DNA was depurinated with 0.25 M HCl, for 
15min, denatured with a solution containing 1.5 M NaCl and 0.5 M NaOH for 15 min and 
finally neutralised with 0.5 Tris/Cl, 1 M NaCl, pH 7.2. The DNA contained by the gel was 
transferred to positively charged nitrocellulose membrane via capillary action with 20 x 
SSC (3 M NaCl, 0.3 M sodium citrate, pH 7.0), the DNA on membrane was then 
covalently bound by UV-crosslinking for 3 min. The membrane was finally rinsed with 
distilled water. 
 The probe was prepared by boiling, snap chilling ad labelled with digoxigenin-
dUTP, using the DIG High Prime DNA labelling and Detection Start Kit (Roche), as 
described in the manual. Meanwhile, the membrane was washed at 42ºC in 10 ml of DIG 
Easy Hyb granules solution for 30 min, the probe was added into the hybridisation bottle 
and then incubated overnight at 65ºC. After the hibridisation, the membrane was washed, 
the probe immunodetected with the antibody and visualized with the chemiluminescence 
as follows: 
- 50 ml (2xSSC + 0.1% SDS). 5 min at 25ºC. Two times 
- 50 ml (0.5 xSSC + 0.1% SDS). 15 min at 65ºC. Two times 
- 50 ml Washing Buffer: Maleic Acid Buffer (0.1 M maleic acid, 0.15 M NaCl, pH 7.5) + 
0.3% v/v Tween-20. 5 min at 25ºC 
- 10 ml Blocking Buffer: 9 ml MAB + 1 ml Blocking Solution. 30 min at 25ºC 
- 10 ml Antibody Solution: 10 ml Blocking Buffer + 1 µl Anti-DIG-AP. 30 min at  25ºC 
- 50 ml Washing Buffer. 15 min at 25ºC. Two times 
- 20 ml Detection Buffer: 0.1 M Tris/Cl, 0.1 M NaCl, pH 9.5. 5 min at 25ºC 
 Finally, the membrane was exposed to CSPD ready-to-use reagent, incubated for 
15 min at 37ºC and exposed to Kodak X-Omat film for 5-10 min. 
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7.7  M. smegmatis lipid extraction 
 M. smegmatis [14C]-labelled polar and non-polar lipids were extracted using the 
methods described by Dobson et al (1985), 10 ml of M. smegmatis cultures were labelled 
during mid-log phase with 50 µCi/ml [14C] acetate, followed by overnight incubation. 
Firstly, the [14C]-labelled cells were collected by centrifugation, a d dried by aeration; later 
cells were mixed with 2 ml of CH3OH/0.3% NaCl (100:10, v/v) and 1ml of petroleum 
ether (b.p. 60-80°C) for 15 min. The mix was centrifuged and the upper layer was collected 
to add 1 ml of petroleum ether to the lower fraction, the suspension was mixed and 
centrifuged again as previously indicated and the upper layer collected again.  
 Both upper layers containing the non-polar lipids were combined, dried and 
dissolved in 200 µl of CHCl3/CH3OH (2:1, v/v), then 5 µl sample were collected in a 
scintillation vial, dried and then mixed with 5 ml scintillation liquid for radioactivity 
measurement.  
 The polar lipids were extracted by adding 2.3 ml of CHCl3/CH3OH/0.3% NaCl 
(90:100:30, v/v/v) to the lower aqueous fraction remaining, the mixture was mixed for 1 h, 
centrifuged and stored after removing the supernatant. The step was repeated by adding 
0.75 ml of CHCl3/CH3OH/0·3% NaCl (50: 100: 40, v/v/v) and mixing for 30 min. 
Delipidated cells were kept for further analysis.  
 A volume of 26 ml of CHCl3/0.3 % NaCl (1:1, v/v) was added to the collected 
supernatants, mixed for 5 min, centrifuged, the lower fraction recovered and dried out. The 
polar lipids were dissolved in 200 µl of CHCl3/CH3OH (2:1, v/v), a 5 µl sample was dried 
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7.8   Thin layer chromatography (TLC) analysis for M. smegmatis lipids 
 Apolar and polar M. smegmatis lipid extracts were analysed by two-dimensional 
thin layer chromatography (2D-TLC). Apolar lipids were analysed using four different 
solvent systems (A–D) and polar lipids by two different systems (D and E) according to 
Dobson et al. (1985). Equal amounts of radioactive counts (20,00  cpm) of each lipid 
sample were spotted on TLC plates (5554 silica gel 60F524, Merck) for consecutive 1D- 
and 2D-TLC analysis using following solution systems and allowing plates to dry between 
each run. Finally, [14C]-labelled lipids were revealed by overnight exposure to Kodak X-
Omat AR film. 
 
Table 7.1: Solvent systems for 2D-TLC lipid analysi 
 
System Direction 1 Runs 
A Petroleum ether 60-80 / Ethyl acetate (98:2) 3 
B Petroleum ether 60-80 / Acetone (92:8) 3 
C Chloroform / Methanol (96:4) 1 
D Chloroform / Methanol / Water (100:14:0.8) 1 
E Chloroform / Methanol / Water (60:30:6) 1 
 
System Direction 2 Runs 
A Petroleum ether 60-80 / Acetone (98:2) 1 
B Toluene / Acetone (95:5) 1 
C Toluene / Acetone  (80:20) 1 
D Chloroform / Acetone/ Methanol / Water (50:60:2.5:3) 1 
E Chloroform / Acetic acid (glacial) / Methanol / Water (40:25:3:6) 1 
 
 
7.9 Generation of M. smegmatis conditional mutants by CESTET (conditional 
 expression–specialized transduction essentiality test) 
 CESTET consists in obtain a merodiploid strain which contains a second copy of a 
putative essential gene (peg) controlled by the acetamidase promoter (Bhatt and Jacobs, 
2009). The general protocol used in this study was cloning the acetamidase promoter and 
the selected gene into a single-copy integrating vector, namely pMV306, which contains a 
gene encoding the mycobacteriophage L5 integrase (int), an attachment site (attP), a 
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kanamycin resistance cassette and that replicates as a plasmid in E. coli. When 
electroporated into mycobacteria, pMV306 integrates in the bacterial chromosome 
integration site (attB) as a single copy.  
 At the same time, a specialized transducing phage (ph∆peg) containing an allelic 
exchange substrate was designed to replace the targt gene by infecting the merodiploid 
strain. If the gene was essential, the ability to obtain transductants was dependent on the 
acetamidase-driven expression of the gene, obtaining transductants only on plates with 
acetamide.  
 In first place, peg was cloned downstream of the acetamidase promoter in the 
mycobacterial expression plasmid pSD26, the continuous fragment containing the 
acetamidase promoter and peg was then cloned into pMV306. The open reading frame 
(ORF) for peg was possible to be cloned into the corresponding sites of pSD26. The entire 
fragment was then cloned in pMV306.  
 Secondly, pMV306-Pacpeg was then introduced into M. smegmatis mc
2155 by 
electroporation and the transformants were selected with 20 µg/mL kanamycin. The 
resistant merodiploid colonies were inoculated into 5 mL TSB cultures containing 0.05% 
Tween-80 and 20 µg/mL kanamycin, grown by shaking at 37ºC until OD600 reaches 
between 0.8 to 1, mixed with 1:1 (v/v) sterile 50% glycerol and stored at -80ºC.  
 Finally, the merodiploids were used for generating a knock-out mutant by 
specialised transduction using the ph∆ eg. Once finished, bacterial suspensions were split 
into equal parts and spread each on TSB-agar plates containing kanamycin and 
hygromycin and TSB-agar plates containing kanamycin, hygromycin, and acetamide. 
Plates were incubated the plates at 37ºC for 3 days before scoring for colonies. The 
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criterion behind the technique is: if hygR and kanR colonies are obtained only in the 
presence of acetamide in the plates, then the targeted ne is essential for growth. 
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